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Previous studies have identified several genes important in rod genesis, however, 
there is little information on how these genes are regulated during development.  The purpose 
of this dissertation is to identify and investigate factors influencing rod photoreceptor 
differentiation.  Using high throughput gene and protein expression data we have identified 
several factors as good candidates for involvement in rod photoreceptor development.  We 
are specifically investigating insulin-like growth factor 1 (IGF-1) and how it affects the 
molecular network controlling rod photoreceptor differentiation. 
 IGF-1 is a growth factor present in the developing retina and has previously been 
shown to influence proliferation, differentiation, and survival of retinal neurons.  We 
characterized IGF-1 receptor expression in developing and mature rod photoreceptors using 
immunohistochemical methods.  IGF-1 receptor immunoreactivity was detected in the outer 
neuroblastic layer in the embryonic retina and in developing and mature rods in postnatal and 
adult mice.  Using a serum free retinal explant culture system we have investigated the 
effects of long term exposure to IGF-1 on E17 and P0 mouse retinas.  Application of 
exogenous IGF-1 significantly increased rhodopsin expression at both time points.  Thus we 
have demonstrated a specific role for IGF-1 in promoting rod photoreceptor differentiation.  
In addition we have shown that IGF-1 acts through a MAP kinase independent pathway to 
mediate the increase in rods.  Our studies are the first to demonstrate a role for IGF-1 in rod 
photoreceptor differentiation in the murine retina.             
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Rod photoreceptors make up approximately 70% of all the cells in the vertebrate 
retina.  Retinal diseases involving degeneration of photoreceptors result in loss of vision, as 
retinal neurons do not regenerate.  In the United States these diseases are expected to become 
an increasing cause of blindness as our population ages.  One such disease, age related 
macular degeneration, currently affects more than 1.75 million people in the US over the age 
of 40 but this number is expected to increase to nearly 3 million people by the year 2020 
(Friedman et al., 2004).  Stem cell transplantation is being pursued as a potential therapy for 
replacing lost photoreceptors.  Directing transplanted cells to differentiate into 
photoreceptors remains a major challenge in advancing transplantation therapy in the retina.  
Recent experimental evidence suggests that transplanting cells into the retina that have 
already been biased towards a rod photoreceptor fate may be much more successful then 
transplantation of less specified cells in terms of integration and differentiation leading to 
functionality (MacLaren et al., 2006).  Currently a small number of molecules are known to 
be important for rod photoreceptor development.  Many of these are transcription factors 
which act to regulate expression of molecules involved in phototransduction (Pittler et al., 
2004; Cheng et al., 2004).  Defining the molecular network controlling rod differentiation 
and the extracellular factors acting on this network may make it possible to bias the fates of 
expanded stem cell populations.   
One extracellular factor that may be promising is insulin-like growth factor 1 (IGF-1).  
IGF-1 has been shown to promote retinal cell growth, proliferation, differentiation and 
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survival and more specifically rod differentiation, maturation and survival ( Calvaruso et al., 
1996; Mack and Fernald, 1993; Yadav et al., 2005).  How IGF-1 affects rod development is 
not known.  The main hypothesis of this dissertation is that IGF-1 signaling influences rod 
photoreceptor genesis and differentiation by acting on the molecular network that controls 
rod development. 
Dissertation organization 
This dissertation is organized into four chapters.  The first chapter includes a general 
introduction and literature review.  Chapter two is a manuscript in preparation investigating 
the effects of IGF-1 on rod photoreceptor differentiation which will be submitted for 
publication.  The third chapter is a manuscript investigating the use of a seed network to 
query large scale expression data and is prepared for submission to BMC Systems Biology.  
Chapter four is a general discussion of the results with concluding remarks and directions for 




Anatomy and histology of the mammalian retina 
The retina is a highly structured tissue with a precise laminar organization consisting 
of three nuclear or cellular layers which house five distinct retinal cell types separated by two 
synaptic layers (Dowling, 1987).  The two types of sensory cells in the outermost layer of the 
retina are the rod and cone photoreceptors.  Photons of light are absorbed by the 
photoreceptors and the signal is transduced and propagated towards the inner retina.  The 
photoreceptor cell bodies are housed in the outermost cellular layer known as the outer 
nuclear layer (ONL).  Photoreceptors have specialized structures called outer segments which 
 3 
are made up of stacks of membranous discs containing the molecules involved in 
phototransduction (Carter-Dawson and LaVail, 1979).  Rod photoreceptors are extremely 
sensitive and function in low light vision while cones are differentially sensitive to specific 
wavelengths of light. Photoreceptors form synaptic connections with bipolar cells in the outer 
plexiform layer (OPL).  The cell bodies of the bipolar cells are found in the inner nuclear 
layer (INL).  The last cell type in the direct pathway responsible for transmitting visual 
signals in the retina is the retinal ganglion cell.  The innermost layer, the retinal ganglion cell 
layer, contains the ganglion cell bodies which project their axons to the brain as the optic 
nerve.  The synaptic connections between the bipolar cells and ganglion cells are located in 
the inner plexiform layer (IPL).  The last two neuronal cell types in the retina are the 
horizontal and amacrine cells.  These cells are located in the INL and mediate lateral 
interactions by forming synaptic connections in the OPL and IPL respectively (Dowling, 
1987).  The principal glial cell type in the retina is the Müller cell.  The cell bodies of the 
Müller glia are located in the INL with their processes projecting radially, spanning the 
thickness of the retina.  The junctions among Müller glial cells and between Müller glia and 
photoreceptors make up the outer limiting membrane at the base of the inner segments.  The 
endfeet of the Müller glia on the vitreal surface of the retina form the inner limiting 
membrane of the retina.  Astrocytes are located in the nerve fiber layer of the retina.  These 
cells are not generated from the neural retinal epithelium but migrate along the optic nerve 








The neural retina forms from cells in the anterior neural plate which evaginate to form 
the optic vesicle.  Contact of the neural ectoderm of the optic vesicle with the surface 
ectoderm induces formation of the lens placode and causes the optic vesicle to begin to 
invaginate to form the bilayered optic cup.  The proximal layer of the cup forms the 
pigmented epithelium while the distal layer forms the neural retina (Chow and Lang, 2001).  
Development of the neural retina occurs in a central to peripheral gradient.  The retina 
thickens as progenitor cells continue to divide throughout the embryonic period, until 
approximately postnatal day 11 in the mouse retina (Young, 1985a).   
During development the seven major cell types in the retina are generated from a 
multipotent retinal progenitor pool.  It has been demonstrated from lineage studies that 
multiple retinal cell types are generated from a single retinal progenitor cell (Turner and 
Cepko, 1987).  The cells are born or exit the cell cycle in a characteristic yet overlapping 
order with certain cell types such as cone photoreceptors and ganglion cells being born early 
in retinal development and others such as bipolar cells, rod photoreceptors, and Müller glia 
being born late (Young, 1985b; Livesey and Cepko, 2001).   
Factors influencing the cell fate choices of the progenitor cell progeny include both 
intrinsic and extrinsic cues (Watanabe and Raff, 1990, 1992).  Retinal progenitors are 
believed to pass through a series of intrinsically regulated competency states during which 
time the progenitors only give rise to a subset of cell types (Cepko et al., 1996).  Extrinsic 
factors also play a role in specification of retinal cell types, but they work within the confines 
of the competency states specified by intrinsic cues.  Progenitors from an early retina do not 
generate late born cell types and a late progenitor is not competent to differentiate into an 
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early born cell type when placed in the environment of the early retina (Belliveau et al., 
2000).  Thus environmental signals only alter the relative percentages of cells born within a 
certain time period but do not change the time at which a particular cell type is born 
(Belliveau et al., 2000). 
The cell types in the retina are generated in specific numbers through the coordination 
of proliferation, cell fate determination, differentiation, and apoptosis.  Mitotically active 
cells in the retina migrate between the vitreal surface during S-phase to the outer retina where 
they undergo mitosis at the scleral surface.  Proliferation of retinal progenitors can be 
influenced by extrinsic factors including TGF-alpha, EGF, FGF, and IGF-1 (Lillien and 
Cepko, 1992; Hernandez-Sanchez et al., 1995; Close et al., 2006).  In general these mitogenic 
factors upregulate D-cyclins which activate cyclin dependent kinases (cdk4/6).  Cyclin D1 is 
the most prevalent D-cyclin expressed in retinal progenitor cells and is important for cell 
cycle progression as Cyclin D1 knockout retinas have decreased cell numbers (Sicinski et al., 
1995; Ma et al., 1998).  Cdk proteins act to phosphorylate and inactivate the retinoblastoma 
protein Rb.  Cdk’s are inhibited by cyclin dependent kinase inhibitors such as p27Kip1 and 
p57Kip2.  Both p27Kip1 and p57Kip2 regulate retinal progenitor cell cycle withdrawal (Dyer 
and Cepko, 2000; Levine et al., 2000) and it has been shown that these cyclin dependent 
kinase inhibitors are differentially expressed in retinal progenitors (Dyer and Cepko, 2001).    
Apoptosis or programmed cell death occurs as a normal process in retinal 
development and may serve to regulate the number of retinal cell types and to fine-tune 
neuronal circuits (Young, 1984; Vecino et al., 2004).  Physiological apoptosis generally 
occurs in phases during vertebrate retinal development however the timing and number of 
phases differs among species (Young, 1984; Georges et al., 1999; Biehlmaier et al., 2001; 
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Francisco-Morcillo et al., 2004).  In the mouse retina the majority of cell death occurs during 
the first two weeks of the postnatal period and physiological apoptosis is rarely observed 
after postnatal day 18 (Young, 1984).  Several factors have been shown to regulate apoptosis 
in the retina including neurotrophins (Frade et al., 1997; Frade et al., 1999), insulin (Diaz et 
al., 1999; Diaz et al., 2000), CNTF (Elliott et al., 2006), and transforming growth factor-beta 
(Duenker, 2005).  These factors control cell death through activation of signaling cascades, 
typically the Akt pathway in the case of anti-apoptotic factors or caspases for pro-apoptotic 
factors (Vecino et al., 2004).  
Rod photoreceptor development 
Rod photoreceptor development begins when a retinal progenitor cell completes a 
final division and exits the cell cycle.  In the mouse retina, the peak of rod birth occurs 
around postnatal day zero (Young, 1985b).  At the time a cell becomes postmitotic it is 
biased towards a cell type but it is not known exactly when the cells are committed to a rod 
fate.  The earliest known marker of cell fate determination in rods is Nrl which begins to be 
expressed soon after cell cycle exit (Akimoto et al., 2006).  Between the time that the rods 
begin expressing Nrl and the time that they reach phenotypic maturity as marked by 
expression of rhodopsin, the rod precursors go through a period when they are sensitive to 
ciliary neurotrophic factor (CNTF).  During this time CNTF can inhibit rhodopsin expression 
through the activation of the STAT3 pathway (Ezzeddine et al., 1997; Schulz-Key, 2002;  
Zhang, 2004).  Rhodopsin expression is a sign of phenotypic differentiation and the majority 
of rods begin expressing rhodopsin approximately 5.5-6.5 days after cell cycle exit (Morrow 
et al., 1998). 
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Intrinsic rod photoreceptor network 
Development of the seven major cell types in the retina is believed to be guided by 
both an intrinsic genetic program and the influence of extrinsic factors.  Several intrinsic 
factors involved in rod photoreceptor development have recently been described.  In general, 
factors influencing rod development can be grouped into those that promote continued 
proliferation of retinal progenitors and those that promote cell fate determination of rods.  
The Notch receptor and its ligand Delta have an established role as negative regulators of 
neurogenesis (Beatus and Lendahl, 1998).  In the retina, Notch signaling pathway genes are 
expressed in retinal progenitors (Bao and Cepko, 1997) where they are thought to be 
important in maintaining the retinal progenitor pool (Dorsky et al., 1995; Tomita et al., 1996; 
Henrique et al., 1997; Jadhav et al., 2006a).  Recent studies using Notch1 conditional 
knockout mice have revealed a specific role for Notch in inhibiting rod photoreceptor 
differentiation.  Deletion of Notch in the postnatal retina increases the percentage of rod 
photoreceptor cells while decreasing the percentage of bipolar and Müller cells (Jadhav et al., 
2006b).  The Hes family of genes are downstream effectors of Notch which function as 
repressors of neural basic helix-loop-helix transcription factors (Iso et al., 2003).  The Hes1 
and Hes5 family members have been shown to mediate the inhibitory effects of Notch on 
neuronal differentiation (Ohtsuka et al., 1999).  Rod photoreceptors differentiate prematurely 
in Hes1 knockout mice suggesting it is important for inhibiting acquisition of a rod fate 
(Tomita et al., 1996).   
Many of the factors known to be involved in promoting rod development are 
transcription factors that regulate rhodopsin expression.  Crx is a homeobox transcription 
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factor that can bind to and activate transcription of rhodopsin and other photoreceptor-
specific genes (Chen et al., 1997; Furukawa et al., 1997; Furukawa et al., 2002).  Crx 
expression in turn can be directly regulated by the related Otx homebox gene family member 
Otx2 (Nishida et al., 2003).  Crx expression can also be affected by the transcription factor 
Chx10 as mice with a mutant Chx10 allele show delayed expression of the gene (Rutherford 
et al., 2004).  Chx10 null retinas also show a reduction in the expression of the cell cycle 
protein Cyclin D1 (Green et al., 2003).  Cyclin D1 has been shown to be involved in retinal 
progenitor cell proliferation (Ma et al., 1998) and exerts its effects by activating cyclin-
dependent kinases 4 and 6.  These kinases can then phosphorylate the Rb protein which 
allows progression of the cell into S phase of the cell cycle (Weinberg, 1995).  Rb is known 
to affect the expression of the rod transcription factor Nrl as Rb null mice have reduced 
expression of Nrl (Zhang et al., 2004a).  Nrl is necessary for rod photoreceptor development 
(Mears et al., 2001) and regulates rhodopsin expression along with Crx and Nr2e3 (Cheng et 
al., 2004).  NeuroD is a transcription factor that is also able to bind rhodopsin and has been 
shown to be important in rod genesis (Ahmad et al., 1998b; Pennesi et al., 2003).   
Rod versus cone photoreceptor development 
Rod and cone photoreceptors are born at separate times during retinal development 
and have distinct biological functions.  However, a link between cell fate determination of 
rods and cones has been demonstrated in several studies (Chen et al., 2005; Oh et al., 2007).  
Rod and cone cell fate determination involves genes that act as both activators and repressors 
to regulate expression of rod and cone specific genes.  Two such genes, the orphan nuclear 
receptor Nr2e3 and thyroid hormone receptor beta, suppress S-cone gene expression while 
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promoting rod and M-cone gene expression respectively (Chen et al., 2005; Roberts et al., 
2006).  Genes specific to rod photoreceptors include Nrl, Nr2e3 and rhodopsin.  Nrl is a 
transcription factor expressed in rods and in the pineal gland.  The factors controlling Nrl 
expression and phosphorylation are not known.  Some studies have implicated retinoic acid 
and retinoic acid receptors as playing a role in regulation of Nrl expression but this is clearly 
not the only factor controlling its expression.  Nrl knockout mouse retinae lack rods but 
contain cells that resemble cones instead.  Recent evidence suggests cells fated to become 
cones can be redirected to a rod fate by misexpression of Nrl (Mears et al., 2001; Oh et al., 
2007).  In the absence of Nrl, cells fated to become rods take on what appears to be an S-
cone phenotype instead (Akimoto et al., 2006).  Thus it has been hypothesized that the 
default state for photoreceptors is the S-cone phenotype and Nrl acts to repress this fate while 
promoting a rod photoreceptor fate. 
Extrinsic factors implicated in rod photoreceptor development 
Extrinsic factors are believed to be important for guiding retinal progenitor cells 
towards a specific cell fate.  It has been demonstrated that cells from the early postnatal 
retina promote differentiation of retinal progenitor cells into rod photoreceptors by a 
diffusible factor or factors (Altshuler and Cepko, 1992; Watanabe and Raff, 1992).  Since 
these studies several factors have been identified as candidates for involvement in rod 
development.  These factors include those which have a stimulatory effect on rods and those 
that are inhibitory.    
One molecule which has been shown to stimulate rod development is the vitamin A 
derivative retinoic acid.  Retinoic acid (RA) is present in the retina beginning early in 
 10 
development (McCaffery et al., 1992).  Addition of RA to embryonic rat retinal cells has 
been shown to increase rod photoreceptor differentiation (Kelley et al., 1994).   
Taurine is another factor that has been shown to promote differentiation of rod 
photoreceptors in vitro.  Taurine was identified as a factor of retinal cell conditioned medium 
that stimulated rhodopsin expression in low density cell culture (Altshuler et al., 1993).  
Taurine is present in the retina during the time when rods are differenting (Lake, 1994) and 
recent evidence suggests it acts through glycine receptors to mediate the increase in rods 
(Young and Cepko, 2004).        
Basic fibroblast growth factor (bFGF or FGF2) has been shown to play an important 
role in proliferation and differentiation retinal neurons (Lillien and Cepko, 1992; Pittack et 
al., 1997; McFarlane et al., 1998).  In retinal explant culture bFGF accelerated the 
differentiation of retinal ganglion cells but did not have an effect on the differentiation of rod 
photoreceptors (Zhao and Barnstable, 1996).  There is some evidence that basic fibroblast 
growth factor increases rod photoreceptor differentiation in retinal cells isolated from 
newborn rats (Hicks and Courtois, 1992) and in a human retinal precursor cell lines (Ezeonu 
et al., 2000; Ezeonu et al., 2003).  However, FGF2 was not found to increase rod 
differentiation in E16 rat retinal explants (Zhao and Barnstable, 1996), suggesting retinal 
progenitors change in their response to basic fibroblast growth factor.  FGF2 also appears to 
induce transdifferentiation of retinal pigment epithelial cells into neural retina in Xenopus 
and chick (Pittack et al., 1991; Sakaguchi et al., 1997).   
Glial derived neurotrophic factor (GDNF) increased rod photoreceptor genesis in 
chicken retinal cultures (Rothermel and Layer, 2003) and in rat retinal cultures GDNF was 
shown to increase photoreceptor survival and differentiation along with docosahexaenoic 
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acid (Politi et al., 2001).  A subsequent study found that GDNF increased proliferation of 
photoreceptor precursors leading to the increase in rods (Insua et al., 2003).   
Epidermal growth factor receptor signaling plays an important role in Drosophila 
retinal development (Spencer et al., 1998; Yang and Baker, 2001) however, its role in 
mammalian retinal development in less well defined.  It has been shown that EGF receptor 
overexpression can alter retinal cell fate (Lillien, 1995) and that EGF signaling can delay rod 
photoreceptor differentiation (Ahmad et al., 1998a).   
Ciliary neurotrophic factor (CNTF) has been shown to have opposite effects on 
development of rod photoreceptors in chick and rodent retina in vitro (Kirsch et al., 1996).  
In embryonic day 8 chick retina CNTF increased rhodopsin expression in low density 
monolayer cultures (Fuhrmann et al., 1995).  In contrast, CNTF inhibited rod differentiation 
in postnatal rat retina (Ezzeddine et al., 1997; Kirsch et al., 1998).    
Insulin-like growth factor 1  
Insulin-like growth factor 1 (IGF-1) is a 70 amino acid polypeptide that is highly 
homologous to insulin (Rinderknecht and Humbel, 1978).  IGF-1 is secreted by the liver in 
response to growth hormone but is also synthesized in many other tissues including the 
nervous system (D'Ercole et al., 1984; Bartlett et al., 1991).  Circulating IGF-1 binds to the 
insulin-like growth factor binding proteins (IGFBPs) with high affinity.  Six forms of 
IGFBPs have been identified and act to prolong the half-life of IGF-1 and mediate their 
interaction with cell surface receptors (Kelley et al., 1996).  In vertebrates, IGF-1 is known to 
be important in somatic growth and cell survival but has also been shown to have effects on 
cell cycle progression, cell proliferation, and differentiation.  
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Insulin-like growth factor 1 signaling 
IGF-1 acts on cells by signaling through the IGF-1 receptor.  The IGF-1 receptor is a 
transmembrane tyrosine kinase composed of two alpha and two beta subunits.  The ligand 
binding domain is on the extracellular alpha subunit while the tyrosine kinase domain is on 
the transmembrane beta subunit.  Like the ligands themselves, the IGF-1 receptor is 
structurally homologous to the insulin receptor (Jones and Clemmons, 1995).  The IGF-1 
receptor can be activated by both IGF-I and IGF-II as well as insulin, however the affinity of 
the IGF-1 receptor for IGF-II and insulin is much lower than for its specific ligand (Germain-
Lee et al., 1992; Jones and Clemmons, 1995).  The specificity of the interaction between 
IGF-1 and its receptor appears to involve the cysteine-rich domain located in the IGF-1 
receptor alpha subunit (Schumacher et al., 1991).   
Binding of IGF-1 to its receptor results in autophosphorylation of the receptor beta-
subunits.  The cytoplasmic signal is propagated through the insulin receptor substrate (IRS) 
proteins which are phosphorylated at multiple sites by the activated IGF-1R (Myers et al., 
1993).  The two major signaling cascades that can be initiated by activation of the IRS 
protein are the phosphoinositol 3-kinase (PI3K) - Akt and mitogen activated protein kinase 
(MAPK) pathways (White, 2002).  However, the specific intracellular signaling pathways 
mediating the various cellular responses to IGF-1 are largely undefined.    
Pathways activated by IGF-1 
 
MAPK/ERK signaling pathway 
Initiation of the ERK cascade involves the activation of the Grb2 protein which forms 
a complex with the guanine nucleotide exchange factor son of sevenless (SOS) to activate 
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ras.  This activates the ras→raf→MEK→MAPK cascade which results in the 
phosphorylation of MAP kinase.  Activated MAPK can phosphorylate several transcription 
factors such as Elk1 and increase transcriptional activity (Shaw and Saxton, 2003).  The 
MAP kinase pathway has been implicated in the proliferative response to IGF-1 in certain 
cell types including myoblasts (Coolican et al., 1997) and adult hippocampal progenitor cells 
(Aberg et al., 2003).  Signaling through the MAPK pathway is also necessary for the neurite 
outgrowth seen upon IGF-1 stimulation of neuroblastoma cells (Kim et al., 1997).          
 
PI3K/Akt signaling pathway  
PI3-kinase is involved in the generation of 3-poly-phosphoinositides which attract 
phosphoinositide-dependent kinase (PDK) and Akt to the plasma membrane allowing PDK 
to phosphorylate Akt.  Once activated, Akt can phosphorylate several downstream target 
proteins involved in processes such as differentiation and survival (Alessi and Downes, 
1998).  The PI3K pathway has been shown to be involved in IGF-1 mediated differentiation 
and cell survival.  Inhibition of the PI3K pathway in myoblasts decreases differentiation 
induced by IGF-1 (Coolican et al., 1997).  In human neuroblastoma cells, inhibition of both 
the MAPK and PI3K pathways was necessary to inhibit IGF-1 mediated differentiation 
(Kurihara et al., 2000).  In fibroblasts exposed to UV-B light, IGF-1 promoted survival of the 
cells through a PI3K/Akt dependent mechanism (Kulik et al., 1997).  Signaling through IGF-
1 pathway components, specifically IRS2 and Akt, has also been shown to be important for 




TOR signaling pathway 
Mammalian target of rapamycin (mTOR) can also be activated by signaling through 
the IGF-1 receptor (Oldham and Hafen, 2003) and is involved in regulation of many cellular 
processes such as growth and proliferation.  The mTOR protein is a kinase known to form 
two distinct multi-protein complexes (Sarbassov et al., 2005b).  In one complex, mTOR 
binds to raptor and is sensitive to rapamycin treatment.  The other complex contains mTOR 
bound to the rictor protein, rendering the complex insensitive to rapamycin (Sarbassov et al., 
2004).  Known effectors of the mTOR-raptor complex include proteins p70S6K and 4E-BP1 
which are involved in mRNA translation (Hara et al., 2002).  The mTOR-rictor complex 
appears to control pathways distinct from those controlled by the raptor complex such as the 
Akt and PKCα pathways to regulate cell proliferation and survival (Sarbassov et al., 2005a).  
A direct involvement of mTOR signaling in mammalian rod photoreceptor development has 
not been shown but the TOR pathway has been shown to play a role in the timing of 
Drosophila photoreceptor differentiation (Bateman and McNeill, 2004).   
 
JAK-STAT signaling pathway  
For many years activation of the Janus kinase (JAK)- signal transducer and activator 
of transcription (STAT) pathway was thought to be specific to cytokine receptors but recent 
studies demonstrate activation of JAK-STAT signaling by several tyrosine kinases including 
the IGF-1 receptor (Ihle, 1996; Zong et al., 2000; Yadav et al., 2005).  STAT proteins are 
phosphorylated on tyrosine residues by JAKs.  Activated STATs form dimers and translocate 
to the nucleus where they act as transcriptional regulators (Darnell, 1997).  The JAK-STAT 
signaling pathway has been studied in the retina for its involvement in inhibiting rhodopsin 
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expression.  Specifically, ciliary neurotrophic factor (CNTF) is known to inhibit rhodopsin 
expression by activation of STAT3 (Zhang et al., 2004b).  The phosphorylated STAT3 
present in the outer neuroblastic layer in the late embryonic retina is downregulated at P0 
(Ozawa et al., 2004) when rod genesis peaks.  JAK-STAT signaling is negatively regulated 
by members of the suppressor of cytokine signaling (SOCS) family (Starr and Hilton, 1999).  
SOCS3, an inhibitor of STAT3 activation, was recently shown to be important for 
downregulation of activated STAT3 in the retina.  In this study, SOCS3 deficiency caused 
increased STAT3 activation and a delay in rhodopsin expression (Ozawa et al., 2007).  A 
possible regulator of SOCS3 in the retina is IGF-1 since SOCS3 is known to bind to and 
become activated by the IGF-1 receptor upon ligand binding (Dey et al., 2000).  
 
Expression of IGF-1 and the IGF-1 receptor in the retina 
IGF-1 mRNA is expressed throughout retinal development in the chick, with peak 








 day) in embryogenesis (Calvaruso et 
al., 1996).  In the rat retina, IGF-1 mRNA is expressed in the ganglion cell layer later in 
retinal development (Lee et al., 1992).   
In addition to IGF-1, IGF-1 signaling components including the IGF-1 receptor, IGF 
binding proteins (IGFBPs), and insulin receptor substrate (IRS) proteins have been shown to 
be expressed in the retina.  In the chicken retina, the presence of IGF-1 receptor mRNA is 
widespread in both early and late stages of embryogenesis (de la Rosa et al., 1994; 
Hernandez-Sanchez et al., 1995).  In the retina of adult goldfish autoradiography experiments 
have revealed the presence of IGF-1 receptors in the inner plexiform layer and 
circumferential germinal zone (Boucher and Hitchcock, 1998a).  The IGF-1 receptor is also 
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present in bovine rod outer segments although IGF-1 binds to ROS at a level significantly 
lower than mixtures of rod inner and outer segments and preparations of whole retina (Zick 
et al., 1987; Waldbillig et al., 1988). 
 
Effects of IGF-1 in the retina 
Insulin-like growth factor 1 is known to be important for proliferation, differentiation, 
and survival of retinal neurons.  Application of exogenous IGF-1 to chick retinal explants has 
been shown to cause an increase in proliferation and differentiation of neurons (Hernandez-
Sanchez et al., 1995; Calvaruso et al., 1996) and was shown to induce neuronal 
differentiation of neuroepithelial cells (Frade et al., 1996).  IGF-1 also has a stimulatory 
effect on proliferation of rod precursor cells in the teleost retina (Mack and Fernald, 1993) 
and on retinal progenitors within the circumferential germinal zone of mature goldfish 
(Boucher and Hitchcock, 1998b).  IGF-1 has also been shown to have an important role in 
survival of retinal neurons.  The IRS-2 protein has been shown to play a role in photoreceptor 
maturation and survival in mice as IRS-2 knockout mice have shortened outer segments and 
extensive loss of neurons in the outer nuclear layer (Yi et al., 2005).  Recently it was 
demonstrated that STAT3 is activated in neurons in response to IGF-1 and may play a role in 
cell survival (Yadav et al., 2005).   
     
High throughput expression data 
Genomic and proteomic profiling studies provide a catalog of the genes or proteins 
that are expressed in a cell under a given condition.  Tools for capturing information about 
the expression levels of genes or proteins include microarray (Schena et al., 1995), serial 
analysis of gene expression (Velculescu et al., 1995), and 2-dimensional gel electrophoresis 
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used in conjunction with mass spectrometry (Gorg et al., 2005).  The data generated from 
these studies provides information about a cell on a molecular level.       
Gene expression profiling using these techniques is a relatively quick and cost 
effective means of gathering a large amount of data about 1000s of genes under several 
conditions.  Obtaining of the protein profile of a cell is more difficult than the gene 
expression profile because protein cannot be amplified and identification of the proteins must 
be carried out for each individual protein because the identities and the location of the protein 
spots cannot be predetermined as it can in microarray experiments.  However, there are some 
advantages of measuring protein expression in cells.  It is not uncommon to have low 
correlation between mRNA and protein expression levels (Gygi et al., 1999; Greenbaum et 
al., 2003; Washburn et al., 2003; Nissom et al., 2006), making it impossible to know if gene 
expression changes are an accurate reflection of the protein product present in the cell.  In 
addition, post-translational modifications can only be captured by identifying the final 
protein products present in a cell.            
 
High throughput expression studies of the retina  
Several large scale gene expression studies characterizing to molecular profile of the 
retina have been carried out in an attempt to identify genes important in retinal development.  
Studies characterizing mRNA expression in normal retinal development include microarray 
datasets of whole retina (Dorrell et al., 2004; Liu et al., 2006; Zhang et al., 2006) and serial 
analysis of gene expression (SAGE) datasets (Blackshaw et al., 2001; Blackshaw et al., 
2004).  More targeted studies of gene expression in specific retinal cell types, specifically in 
retinal progenitor cells (Livesey et al., 2004), developing rod progenitors (Akimoto et al., 
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2006) and retinal ganglion and amacrine cells (Trimarchi et al., 2007) have recently been 
done.  Retinal expression profiles of several mutant mice have also been characterized 
including a conditional retinoblastoma knockout (Zhang et al., 2004a), Crx knockout 
(Livesey et al., 2000), Nrl knockout (Yoshida et al., 2004), and Math5 (Mu et al., 2005) and 
Brn3b knockouts (Mu et al., 2004).   
There are also studies characterizing the protein expression profile of the developing 
retina, although they are far less numerous than retinal gene expression studies.  These 
proteomic studies include profiles of whole retina in postnatal mouse and chick (Haniu et al., 
2006; Lam et al., 2006) as well as embryonic and postnatal mouse (Barnhill et al., manuscript 
in preparation).   
 
Analysis of high throughput expression data 
Many bioinformatics tools have been developed to aid in analysis of large scale 
expression data.  One of the most basic approaches to analyzing high throughput data is to 
identify significant changes in a genes’ expression level over all experimental conditions 
measured.  Significance can be assessed using variations of standard statistical tests that have 
been adapted specifically for microarray or proteomic data (Tusher et al., 2001; Listgarten 
and Emili, 2005).  Pattern discovery can be used as a means of simplifying a data set.  Genes 
are often clustered based on their expression profiles in an attempt to identify structure within 
the data without using information outside of the data itself.  Genes that display similar 
patterns of expression over time indicate possible interactions while genes that show no 
correlation with each other are less likely to influence each other or be co-regulated.  There 
are several different clustering methods that can be used (Datta and Datta, 2006; Thalamuthu 
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et al., 2006) based on the type of data to be analyzed and the biological questions being 
addressed.  Commonly used clustering methods are those that use hierarchical or partitioning 
algorithms.  An analysis of time-series data can be further focused by incorporating 
information about the biologically relevant events occurring over the measured time points 
(Zhang et al., 2006).  For example a group of genes that show increased expression from 
postnatal day 0 to postnatal day 5 in the mouse retina would be implicated in rod 
differentiation which occurs over that time span. 
Another level of high throughput data analysis is the reconstruction of pathways or 
networks from gene expression data.  From a mathematical standpoint most microarray 
studies do not capture enough information to extract biologically meaningful relationships 
among genes.  More measurements of a gene under several conditions is needed to 
strengthen the analysis but collecting measurements of gene expression under many 
conditions is generally not feasible in high throughput studies.  Several strategies have been 
employed in an attempt to focus analyses of large scale expression studies.  Expression 
measurements from several datasets can be combined in an attempt to increase the robustness 
of the analysis.  Several studies have found that combining datasets can help to more 
accurately identify true genes of interest (Stevens and Doerge, 2005; Warnat et al., 2005; 
Conlon et al., 2006).   
Another approach to analyzing high throughput data is to decrease the number of 
genes analyzed.  This can be done using a seed network to query datasets (Bader, 2003; 
Cabusora et al., 2005).  A seed network is composed of genes that are known to interact in a 
specific biological process.  This allows the analysis to be narrowed only to the correlations 
between the genes in the seed network with the genes in the dataset rather than all possible 
 20 
pairs of correlations.  Genes in the expression dataset that are highly correlated with multiple 
seed network members are good candidates for addition to the existing defined network.  
Further analysis of a list of genes highly correlated with a seed network can be done 
by looking for highly represented classes of genes.  Genes can be classified by their 
biological process, cellular location, and molecular function.  This information has been 
organized by the gene ontology (GO) project (Ashburner et al., 2000) which provides 
consistent annotation of genes.  Databases such as the Kyoto Encylopedia of genes and 
genomes (KEGG; http://www.genome.jp/kegg) (Kanehisa and Goto, 2000) provide 
information about the molecular networks known to be involved in specific metabolic and 
cellular processes.  Use of this information pertaining to the genes identified as relevant to 
specific biological processes such as rod photoreceptor development in high throughput 
studies can provide new information on potentially relevant biological pathways involved in 
the process.       
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The molecular network controlling rod photoreceptor genesis and differentiation is 
largely unknown.  Previous studies have identified a number of genes important for 
regulating rod development but information on regulation of these genes is limited.  Very 
few molecules are known to increase rod photoreceptor differentiation and little is known 
about the mechanisms by which these factors influence the process.  Insulin-like growth 
factor is an attractive candidate for further study for its role in rod photoreceptor 
development as it has been shown to have effects on proliferation, differentiation and 
survival of retinal neurons.   
We have shown that an important component of IGF-1 signaling, the IGF-1 receptor, 
is present in developing and mature rod photoreceptors.  Using a serum free explant culture 
system we have shown that IGF-1 significantly increases rod differentiation in E17 and P0 
mouse retina.  IGF-1 does not appear to act through the MAP kinase pathway to promote rod 
differentiation as inhibition of MEK did not block the increase in rhodopsin expression 
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caused by treatment of explants with IGF-1.  This study is the first to demonstrate a role for 




Development of the seven major cell types in the retina is believed to be guided by 
both an intrinsic genetic program and the influence of factors extrinsic to the cell (Livesey 
and Cepko, 2001).  All the cell types arise from a pool of progenitors which are believed to 
pass through various competency states during development producing only a certain subset 
of cell types at a given time period during development (Cepko et al., 1996).  The majority of 
cells in the retina are rod photoreceptors whose genesis peaks relatively late in development, 
coinciding with the day of birth in mice (Young, 1985).  Many retinal dystrophies result from 
the degeneration of rod photoreceptors and lead to irreversible loss of vision.  
Transplantation of neural progenitor cells is being investigated as a potential therapy for 
replacing lost photoreceptors.  Successful integration and maturation of transplanted cells has 
been limited.  However, recent transplantation studies using post-mitotic rod precursors have 
shown significant promise for replacing lost photoreceptors as they were able to differentiate 
and fully integrate into the damaged retina (MacLaren et al., 2006).  Identifying extrinsic 
factors that promote rod differentiation may allow retinal progenitors to be biased towards a 
rod precursor fate, making transplantation of expanded retinal progenitor cells a feasible 
therapy.   
Environmental factors shown to promote rod photoreceptor differentiation include 
retinoic acid, taurine, and fibroblast growth factor (Altshuler et al., 1993; Hicks and Courtois, 
1992; Hyatt et al., 1996; Kelley et al., 1994).  Insulin-like growth factor 1 (IGF-1) is also an 
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attractive candidate for further investigation as a stimulatory factor for rod photoreceptor 
development.  IGF-1 is endogenously expressed in the retina and previous studies have 
indicated a role for the molecule in proliferation, differentiation and survival of retinal 
neurons (Bergman et al., 2005; Calvaruso et al., 1996; Hernandez-Sanchez et al., 1995). 
IGF-1 signals through the IGF-1 receptor (IGF-1R) which binds to its ligand with 
high affinity.  The IGF-1R is a heterotetramer tyrosine kinase receptor that is structurally 
homologous to the insulin receptor (Jones and Clemmons, 1995).  The cytoplasmic signal is 
propagated through the insulin receptor substrate (IRS) proteins which are phosphorylated at 
multiple sites by the activated IGF-1R (Myers et al., 1993).  The two major signaling 
cascades activated by the IRS protein are the PI3-kinase/Akt and ERK (MAPK) pathways 
(Jones and Clemmons, 1995).   
In this study we investigated IGF-1 receptor expression in the developing retina and 
the role of IGF-1 during murine rod development.  We found that the IGF-1 receptor was 
expressed in the developing retina including developing rod photoreceptors.  Exogenous 
IGF-1 applied to retinal explants was found to promote rod photoreceptor differentiation in 
embryonic day 17 and postnatal day 0 explants independent of MAP kinase activation.  This 
is the first demonstration of a role for IGF-1 in promoting rod photoreceptor differentiation in 
the mammalian retina.   
 




C57BL/6 and Nrl-GFP mice were obtained from a colony maintained at Iowa State 
University.  The gestational period of C57BL/6 mice is approximately 19 days and date of 
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birth is designated as postnatal day 0 (P0).  The developmental time series investigated 
included pups from embryonic days 15 and 17 and postnatal days 0, 5, and 10 as well as 
adult mice.  Mice ages E15 to P5 were euthanized and their heads were removed and 
immersion fixed in 4% paraformaldehyde in 0.1 M PO4 buffer (pH 7.5).  Postnatal day 10 
and adult mice were euthanized and their globes were immersion fixed in 4% 
paraformaldehyde.  The tissue was cryoprotected in a 30% sucrose solution in 0.1 M PO4 
buffer (pH 7.4) and embedded in OCT mounting media (Richard-Allan Scientific, 
Kalamazoo, MI).  Tissue was sectioned at a thickness of 20 µm on a cryostat and the sections 
were thaw-mounted onto microscope slides and stored at -20ºC.  All animal procedures had 
the approval of the ISU committee on animal care and were conducted in accordance with 




All primary antibodies were diluted in potassium phosphate buffered saline (KPBS; 
0.15 M NaCl, 0.034 M K2HPO4, 0.017 M KH2PO4, pH 7.4) containing 1% bovine serum 
albumin (BSA; Fisher, Pittsburgh, PA), 0.4% Triton-X 100, and 1.5% normal donkey serum 
(NDS; Jackson ImmunoResearch Laboratory, West Grove, PA).  Rabbit polyclonal anti-IGF-
1 receptor antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was diluted 1:50.  Mouse 
monoclonal anti-rhodopsin antibody (a generous gift from Dr. Colin Barnstable, Yale 
University) was diluted 1:250.  Rabbit polyclonal anti-PKC-alpha and anti-gluatamine 
synthetase antibodies (Sigma, Saint Louis, MO) were diluted 1:10,000.  The fluorescent 
secondary antibodies Alexa Fluor® 594 donkey-anti mouse and Alexa Fluor® 488 donkey-
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anti rabbit (Molecular Probes, Eugene, OR) were diluted 1:500.  Secondary antibodies were 




Frozen tissue sections were rinsed in 0.5M KPBS and incubated in blocking solution 
consisting of KPBS containing 1% BSA, 0.4% Triton-X 100 (Sigma), and 1.5% NDS for two 
hours.  Cells were incubated in primary antibody overnight at 4ºC.  The following day slides 
(tissue or cells) were washed in KPBS containing 0.02% Triton-X 100 after which 
fluorescent secondary antibody was applied for two hours.  After washes in KPBS containing 
0.02% Triton-X 100, the slides were incubated in 300 µM 4',6-diamidino-2-phenylindole 
(DAPI) diluted in KPBS.  The slides were rinsed in KPBS before cover-slipping with 
Vectashield fluorescence mounting medium (Vector Laboratories, Burlingame, CA).  For 
double-labeling experiments two successive labeling procedures (as described above) were 
done prior to DAPI nuclear staining.  Negative controls were run in parallel during the 
immunohistochemical procedure by omitting the primary or primary and secondary 
antibodies.     
 
Retinal explant culture 
 
The explant culture procedure was adapted from Zhao and Barnstable (Zhao and 
Barnstable, 1996).  Briefly, eyes from E17 and P0 pups were dissected in culture media and 
whole retinae with lenses intact were isolated away from the RPE.  The culture medium used 
was UltraCulture (Cambrex, East Rutherford, New Jersey) with 2 mM L-glutamine 
(Invitrogen, Carlsbad, CA) and 10 µg/mL of gentamicin (Invitrogen).  One retina, lens face 
up, was added to each well of a 24 well plate with one mL of culture media.  Half the volume 
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of media was changed every two to three days.  To some explants, human recombinant IGF-1 
(Sigma) at a concentration of 10 ng/ml was added to the UltraCulture media prior to use.  
Inhibitors, when used, were added to culture media prior to feeding.  The MEK specific 
inhibitor PD 98059 (Calbiochem, San Diego, CA) was used at concentrations of 25 µM and 
50 µM and the Akt inhibitor triciribine (Calbiochem) at 10 and 20 µM.  An equal amount of 
vehicle (dimethyl sufoxide) was added to control explants.  After 14 days in culture the 
explants were harvested.   
 
Cell dissociation 
Following lens removal, two retinas per experimental condition were collected and 
washed in sterile phosphate buffered saline (PBS; 14 mM NaCl, 2.7 mM KCl, 5.37 mM 
Na2HPO4, 1.76 mM KH2PO4).  Tissue was incubated at 37ºC for five minutes in PBS 
containing 0.25% trypsin (Invitrogen) and titrated with a glass pipette to generate a single 
cell suspension.  The cells were centrifuged and resuspended in PBS with 0.0025% trypsin 
inhibitor (Invitrogen) and incubated at 37ºC for five minutes.  Cells were centrifuged and 
resuspended in two mLs of explant culture media.  The number of cells in each explant 
culture condition was approximated following dissociation of the retinal explants in the 
media.  Cells were stained with trypan blue (Invitrogen) to obtain viable cell counts.  
Specifically, 20 µl of the explant cell suspension was pippeted into a hemocytometer.  Cells 
in five fields specified by the grid pattern on the slide were counted to obtain a total cell 
count.  This total cell number was divided by five and multiplied by 10,000 to obtain an 
approximation of the number of cells per mL of the cell suspension.  Cell viability counts 
were obtained by counting only those cells excluding the trypan blue stain.  The cells were 
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transferred to 0.01% poly-L-lysine (Sigma, St. Louis, MO) coated eight well chamber slides 
(Nalge Nunc International, Rochester, NY) and incubated at 37ºC for 30 minutes prior to 




Retinal cells from cultured explants or acutely isolated cells from Nrl-GFP retinas 
were fixed with 4% paraformaldehyde in 0.1 M PO4 buffer (pH 7.5) for 30 minutes and 
washed twice in PBS.  Cells were then incubated in blocking solution (described above) for 
two hours.  Cells were incubated in primary antibody overnight at 4ºC.  The following day 
the cells were washed in KPBS containing 0.02% Triton-X 100.  The fluorescent secondary 
antibody Alexa Fluor® 594 donkey-anti mouse (Molecular Probes, Eugene, OR) was diluted 
1:500 in blocking solution and applied for two hours.  The slides were washed three times in 
KPBS and 300 µM DAPI diluted in KPBS was applied to the cells for five minutes.  The 
cells were then washed three times in KPBS and two times in dH2O.  The slides were cover-
slipped with Vectashield fluorescence mounting medium (Vector Laboratories, Burlingame, 
CA).  Negative controls were run in parallel during the immunohistochemical procedure by 




For obtaining percentages of cells expressing rod photoreceptor markers, cells were 
counted using a fluorescence microscope with a 20x objective.  Ten fields in two chambers 
of an eight well chamber slide were counted for each condition.  A total of three replicates 





Analysis of the statistical significance of the observed differences between treatments 
in retinal explant culture was done using SUPERANOVA software (Abacus Concepts, 
Berkeley, CA).  Tukey-Kramer and Bonferroni/Dunn (All means) tests were performed at a 




Tissue sections and plated cells were imaged with a Nikon fluorescence microscope 
(Nikon Instruments, Melville, NY) equipped with a Retiga 1300 digital camera (QImaging, 




IGF-1 receptor is present in the developing and mature retina  
 
To examine the temporal and spatial expression of the IGF-1 receptor in the 
developing and mature mouse retina, immunohistochemical analysis was performed on 
embryonic and postnatal tissue sections.  IGF-1 receptor immunoreactivity-(IR) was 
observed in both plexiform layers and in the nuclear layers.  Here we focus our analysis on 
the expression of the IGF-1R in the outer retina in the area of the developing photoreceptors.  
At embryonic day 15 (E15), moderate IGF-1 receptor immunoreactivity was observed in the 
outer neuroblastic layer with slightly more intense labeling in the cells near the ventricular 
surface (Fig. 1A, arrow). IGF-1 receptor immunoreactivity in the developing outer nuclear 
layer at E17 was diffuse with slightly more intense labeling in the outer portion of the outer 
neuroblastic layer (Fig. 1B, arrow).  At postnatal (PN) day 0, IGF-1 receptor-IR in the outer 
neuroblastic layer was similar to that of the E17 retina with areas of slightly more intense 
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staining throughout (Fig. 1C, asterisk).  Immunoreactivity appeared to be even more intense 
in the outer portion of the developing ONL (Fig. 1C arrow).  IGF-1 receptor-IR was 
uniformly intense in the developing outer nuclear layer at P5.  More intense labeling was 
observed in the region of the developing outer segments (Fig. 1D, arrow).  IGF-1 receptor-IR 
was moderately intense in the OPL (Fig. 1E, dark arrow) and the developing outer segment 
regions at P10 (Fig. 1E, light arrow) with lighter immunoreactivity observed in the cell 
bodies in the outer nuclear layer (Fig. 1E).  In the adult, IGF-1 receptor immunoreactivity 
was most intense in the outer segment region (arrow) with more diffuse labeling in the ONL 
(Fig. 1F).  
 
IGF-1 receptor colocalizes with rhodopsin in the developing mouse retina 
 
To determine if the IGF-1 receptor is present in rod photoreceptors, an 
immunohistochemical analysis with antibodies against rhodopsin and the IGF-1 receptor was 
performed in C57/Bl6 mouse retinal tissue sections from 10PN and adult mice.  
Immunoreactivity for both rhodopsin and the IGF-1R was observed in the vast majority of 
cells in the outer nuclear layer at 10PN (Fig. 2 A-C).  IGF-1 receptor immunoreactivity in the 
outer retina of the adult was observed to be most intense in the inner segments (Fig. 2D, 
asterisk) whereas rhodopsin immunoreactivity was localized to the outer segment region 
(Fig. 2E, asterisk).  Thus the IGF-1 receptor appeared to be present in differentiated rod 
photoreceptors evidenced by the coexpression of the IGF-1 receptor and rhodopsin in cells 





IGF-1 receptor colocalizes with Nrl in the developing mouse retina 
 
Neural retina leucine zipper (Nrl) is the earliest known marker for rod photoreceptors 
with expression detected shortly after cell cycle exit (Akimoto et al., 2006).  Transgenic mice 
expressing GFP under the control of the Nrl promoter were used to detect expression of Nrl.  
Retinas from P0 and P5 Nrl-GFP mice were dissociated and plated on chamber slides.  An 
immunocytochemical analysis was performed on dissociated cells using the anti-IGF-1 
receptor antibody.  In the P0 retina 92.5% ± 0.88 of Nrl positive cells were also positive for 
the IGF-1 receptor.  At P5 78.0% ± 1.58 of Nrl positive cells expressed the IGF-1 receptor.  
This data suggests that developing photoreceptors express the IGF-1 receptor and therefore 
are capable of responding to insulin-like growth factor.    
 
IGF-1 promotes rod differentiation in retinal explants 
 
To investigate the effect of IGF-1 on rod photoreceptor differentiation, retinal 
explants from E17 or P0 mice were cultured in serum free media and treated with exogenous 
IGF-1 for 14 days.  After 14 days in culture the explants were dissociated, and cells adhered 
to chamber slides.  Expression of the rod specific photopigment rhodopsin was examined by 
immunofluoresence.  There was a significant difference in the percentage of cells expressing 
rhodopsin between the control (untreated) and IGF-1 treated explants at E17 (39.3% ± 4.9 
above control) [Fig. 3; F(3, 40) = 10.9, P = 0.0001].   
To address whether the increase in the number of rods following exposure to IGF-1 
could be attributed to an increase in proliferation, the density of cells were compared 
between associated preparations of an equivalent number of E17 explants with or without 
exposure to IGF-1.  Cell density was not significantly different between the two conditions 
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after 14 days in culture [Fig. 4; F(3, 40) = 0.4, P = 0.76].  We also used a trypan blue 
exclusion assay to obtain live-dead cell counts in order to determine if the increase in the 
number of cells expressing rhodopsin in IGF-1 treated explants could be due to increased cell 
survival.  There was no indication of increased survival in E17 explants exposed to IGF-1 as 
compared to the control (data not shown).   
P0 retinal explants treated with IGF-1 also showed a significant increase in the 
percentage of rhodopsin positive cells compared to the control (28.2% ± 4.3) [Fig. 3; F(3, 20) 
= 7.0, P = 0.0021), although the effect appeared to be slightly less robust than in E17 
explants.  No significant change in cell density was found in IGF-1 treated P0 retinal explants 
[Fig. 4; F(3, 20) = 3.6, P = 0.031] and the live-dead cell counts did not reveal a significant 
difference in cell survival.   
Two other types of retinal neurons, bipolar cells and Müller glia, are born around the 
same time as rod photoreceptors (Young, 1985).  To investigate the possibility that IGF-1 
may be increasing rod differentiation at the expense of the other late born cell types, the 
percentage of total cells expressing the rod bipolar cell marker PKCα and the Müller glia cell 
marker glutamine synthetase were calculated for P0 retinal explants cultured 14 days.  The 
percentage of cells expressing glutamine synthetase was not significantly different between 
control and IGF-1 treated explants.  However, a significant increase in the percentage of cells 
positive for PKCα in explants exposed to IGF-1 was observed (data not shown).  Thus it 





Signaling cascades involved in IGF-1 influence on rod differentiation in retinal explants 
 
To determine whether the increase in rhodopsin expression observed with application 
of IGF-1 to developing retinal explants is mediated by activation of the MAP kinase 
pathway, retinal explants were treated with the MEK inhibitor PD98059 throughout the 14 
day culture period either with or without exposure to IGF-1.  A significant increase in the 
percentage of rhodopsin positive cells was observed in E17 explants exposed to the MEK 
inhibitor (29.7% ± 6.5) or the MEK inhibitor with IGF-1 (30.3 ± 8.0) as compared to the 
control [Fig. 3; F(3, 40) = 10.9, P = 0.0001].  These data demonstrate the effect of IGF-1 on 
rod differentiation is not due to activation of the MAP kinase pathway.  However, these data 
do suggest that inhibition of MEK alters signaling in the E17 retina and results in an increase 
in rod differentiation.  Cell density was not significantly different from the control when 
MAP kinase activation was inhibited in E17 explants with or without IGF-1 treatment (Fig. 
4; F(3, 40) = 0.4, P = 0.757).   
Inhibition of MEK in P0 explants did not significantly alter the percentage of cells 
expressing rhodopsin as compared to the control and exposure of explants to IGF-1 in the 
presence of the inhibitor did not abolish the increase in rhodopsin expression (Fig. 3).  This 
suggests that IGF-1 does not increase rod differentiation via activation of ERK signaling in 
P0 explants.  A live-dead cell count did not reveal a difference in survival when explants 
were treated with the MEK inhibitor or the MEK inhibitor with exposure to IGF-1 (data not 
shown).   
The other major signaling cascade activated by IGF-1 is the phosphoinositol 3 
kinase/Akt pathway.  This pathway has been shown to be important for survival of 
photoreceptors.  Inhibition of Akt with tricirbine in untreated and IGF-1 treated P0 explants 
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caused extensive cell death and thus few to no rhodopsin positive cells were seen after 14 
days in culture (data not shown).  Due to the substantial decrease in cells, rhodopsin positive 




The IGF-1 signaling pathway has been shown to have an important yet not well 
defined role in retinal development.  To establish a potential role for IGF-1 signaling during 
rod development, we immunolabeled with an antibody against the IGF-1 receptor. The IGF-1 
receptor was expressed in the retina at the embryonic and postnatal ages characterized.  IGF-
1 receptor immunoreactivity was found in all nuclear layers of the retina as well as both 
plexiform layers.  The IGF-1 receptor was present in mature photoreceptors evidenced by the 
coexpression of the IGF-1 receptor and rhodopsin in cells located in the outer retina.  The 
receptor was more highly expressed in the inner segment region in the adult retina compared 
to the outer segment region.  This expression pattern corresponds to previous findings in the 
adult bovine retina (Waldbillig et al., 1988; Zick et al., 1987).  IGF-1 receptor expression in 
mature photoreceptors is likely important for facilitating survival as disruption of the IGF-1 
signaling pathway directly downstream of the receptor has been shown to promote loss of 
photoreceptors in postnatal mice (Yi et al., 2005).  
The IGF-1 receptor was also observed in cells in which the Nrl transcript was 
expressed.  At P0, when the majority of rod photoreceptors are born, almost all Nrl positive 
cells expressed the IGF-1 receptor.  At P5, when many rods begin expressing rhodopsin 
(Morrow et al., 1998), fewer of the Nrl positive cells expressed the receptor.  It is possible 
 52 
that cells fated to become rods express the IGF-1R early after cell cycle exit but that 
expression levels are not detectible in some cells as the rod begins to mature.    
Based on an observed increase in rhodopsin expressing cells in retinal explants 
treated with exogenous IGF-1 we conclude that IGF-1 is a stimulatory factor for rod 
differentiation.  In E17 and P0 retinal explants exposed to IGF-1, the total percentage of cells 
expressing rhodopsin significantly increased compared to the percentage observed in 
untreated explants.  An increase in rhodopsin expression could be due to increased 
proliferation of rod progenitors, increased cell survival of rods or an increase in the number 
of cells differentiating into rods.  We did not observe a significant increase in cell density in 
E17 or P0 explants with and without exposure to IGF-1.  This suggests that the increase in 
rhodopsin expression in IGF-1 treated explants was not due to increased proliferation.  E17 
or P0 explants treated with IGF-1 did not show a significant increase in survival of cells as 
there was no significant change in the total percentage of dead cells found in a dye exclusion 
assay when compared to the control.  Therefore, the increase in the percentage of rhodopsin 
positive cells after exposure to IGF-1 is due to an increase in the number of cells adopting a 
rod photoreceptor fate.  The increase in rhodopsin expression in both E17 and P0 retinal 
explants demonstrates that the retina is competent to respond to IGF-1 stimulation at E17, a 
time in development just prior to the peak of rod genesis, and during the time when the 
majority of rods are born at P0.  This does not appear to be the case for fibroblast growth 
factor which was shown to increase rhodopsin expression in dissociated postnatal rat retinal 
cells (Hicks and Courtois, 1992) but not in embryonic retinal explants (Zhao and Barnstable, 
1996).   
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The signaling mechanism leading to the increase in rod differentiation upon 
stimulation with IGF-1 does not involve activation of MAP kinase.  This is evidenced by the 
fact that E17 and P0 explants exposed to IGF-1 in the presence of the MEK specific inhibitor 
PD 98059 still show a significant increase in rhodopsin expression.  Thus the effect of IGF-1 
on rhodopsin expression was not attenuated by inhibition of MEK.  Interestingly, there was a 
significant increase in rhodopsin positive cells when the MEK inhibitor was applied to E17 
retinal explants without application of IGF-1.  Signaling through the MAP kinase pathway is 
an important regulator of proliferation in cells (see (Meloche and Pouyssegur, 2007) for 
review).  Perhaps inhibition of MEK in the E17 retinal explants is reducing the number of 
cells that are cycling, thus making more cells available to respond to differentiation cues.  
We did observe a slight decrease in cell density in E17 explants exposed to the MEK 
inhibitor, however this decrease was not significant.  In P0 explants the difference in the 
percentage of rhodopsin positive cells between control and MEK inhibited explants was not 
significant.  Since the majority of cells in the retina are exiting the cell cycle around P0 the 
effect of MEK inhibition on the number of cycling cells may not be as great in the P0 retinal 
explants.   
It is possible that chronic inhibition of MEK in retinal explants alters signaling to 
promote differentiation of rods.  In 3T3 fibroblast cells exposure to the MEK inhibitor PD 
98059 has been shown to cause enhanced and prolonged basal levels of Raf-1.  MEK is a 
known downstream target of Raf-1 that is involved in increasing proliferation.  However, 
there have been several studies demonstrating a role for Raf-1 in differentiation independent 
of MAPK signaling such as in an immortalized rat hippocampal cell line (Kuo et al., 1996) 
and insulin induced differentiation in 3T3 L1 cells (Porras et al., 1994). There have been 
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studies showing that Raf-1 activates p90RSK or p70S6K (Lenormand et al., 1996) which are 
both involved in translational processes.   
Inhibition of Akt in P0 explants caused a substantial decrease in the number of total 
cells compared to untreated explants.  The cells that remained in explants exposed to the Akt 
inhibitor did not express rhodopsin.  This suggests that Akt is important for survival of rod 
photoreceptors.  Akt is known to be important in mediating cell survival.  The importance of 
IGF-1 in rod photoreceptor survival has been demonstrated in vivo in IRS2 knockout mice 
(Yi et al., 2005).  Inhibition of molecules further downstream of Akt may reveal a role for 
this pathway in the IGF-1 mediated increase in rod photoreceptor differentiation.       
IGF-1 may be acting to enhance rod differentiation by signaling through a mechanism 
independent of MAP kinase signaling or the PI3-kinase pathway.  The binding of IGF-1 to its 
ligand has been shown to activate the suppressor of cytokine signaling 3 (SOCS3) protein 
(Dey et al., 2000).  SOCS3 inhibits Stat3 activation in the retina and appears to be important 
for downregulation of Stat3 activation (Ozawa et al., 2007).  Stat3 activation in the retina has 
been shown to inhibit rhodopsin expression (Zhang et al., 2004).  The phosphorylated Stat3 
present in the outer neuroblastic layer late in embryogenesis is downregulated at P0 
coincident with the peak of rod genesis (Ozawa et al., 2004).  The downregulation of 
activated Stat3 in the retina may be controlled by IGF-1.  IGF-1 has been shown to activate 
Stat3 in certain cell types including cortical neurons (Yadav et al., 2005).  However, we did 
not find evidence of Stat3 activation in P0 retinal explants exposed to IGF-1 (unpublished 
observation).    
IGF-1 has also been shown to increase expression of the early response genes c-jun 
and c-fos (Heidenreich et al., 1993; Leon et al., 1998; Leon et al., 1995, Leon et al., 1998).  
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These proteins form the activating protein 1 (AP-1) complex which binds to AP-1 sites 
located in the promoter region of several genes.  The rod photoreceptor genes Nrl and 
rhodopsin both have putative AP-1 binding sites in their promoter regions (Farjo et al., 1993; 
Rehemtulla et al., 1996).  Nrl and c-fos show colocalized expression patterns in the 
developing retina and may dimerize to activate rhodopsin (He et al., 1998).  Thus IGF-1 may 
act to increase expression of early response genes in the retina leading to increased 
expression of rhodopsin.       
It is apparent from this study that IGF-1 is important in rod photoreceptor 
development.  We are the first to show that a growth factor can increase rod differentiation in 
both late embryonic and postnatal retina.  Future studies regarding IGF-1 activation of 
signaling in the retina may reveal transcription factors important for regulation of rod 
specific genes.  Though the ability of IGF-1 to influence retinal progenitors is not well 
understood this study demonstrates its promise to bias populations of cells for use in 
transplantation.   
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Figure 1:  The IGF-1 receptor is expressed in the developing and mature mouse retina.  
Immunoreactivity for the IGF-1 receptor was observed in both the inner and outer plexiform 
layers as well as the nuclear layers.  Specifically in the outer retina, moderate 
immunoreactivity for the receptor was observed in the NBL at E15 (A), with more intense 
labeling near the ventricular surface (arrow).  A similar pattern of immunoreactivity was seen 
in the outer retina at E17 (B; arrow indicates more intense labeling in the outer portion of the 
NBL).  At P0 (C) areas of slightly more intense immunoreactivity were observed throughout 
the retina (asterisks) with more intense labeling along the scleral surface of the NBL (arrow).  
IGF-1 receptor-IR was moderately intense in the ONL at P5 (D) with more intense labeling 
in the developing OS region (arrow).  At P10 (E) the most intense labeling in the outer retina 
was observed in the OPL (black arrow) and OS region (white arrow) with lighter 
immunoreactivity is the ONL.  Intense IR for the IGF-1 receptor was also observed in the OS 
region (arrow) in the adult retina (F).  Abbreviations: GCL, ganglion cell layer; NBL, 
neuroblastic layer; INL, inner nuclear layer; IPL, inner plexiform layer; ONL, outer nuclear 
layer; OPL, outer plexiform layer; OS, outer segments.  Scale bars = 20 µm 
 
Figure 2: Colocalization of rhodopsin and the IGF-1 receptor in cells of the mouse retina at 
P10 (A-C) and in the adult (D-F).  Immunoreactivity for the IGF-1 receptor was observed in 
the outer retina at P10 (A), and in the IS region (asterisk) in the adult (D).  Rhodopsin-IR was 
observed in cells in the ONL at P10 (B), and in the OS (asterisk) in the adult retina (F).  
Merged images are shown in C (P10) and F (adult).  NBL, neuroblastic layer; IPL, inner 
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plexiform layer; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear 
layer; OS, outer segments; IS, inner segments.  Scale bars = 20 µm.      
 
Figure 3: IGF-1 increases rhodopsin expression in developing retinal explants.  The 
percentage of cells expressing the rod marker rhodopsin in E17 (light bars) and P0 (dark 
bars) explants after culturing retinal explants for 14 days.  Addition of 10 ng/ml IGF-1 
increased the percentage of total cells expressing rhodopsin.  The MEK inhibitor PD98059 at 
a concentration of 50 µM was added to explant cultures both with and without addition of 
IGF-1.  Percentages of rhodopsin positive cells are shown as a percentage of the control.  * 
p< 0.05 
 
Figure 4: IGF-1 does not affect cell density in developing retinal explants.  Total cells in an 
equivalent area were counted and expressed as a percentage of the control.  The MEK 
inhibitor PD98059 was added to explant cultures at a concentration of 50 µM, both with and 
without addition of 10 ng/ml IGF-1.  Cell density was not significantly different between the 
control and explants treated with the MEK inhibitor, IGF-1 or a combination of the inhibitor 
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Photoreceptor cell fate determination in the developing retina is a well-studied area, 
due not only to its potential therapeutic application to treat retinal degeneration, but also 
because the developing retina has long been considered an excellent model to study CNS 
development.  There are a number of published studies that have profiled changes in gene 
expression during normal retinal development.  However, the large number of genes profiled 
at comparatively few time points or conditions has made extraction of gene networks from 
this data extremely difficult. To begin to address this issue we have begun using a ‘seed-
network’ to query multiple large-scale expression datasets.  The seed network used was 





Using the Spearman Rank measure of correlation, we calculated how well gene 
relationships were correlated between datasets.  We found that when looking at all genes 
common between any two datasets the most highly correlated datasets had a correlation value 
of 0.33.  However, when the pairwise-correlation values were limited to members of the 
seed-network, there was much more agreement between datasets.  Correlation values of at 
least 0.65 between six pairs of seed-network members were present in at least two datasets. 
We then used the seed-network to identify genes that were correlated (0.65 corrlelation in at 
least two datasets) with multiple seed-network members.   KEGG pathway annotations were 
retrieved for this list of genes.  The most highly represented pathways in this list were:  
Calcium signaling, G-protein coupled receptor signaling, Jak-STAT signaling, MAPK 
signaling, Notch Signaling and Wnt signaling.  From the list of genes correlated with 
multiple seed-network members we manually identified 10 genes for hypothesized inclusion 
into the seed-network.    
 
Conclusions 
We have demonstrated that the use of an experimental based seed-network is an 
effective strategy for querying large-scale expression analysis and may be useful for 
generating hypothesis-based experiments using ‘omics’ data. 
 
Background 
Blinding degenerative retinal diseases including retinitis pigmentosa and macular 
degeneration are characterized by a loss of photoreceptors. At present there is no way to 
replace retinal cell loss due to disease or injury because differentiated retinal cells are unable 
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to regenerate. Neural progenitor cells have been proposed as a potential source of 
transplantable cells to replace lost cells in the damaged retina. The retina is composed of five 
major neuronal types and one glial cell type that all originate from the same progenitor cell. 
The rod photoreceptors, the most numerous among retinal cells, together with cone 
photoreceptors, are responsible for transduction of light and are required for vision.  Recent 
studies demonstrate that post-mitotic rod precursors are able to differentiate and fully 
integrate into the damaged retina, whereas the less differentiated stem cells are not [1].  Thus, 
understanding the network of genes that orchestrate the differentiation of retinal progenitors 
may make it possible to bias the distribution of cell types in expanded stem cell populations.  
Large scale gene expression profiling is aimed at helping to elucidate how genes influence 
each other in networks, which then control cell fate commitment and differentiation.  There 
are a number of published studies that have profiled changes in gene expression during 
normal retinal development [2-6].  However, the large number of genes profiled at 
comparatively few time points or conditions presents significant statistical challenges in 
inference of genetic networks from expression data. 
One way to more effectively understand relationships between genes is to increase the 
number of expression measurements for a given gene, and decrease the number of genes 
considered (e.g., by focusing the investigation on a small number of genes of interest, or on 
interactions between clusters of genes that have similar expression profiles) [7].  In this 
study, we integrated the data from five previously published expression studies [2, 6, 8-10] to 
increase the number of measurements available for each gene under comparable conditions. 
We analyzed the resulting composite dataset using a ‘seed network’ of genes constructed 
from published experimental data suggesting their role in retinal development [11-21].  We 
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hypothesize that additional genes important for rod differentiation are likely to be highly 
positively or negatively correlated with genes that belong to the seed network.  We generated 
a list of such candidate genes based on the correlation of their expression with that of genes 
in the seed network.  We further prioritized the resulting candidate genes, based on their gene 
ontology annotations, evidence of their membership in known cellular signaling pathways, 
and biological knowledge (whenever such knowledge is available).  Using this approach, we 
identified 986 genes correlated with multiple genes of interest and short-listed seven as 
interesting candidates for expanding our seed network.  We believe that our results 
demonstrate the utility of querying multiple large scale gene expression profiles using a seed 
network to prioritize genes for further investigation using detailed experimental studies.  
 
Results 
We first determined how well pairwise gene correlations correspond across analysis 
platforms, using the “correlation of correlations”, or rc [24], between each pair of datasets.  
This measure is a useful way to compare agreement between datasets without comparing 
absolute expression values.  It is also useful because different pairs of datasets have different 
genes in common.   We use a Spearman rank correlation version of the rc, which does not 
assume a particular distribution, but rather the relative ranks of the expression values (for 
example if expression values for a set a genes were 5.74, 2.18, 3.65 and 9.13, then their ranks 
relative to one another would be 3, 1, 2 and 4).  The rc between each pair of datasets, 
computed using the R statistical software (http://www.r-project.org) [25], is given in table 1.  
The most highly correlated pair of datasets had a correlation value of 0.33.  Significance was 
computed in R by means of permutation testing, which yielded p-values < 0.001 for each pair 
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of datasets except when one of them was the 2D PAGE data set, in which case the p-values 
ranged from ~ 0.016 to ~ 0.574.  The relatively low correspondence between datasets is not 
especially surprising in light of published comparisons of mRNA gene expression data from 
multiple studies involving overlapping or even the same sets of genes [59, 61-62].  
We examined the agreement between datasets with respect to correlations between 
expression levels of genes that are known to be active during rod photoreceptor development.  
Specifically, we extracted from the literature a seed network of known rod development 
genes together with their known interactions (Figure 1) and assayed the correlation values 
between each pair of seed genes in each data set.  The edges between genes in the network 
represent several types of links including non-directional interactions drawn from knockout 
studies [11, 12] indirect effects on expression based on knockout studies [13], 
phosphorylation events based on mutation and transfection experiments [26], and direct 
transcriptional control of one gene over another [14-21]. 
To see how well our seed network could be reconstructed using only gene expression 
data, we constructed a graph with a link connecting any two seed genes that had a positive or 
negative correlation of magnitude at least 0.65 in at least two of the five mRNA expression 
datasets. The 2D gel electrophoresis (2DGE) dataset was omitted since none of the seed 
network genes were identified in it.  Our choice of the threshold of 0.65 for correlation was 
influenced by similar choices in previous studies [27-29] that have revealed biologically 
relevant links between coexpressed genes.  The resulting network diagram is depicted in 
figure 2 with negative correlations represented in red and positive correlations in blue.  Six of 
the nine positive links in this graph are also present as links in the seed network (see Table 
2).  In addition to the positive correlations, there are four links representing negative 
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correlations between genes in the seed network.  These negative correlations partition the 
graph into two sets of genes, one consisting of genes expressed by proliferating retinal 
progenitors and the other consisting of genes expressed by cells in the process of 
differentiating into rods.  Thus, in the case of genes in the seed network, the agreement 
between the multiple datasets in terms of coexpressed genes appears to be much higher than 
that observed across all genes present in the multiple datasets. Thus, biologically relevant 
links between genes seem to be supported by correlations between expression values across 
multiple datasets. This supports the notion that links between genes that are supported by 
multiple expression datasets warrant further investigation. 
To examine the value of combining datasets we checked which datasets supported 
each of the nine positive links in the correlation graph shown in figure 2.  It is interesting to 
note that no single dataset supported all nine.  Three of the datasets supported six edges, one 
dataset supported 4 edges, and one supported three (Table 2).  Thus, combining multiple 
datasets appears to increase the robustness of the analysis. 
Based on our ability to partially reconstruct the seed network using correlation of 
gene expression values, we then used the seed network to query the combined dataset for 
additional genes that may be involved in rod differentiation.  For each of our seed genes, we 
generated a list of all genes with a correlation of at least 0.65 with the seed gene in at least 
two of the five datasets.  We then sorted each list by the number of datasets in which a gene 
met the threshold value of a 0.65 correlation with a particular seed gene, as well as by the 
mean value of these correlations across those datasets, thus producing a list of prioritized 
candidate genes correlated with each seed gene. 
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To further prioritize the candidate genes, we generated a list of genes linked, 
according to the same criterion (0.65 correlation in two or more datasets), with more than one 
of our seed network genes (Nrl, Nr2e3, Crx, Rb1, Chx10, Rho and Neurod1) (Supp. Table 1; 
see appendix).  We excluded the cyclins due to large number of genes with which they 
interact.  We then retrieved Gene Ontology and KEGG pathway annotations for the genes in 
this list.  Based on this information we found the most highly represented pathways to be the 
Notch, MAPK, Wnt, JAK-STAT, G-protein coupled receptor, pentose phosphate, calcium, 
and insulin signaling pathways (Table 3a). 
 
Discussion 
Several large scale gene expression studies of the murine retina have been conducted 
in an attempt to identify genes important for retinal development [2, 6, 8-10, 30].  The data 
from these studies provide useful information about the molecular networks that act to guide 
retinal cell fates. However, these studies offer at best only a starting point for functional 
studies focused on a smaller subset of genes.  The gene expression datasets we analyzed do 
not correlate over all genes.  It is therefore difficult to use multiple datasets to extract a small 
subset of the genes as good candidates for a role in specific events in retinal development 
such as rod photoreceptor genesis without a more targeted approach.  We have chosen a 
novel approach to identify genes in these datasets that may play key roles in rod 
photoreceptor development.  By using a seed network composed of genes known to be 
important in rod development we were able to focus our analysis on a small number of genes 
and identify genes highly correlated with these rod genes in multiple datasets.     
 
 73 
Genes with known links to photoreceptors 
Several of the genes whose expression levels are found highly correlated with those 
of multiple genes in the rod seed network (based on analysis of more than one data set) are 
known to be important for rod photoreceptor function, e,g., phosphodiesterase 6G, cGMP-
specific rod gamma, recoverin, rod outer segment membrane protein 1, and phosducin (Supp. 
Table 2; see appendix).  The fact that our list of candidate genes includes many genes that 
have strong experimental evidence of involvement in rod photoreceptor functions suggests 
that the other candidate genes that we have identified through our approach of using a seed 
network to query multiple expression datasets are worthy of careful experimental 
investigation in the context of rod development. 
Candidate genes for addition to seed network 
Based on the lists generated by this analysis we have identified 7 genes or groups of 
genes that are candidates for immediate inclusion into our network including: Uhmk1, 
Kruppel-like transcription factor-7, Ext1 and other genes involved in heparan sulfate 
biosynthesis, cystatin C, N-myc downstream regulated genes 3 and 4, Nr1d2, and RORα.   
U2AF homology motif (UHM) kinase 1, (Uhmk1; also called Kis or Kinase 
interacting with stathmin), is a serine/threonine kinase that contains an RNA binding motif 
[31, 32].  Uhmk1 is positively correlated with Nrl, Nr2e3, rhodopsin, and Crx and is 
negatively correlated with NeuroD1.  Uhmk1 has been found to bind to and negatively 
regulate the cell cycle inhibitor p27Kip [33], which is involved in regulation of retinal 
progenitor cell fate.  This, together with the observed correlation in Uhmk1’s expression with 
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the expression of two well characterized transcription factors that direct photoreceptor cell 
fate (Crx and Nrl) is highly suggestive of its involvement in rod progenitor cell cycle exit.           
Several of the Kruppel-like transcription factors are highly correlated with multiple 
genes in the rod seed network.  The Kruppel-like factors function as repressors or activators 
of transcription and are good candidates for regulation of genes involved in rod development 
as they are involved in cell proliferation and differentiation in many tissues including the 
retina [34].  Kruppel-like transcription factor 7 (Klf7) is highly negatively correlated with 
Crx and Nrl in multiple datasets.  Klf7 is expressed in differentiating cells in the embryonic 
retina and other parts of the central nervous system [35; 60].  Klf7 knockout mice show 
downregulation of the cdk inhibitor p27Kip and there is evidence that it directly activates the 
p27Kip promoter.  Klf7 may therefore play a key role in regulating the cell cycle of retinal 
progenitors. 
Several genes involved with heparan sulphate biosynthesis are correlated with the 
expression of genes in the seed network. Exostoses (multiple) 1 or Ext1 is positively 
correlated with Nrl, rhodopsin, Nr2e3 and Crx.  Ext1 is a glycosyltransferase involved in the 
synthesis of heparan sulfate and is known to be highly expressed in developing mouse brain 
[36].  Other genes involved in heparan sulfate biosynthesis are also highly correlated with 
multiple genes in our seed network.  These include heparan sulfate (glucosamine) 3-O-
sulfotransferase 3B1 which is positively correlated with Nrl, rhodopsin and Nr2e3, beta-1,3-
glucuronyltransferase 1 (glucuronosyltransferase P) which is positively correlated with Nrl 
and rhodopsin, and carbohydrate (chondroitin) synthase 1 which is also positively correlated 
with Nrl and rhodopsin.  A role for heparan sulfate in retinal development has been suggested 
by studies of its expression and heparan sulfate has been shown to have an effect on several 
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pathways important in development such as the hedgehog and fibroblast growth factor 
pathways [37, 38]. 
Cystatin C is positively correlated with Nrl, Nr2e3, Crx, and rhodopsin.  Cystatin C is 
a cysteine protease inhibitor found in many tissues including the retina.  Cystatin C RNA and 
protein expression have been detected in the embryonic and postnatal rodent retina with peak 
levels of the protein expressed around the time of photoreceptor maturation [39, 40].  
Recently, Kato et al. [41] isolated cystatin C from conditioned media of primary 
neurospheres and demonstrated that addition of cystatin C to embryonic stem cells facilitated 
the differentiation into cells expressing neural genes.  The fact that cystatin C is expressed in 
the developing retina, is implicated in promoting neuronal cell fate determination, and is 
correlated with multiple seed network genes makes it a likely candidate for involvement in 
photoreceptor development.         
N-myc downstream regulated gene 3 (Ndrg3) is highly positively correlated with Crx, 
Nrl, and rhodopsin.  Another N-myc downstream regulated gene, Ndrg4 is highly correlated 
with Nrl in two datasets.  Ndrg3 and Ndrg4 are inhibited by N-myc, one of the members of 
the myc family of proto-oncogenes.  N-myc has been shown to be important in central 
nervous system development and is thought to play a role in CNS cell proliferation and 
differentiation [42].  N-myc is highly negatively correlated with Nrl and rhodopsin.  N-myc 
is expressed in the developing retina but not in mature retinal neurons [43].  N-myc is 
inhibited by retinoblastoma (Rb1) and expression of Ndrg3 and Ndrg4 are reduced in the Rb 
knockout retina (data accessible at NCBI GEO database, accession number GSE1129; 
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE1129).  Therefore Rb1 may be 
important for inhibition of N-myc during cell fate determination in the retina which in turn 
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increases expression of Ndrg 3 and 4.  Ndrg3 and 4 may promote rod differentiation through 
enhancement of AP-1 activity as Ndrg4 has been shown to regulate activity of the protein 
complex [44].  AP-1 binding sites are found in the Nrl promoter region and the promoters of 
other rod specific genes [45]. 
The orphan nuclear receptor Nr1d2 is highly correlated with Crx, Nrl, Nr2e3 and 
rhodopsin.  This gene is a member of the Rev-erb nuclear receptor subgroup along with Rev-
erb alpha (Nr1d1) which can function as transcriptional silencers and can repress 
transcriptional activation by retinoid-related orphan receptor alpha (Nr1f1) and thyroid 
hormone receptor [46].  There is evidence that Nr1d1 interacts with Nr2e3 and Nrl to activate 
transcription of rhodopsin in the retina [19].  Both Rev-erb proteins bind to the same core 
promoter sequence suggesting that Nr1d2 may also be involved in activating transcription of 
rhodopsin and other rod photoreceptor genes.      
Another orphan nuclear receptor highly correlated with the rod seed genes Nrl and 
Crx was retinoid-related orphan receptor alpha (ROR alpha).  ROR alpha is a member of the 
steroid/thyroid hormone receptor superfamily.  Interestingly it has recently been shown that 
Nrl contains a putative ROR alpha response element and other retinoic acid receptor binding 
sites in its promoter region and that deletion of these elements decreases retinoic acid 
induced luciferase activity in Nrl promoter-luciferase constructs [47].  Discovering the 
ligands for ROR alpha and the Rev-erb nuclear receptors could reveal factors important for 
controlling Nrl expression in developing photoreceptors.  The mouse retina SAGE library 
(http://itstgp01.med.harvard.edu/retina) data suggests that ROR alpha is more highly 
expressed in the ONL than retinoic acid receptor alpha (RAR alpha) and its temporal RNA 
expression more closely correlates with that of Nrl.      
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Summary of candidate genes 
The information available in the literature on the candidate genes identified above, 
makes them likely candidates for linking with specific genes in the rod seed network (Figure 
3).  Both Uhmk1 and Klf7 may be involved in rod genesis through regulation of cell cycle 
progression by negative or positive regulation of p27Kip.  The orphan nuclear protein RORα 
is shown linked directly to Nrl based on a putative binding site present in the Nrl promoter 
region.  Nr1d2 is linked to rhodopsin based on its similarites to Nr1d1, a protein that is 
known to bind to the rhodopsin promoter region.  Ndrg 3 and 4, genes involved in heparan 
sulfate biosynthesis, and cystatin C correlated with several rod genes and are shown to have 
links with all rod specific genes. 
Related work 
In our analysis of this data, we relied on (a) integration of multiple datasets, and (b) 
retrieval of genes that are positively or negatively correlated with genes in our seed network.  
Related studies examining correlation between multiple gene expression datasets have been 
reported by Griffith, et al. [27] and Lee et al. [28].  Griffith et al. compared three different 
platforms (SAGE, cDNA microarray and oligonucleotide microarray), using data from many 
gene expression experiments on each platform.  They took correlations between all pairs of 
genes for each platform, where each gene was represented by a vector of the expression 
levels from the experiments for that platform where both genes were measured.  In contrast, 
we didn't combine datasets from the same platform to determine correlation between genes. 
We also required each individual gene correlation to meet the threshold, rather than just 
checking whether the average correlation meets the threshold, which would allow a high 
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correlation in one dataset to compensate for a low correlation in another.  Lee et al. used a 
"vote-counting" procedure where each dataset votes in favor of links between genes.  Both 
studies, like others in the literature [27-29, 48-50] used the correlation between the 
expression profiles of genes as measured by the Pearson correlation coefficient to 
hypothesize potential relationship between the corresponding genes.  However, it has been 
shown that gene expression data are not normally distributed, which makes the often-used 
Pearson correlation unsuitable for use with such data [51].  Hence, we used a non-parametric 
correlation measure, namely, Spearman rank correlation which has been demonstrated to be 
among the most effective for detecting functional relationships between genes [52].  Our 
study is, to the best of our knowledge, the first study of gene correlation across time-series 
datasets from different platforms. 
Several previous studies have examined ways of extending a known seed network: 
Bader [53] used a network with confidence scores for each edge based on two-hybrid and 
mass spectrometry data for yeast, filtering out all edges not meeting a user-selected 
threshold. The procedure starts with an initial set of seed genes, and adds genes to the seed 
network prioritized by the probability of the path connecting the genes in question to one the 
seed genes. The probability of a path is calculated as the product of the confidence scores of 
the links along its length. They reported that tests involving the DNA repair pathway 
suggested possible mechanisms for certain processes. Cabusora et al. [54] have used a 
network constructed from protein interaction data, metabolic reaction data, co-expression in 
regulons data and gene expression data. They found the shortest paths between all pairs of 
seed nodes, where the weights on the edges were calculated from gene expression data.  Next 
they identified the sub-networks that were bounded by the seed genes. They compared the 
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networks generated for the isoniazid (INH) and H2O2 responses of M. tuberculosis and were 
able to observe a link between the FAS-II pathway and the fatty acid degradation pathway in 
the INH network.  Hashimoto et al. [55] used a network based on transcriptome data from 25 
human glioma tissues. They used two different measures to determine the strengths of the 
interactions: the coefficient of determination [56] and Boolean-function influence [57]. 
Starting with some seed genes, they expanded the seed network by iteratively adding genes.  
The added genes were chosen to maximize the collective strength of interactions within the 
growing seed network and to minimize the strength of influences from nodes outside the seed 
network. They reported that the sub-network grown using VEGF as a seed is “highly 
consistent with prior biological knowledge”. Can et al. [58] analyzed three different yeast 
networks from previous studies using a simulated random walk over a network to rank the 
genes in the network according to the estimated strengths of their interaction with a selected 
set of seed genes. Based on leave-one-out tests using 27 MIPS complexes and 10 KEGG 
pathways they report that the random walk algorithm to be “suitable for predicting candidate 
members of a core complex or partially known pathway”.  
In contrast, our approach does not seek to automatically extend the seed network as 
do the three methods summarized above.  Like Can et al. [58] our method simply prioritizes a 
list of genes, albeit using a different criterion, namely, Spearman rank correlation for the 
purpose. However, instead of producing a single ranking of all genes for relatedness to the 
whole seed network, our approach produces a ranking for each seed gene as well as a ranking 
of those genes that are correlated with multiple seed genes. The latter is especially useful in 
showing at a glance the specific genes in the seed network that are likely to be involved in 
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interactions with a candidate gene. The resulting prioritized list can then be further examined 
by human experts in the broader context of related literature and biological knowledge. 
Summary 
By using a seed network to query a composite dataset comprised of several retinal 
gene expression datasets we were able to identify candidate genes important in rod 
photoreceptor development.  We used the seed network to prioritize genes in the datasets 
based on their correlation with multiple seed gene members.  By using gene ontology 
annotations and available biological knowledge, we were able to identify a small subset of 
genes from the prioritized lists and add them to our seed network based on further analysis of 
the prioritized in the context of evidence obtained from the literature in support of the new 
links.  These new links offer a rich source of hypotheses that can help focus the experiments 
in the lab.  We believe that this approach offers a powerful means of leveraging 
computational analysis of high throughput gene expression data, together with the 
interpretation of the results by human experts in the context of existing biological knowledge, 
to rapidly identify and prioritize experimental targets. 
 
Materials and methods 
Datasets measuring gene or protein expression in the developing retina  
Datasets measuring gene or protein expression in the developing retina at multiple 
time points include: SAGE of whole retina [2], two Affymetrix microarrays of whole retina 
using the Mu74Av2 chip (hereafter referred to as Mu74Av2_1 [6] and Mu74Av2_2 [8], one 
cDNA microarray of whole retina [10], one Affymetrix microarray of only developing rod 
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progenitors using the MOE430.2.0 chip [9], and 2D PAGE of whole retina (Barnhill et al., 
manuscription in preparation). 
ID mapping 
Genes or proteins from each of these datasets were matched by Entrez gene ID.  
These IDs were determined using NCBI's gene database 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=gene) [22] and 
WebGestalt (http://bioinfo.vanderbilt.edu/webgestalt/) [23].  In cases where multiple SAGE 
tags or 2D PAGE spots mapped to a single gene, we summed the tags'/spots' expressions to 
arrive at a total expression for the gene.  In cases where multiple microarray probes mapped 
to a single gene, we took the median of the probes' expressions to arrive at a total expression 
for the gene.   
Gene and pathway annotation 
KEGG (Kyoto Encyclopedia of Genes and Genomes) pathways and GO (Gene Ontology) 
annotations were retrieved using WebGestalt [23].  The most highly represented pathways in 
the table of correlations with multiple genes (supplementary data) were determined by 
grouping all genes containing a pathway annotation by the given annotation.  Signaling 
pathways represented by five or more gene members were considered highly represented. 
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Figure. 1: Representation of an intrinsic seed network controlling rod photoreceptor 
development.  The network was constructed based on published experimental evidence and is 
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made up of ten genes.  Direct effects between seed genes are indicated by arrows, indirect 
effects are shown as arrows interrupted by circles.  
 
Figure 2:  A rod network reconstructed based on correlations among seed genes in the 
expression datasets.  Links were drawn to connect any two seed genes with a correlation of ± 
0.65 in two or more of the five datasets.  Blue lines represent positive correlations, red lines 
represent negative correlations.  Six of the nine positive correlations in the graph are present 
in the seed network (shown in Figure 1). 
 
Figure 3: Expansion of the seed network to include candidate genes.  Genes highly correlated 
with multiple seed network members were considered for inclusion into the original seed 
network.  Based on published experimental evidence, seven candidate genes or gene families 
(represented by blue ovals) were identified and proposed links were added to the seed 
network genes (represented by gray ovals).  Red arrows indicate a negative interaction 
between genes, blue arrows a positive interaction.  The dashed arrows indicate hypothesized 
links not backed by direct experimental evidence found in the literature.  The box 
surrounding Nrl, Nr2e3, and rhodopsin indicates seed network genes which are specific to 
rod photoreceptors.  Candidate genes (blue) which have a link to this box are proposed to 
interact with several rod genes.     
 
Table 1: Correlations of correlations values between each of the gene expression datasets.  In 
calculating each correlation of correlations, only the subset of genes in common between the 
two datasets was used.  This subset was different for each pair of datasets.  SAGE = SAGE 
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data from whole retina [2]; MOE430.2.0 = Affymetrix microarray data from developing rod 
progenitors [9]; Mu74Av2_1 =  Affymetrix microarray data from whole retina [6]; 
Mu74Av2_2 = Affymetrix microarray data from whole retina [8]; cDNA microarray = 
cDNA microarray data from whole retina [10]; 2DGE = 2D-PAGE data from whole retina 
(Barnhill et al., manuscript in preparation).  * p < 0.001, ** p < 0.02, *** p < 0.05   
 
Table 2:  Datasets supporting each positive edge between all pairs of genes shown to be 
linked in Figure 2.  Datasets supporting a particular link between seed genes (based on 
correlation) are marked with an X.  The last column indicates whether that edge was present 
in the network based on the literature (Figure 1).  It can be seen that each dataset had a part in 
confirming the edges of the correlational network (Figure 2).  No one dataset confirmed all 
edges.   
 
Table 3a: The most highly represented pathways in the list of genes correlated with multiple 
rod seed network genes.  Signaling information was retrieved using WebGestalt and the 
KEGG pathway database.  Pathways were considered highly represented if they had at least 
five genes correlated with multiple seed network genes.     
 
Table 3b: This list contains genes highly correlated with multiple seed network genes that 
also have an annotation linking them to a pathway.  Genes are listed by their Unigene symbol 














































































































  SAGE MOE430.2.0 Mu74Av2_1 Mu74Av2_2 
cDNA 
microarray 2DGE 
SAGE     0.10*  0.23*  0.12*  0.09* 0.05 
MOE430.2.0  0.10*    0.18*  0.09*  0.04* 0.00 
Mu74Av2_1  0.23*   0.18*    0.33*  0.09* 0.07 
Mu74Av2_2  0.12*   0.09*  0.33*    0.02* 0.06 
cDNA microarray  0.09*   0.04*  0.09*  0.02*   0.06 
2DGE      0.05*** 0.00    0.07**    0.06** 0.06   





































 SAGE MOE430.2.0 Mu74Av2_1 Mu74Av2_2 
cDNA 
microarray 
In network from 
literature 
Cyclin D1-Cdk4  X X X X Yes 
Cyclin D1-Chx10    X X Yes 
Cyclin D1-Rb  X  X  No 
Cdk4-Rb  X X  X Yes 
Cdk4-Chx10    X X No 
Crx-Nrl X  X   No 
Nrl-Nr2e3 X X   X Yes 
Nrl-Rho X X  X X Yes 





































# of genes 
in pathway 
G-protein coupled receptor protein signaling pathway   21   
MAPK signaling pathway   19   
Insulin signaling pathway   12   
Wnt signaling pathway   11   
Calcium signaling pathway   10   
Jak-STAT signaling pathway   8   
Pentose phosphate pathway   7   
Notch signaling pathway   5   
Adipocytokine signaling pathway   4   
gamma-aminobutyric acid signaling pathway   4   
T cell receptor signaling pathway   3   
TGF-beta signaling pathway   3   
Transmembrane receptor protein tyrosine phosphatase signaling pathway   3   
BMP signaling pathway   2   
Hedgehog signaling pathway   2   
Neuropeptide signaling pathway   2   
B cell receptor signaling pathway   2   
Epidermal growth factor receptor pathway   1   
Integrin-mediated signaling pathway   1   
Main pathways of carbohydrate metabolism   1   
Smoothened signaling pathway   1   
Toll-like receptor signaling pathway   1   




















                                                                                                                                                                     
Gene Signaling pathway 
Cpt1a Adipocytokine signaling pathway 
Adipor1 Adipocytokine signaling pathway 
Jak1 Adipocytokine signaling pathway//Jak-STAT signaling pathway 
Frap1 Adipocytokine signaling pathway//Insulin signaling pathway 
Tob1 BMP signaling pathway 
Vdac1 Calcium signaling pathway 
Mylk Calcium signaling pathway 
Slc25a5 Calcium signaling pathway 
Slc25a4 Calcium signaling pathway 
Cacna1f Calcium signaling pathway///MAPK signaling pathway 
Atp2a2 Calcium signaling pathway//ER-nuclear signaling pathway 
Eps8 epidermal growth factor receptor pathway  
Arl3 G-protein coupled receptor protein signaling pathway 
Rho G-protein coupled receptor protein signaling pathway 
Rgs8 G-protein coupled receptor protein signaling pathway 
Pde6g 
G-protein coupled receptor protein signaling pathway//epidermal growth factor 
receptor signaling pathway//activation of MAPK activity 
Pdc G-protein coupled receptor protein signaling pathway 
Ramp3 G-protein coupled receptor protein signaling pathway 
Mc1r G-protein coupled receptor protein signaling pathway 
Drd4 G-protein coupled receptor protein signaling pathway 
Drd2 
G-protein coupled receptor protein signaling pathway//dopamine receptor, adenylate 
cyclase inhibiting pathway 
Grm8 G-protein coupled receptor protein signaling pathway 
Gpr162 G-protein coupled receptor protein signaling pathway 
Gngt1 G-protein coupled receptor protein signaling pathway 
Gnb5 G-protein coupled receptor protein signaling pathway 
Gnb3 G-protein coupled receptor protein signaling pathway 
Gnb2 G-protein coupled receptor protein signaling pathway 
Gnb1 
G-protein coupled receptor protein signaling pathway//acetylcholine receptor signaling, 
muscarinic pathway 
Gnaz G-protein coupled receptor protein signaling pathway 
Gnat2 G-protein coupled receptor protein signaling pathway 
Gnat1 G-protein coupled receptor protein signaling pathway 
Gnao1 G-protein coupled receptor protein signaling pathway//dopamine receptor signaling  
Gabbr1 G-protein coupled receptor protein signaling pathway 
Gabrr2 gamma-aminobutyric acid signaling pathway 
Gabrr1 gamma-aminobutyric acid signaling pathway 
Gabrg2 gamma-aminobutyric acid signaling pathway 
Gabra1 gamma-aminobutyric acid signaling pathway 
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Table 3b continued 
  
Dhh Hedgehog signaling pathway 
Raptor Insulin signaling pathway 
Flot1 Insulin signaling pathway 
Zfp106 insulin receptor signaling pathway 
Prkcz Insulin signaling pathway 
Prkar1b Insulin signaling pathway 
Prkar1a Insulin signaling pathway 
Pkm2 Insulin signaling pathway 
Pfkp Insulin signaling pathway//Pentose phosphate pathway 
Pfkl Insulin signaling pathway//Pentose phosphate pathway 
Adam9 integrin-mediated signaling pathway 
Ifngr1 Jak-STAT signaling pathway 
Isgf3g Jak-STAT signaling pathway 
Pkd1 JAK-STAT cascade 
Pias3 Jak-STAT signaling pathway 
Pias1 Jak-STAT signaling pathway 
Socs5 Jak-STAT signaling pathway//epidermal growth factor receptor signaling pathway 
Idh3a main pathways of carbohydrate metabolism 
Rps6ka4 MAPK signaling pathway 
Rasgrf1 MAPK signaling pathway 
Pla2g5 MAPK signaling pathway 
Casp7 MAPK signaling pathway 
Cacnb2 MAPK signaling pathway 
Ddit3 MAPK signaling pathway 
Daxx MAPK signaling pathway 
Map4k3 MAPK signaling pathway 
Hspa9a MAPK signaling pathway 
Hspa5 MAPK signaling pathway 
Hspa1a MAPK signaling pathway 
Atf4 MAPK signaling pathway 
Map3k1 MAPK signaling pathway//transforming growth factor beta receptor signaling pathway 
Map2k1 MAPK signaling pathway//Insulin signaling pathway 
Sgne1 neuropeptide signaling pathway 
Rassf5 neuropeptide signaling pathway 
Neurod4 Notch signaling pathway 
Ncor2 Notch signaling pathway 
Pcaf Notch signaling pathway 
Jag1 Notch signaling pathway 
Ctbp2 Notch signaling pathway//Wnt signaling pathway 
Taldo1 Pentose phosphate pathway 
Pgm2 Pentose phosphate pathway 
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Table 3b continued 
  
Gpi1 Pentose phosphate pathway 
Aldoc Pentose phosphate pathway 
Aldoa Pentose phosphate pathway 
Fkbp8 smoothened signaling pathway 
Grb2 T cell receptor signaling pathway//Insulin signaling pathway//MAPK signaling 
pathway//Jak-STAT signaling pathway 
Nfat5 T cell receptor signaling pathway//Wnt signaling pathway//B cell receptor signaling  
Tfdp1 TGF-beta signaling pathway 
Smad1 TGF-beta signaling pathway//BMP signaling pathway//MAPKKK cascade 
Mapk14 Toll-like receptor signaling pathway//MAPK signaling pathway 
Ptpro transmembrane receptor protein tyrosine phosphatase signaling pathway 
Ptprk transmembrane receptor protein tyrosine phosphatase signaling pathway 
Ptprd transmembrane receptor protein tyrosine phosphatase signaling pathway 
Prickle1 Wnt signaling pathway 
Ppp2r2b Wnt signaling pathway 
Wisp1 Wnt receptor signaling pathway 
Camk2g Wnt signaling pathway//Calcium signaling pathway 
Camk2d Wnt signaling pathway//Calcium signaling pathway 
Prkca Wnt signaling pathway//Calcium signaling pathway//MAPK signaling pathway 
Fbxw11 Wnt signaling pathway///Hedgehog signaling pathway 
Ppp3r1 Wnt signaling pathway//B cell receptor signaling pathway//Calcium signaling 
pathway//MAPK signaling pathway//T cell receptor signaling pathway 
Rbx1 Wnt signaling pathway//TGF-beta signaling pathway 
Guca1b receptor guanylyl cyclase signaling pathway 
Klf9 progesterone receptor signaling pathway 


















CHAPTER 4: GENERAL CONCLUSIONS 
 
 
This dissertation specifically addressed the role of insulin-like growth factor 1 in rod 
differentiation and how it may influence the molecular network controlling rod development.  
We have demonstrated that IGF-1 promotes rod differentiation in the developing mouse 
retina.  In addition, we have identified several factors as good candidates for involvement in 
rod photoreceptor development through analysis of large scale gene expression studies of 
mouse retinal data.  Elucidating the mechanisms by which expanded cell populations can be 
biased towards a rod photoreceptor fate will be important for advancing the viability of 
transplantation therapies for retinal dystrophies.  Our findings contribute important 
information on factors that may control rod cell fate specification and have generated several 
questions which are feasible to address in future studies.  
Summary 
 In chapter two of this dissertation, the effects of IGF-1 on developing rod 
photoreceptors in retinal explants were investigated.  Application of IGF-1 to E17 and P0 
murine retinal explants over a two week period caused a significant increase in the 
percentage of cells expressing the rod specific marker rhodopsin.  There was no significant 
difference in cell density or the percentage of dead cells in IGF-1 treated explants compared 
to the control.  Therefore, we concluded that IGF-1 promotes rod photoreceptor 
differentiation.  The mechanism by which IGF-1 mediates the increase in rods was 
investigated through inhibition of the two main cascades of the IGF-1 signaling pathway, and 
MAP kinase and PI3 kinase pathways.  Inhibition of the MAP kinase pathway did not abolish 
the increase in rods observed upon treatment of explants with IGF-1.  Inhibition of the PI3 
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kinase pathway caused extensive cell death in retinal explants and few to no rods were 
detected after ten days in culture.   
 In chapter three we investigated the use of a seed network to query large scale 
expression datasets from previous studies of mouse retinal development.  Specifically, we 
queried data from a proteomic study of the developing retina (Barnhill et al., manuscript in 
preparation) and several retinal gene expression studies (Akimoto et al., 2006; Blackshaw et 
al., 2004; Dorrell et al., 2004; Liu et al., 2006; Zhang et al., 2006).  By using a seed network 
constructed from biologically relevant interactions demonstrated in the literature we were 
able to focus our analysis on genes involved in rod photoreceptor development.  We have 
demonstrated that combining several high throughput datasets increases the robustness of the 
analysis.  Using this querying approach we were able to identify a small number of candidate 
genes to investigate using experimental techniques.   
Recommendations for Future Research 
 
Proteomic profiling of IGF-1 treated explants  
 
We have shown that the increase in rhodopsin expression in retinal explants after 
exposure to IGF-1 is not propagated through activation of MAPK.  Since this signaling 
cascade known to be activated by IGF-1 signaling did not seem to affect of IGF-1 on rod 
photoreceptor development, alternative pathways should be investigated.  One way to 
identify potential molecules or specific pathways for further investigation is through 
proteomic analysis of IGF-1 treated explants.  Phosphorylation levels of the total protein 
complement of the cells could be compared between untreated and IGF-1 treated explants 
using a phosphoprotein stain.  Protein spots showing differential expression between 
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conditions could be picked and identified by mass spectrometry.  The list of genes generated 
from the proteomic analysis could then be examined for having a role in promoting rod 
photoreceptor differentiation.   
 SOCS3 phosphorylation in response to IGF-1 
 
One potential downstream target of the IGF-1 receptor in the retina is the suppressor 
of cytokine signaling (SOCS3).  It has been demonstrated that SOCS3 interacts with the IGF-
1 receptor upon ligand binding (Dey et al., 2000) and negatively regulates STAT3.  SOCS3 
has been shown to be expressed in the late embryonic and postnatal mouse retina.  IGF-1 
activation of SOCS3 as a potential mechanism of increased expression of rhodopsin could be 
investigated through immunoprecipitation using anti-SOCS3 and anti-phosphotyrosine 
antibodies.  If IGF-1 does act to increase rod differentiation through SOCS3, potentially IGF-
1 could decrease the inhibitory effects of CNTF on rhodopsin expression.   
 
Characterization of early response genes in IGF-1 treated explants 
 
IGF-1 has been shown to increase expression of the early response genes c-jun and c-
fos (Heidenreich et al., 1993; Leon et al., 1998; Leon et al., 1995) making these genes 
potential downstream targets of IGF-1 signaling in the retina.  The early response genes form 
the activating protein 1 (AP-1) complex which binds to facilitate transcription of genes 
containing AP-1 response elements such as Nrl and rhodopsin.  Nrl is a transcription factor 
that is essential for rod photoreceptor genesis.  Nrl has been shown to dimerize with bZIP 
proteins in vitro including c-fos (Kerppola and Curran, 1994).  It has been demonstrated that 
Nrl and c-fos colocalize in the developing mouse retina.  Furthermore, adult mice lacking c-
fos have a reduced number of rod photoreceptors (He et al., 1998), suggesting that c-fos may 
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be important for normal rod photoreceptor development.  Protein samples from retinal 
explants treated with IGF-1 could be subjected to western blot analysis to examine 
expression levels of c-fos in treated versus untreated samples to determine if IGF-1 increases 
expression of c-fos in the developing retina.  Protein-protein and protein-DNA binding 
experiments could be done to determine the interaction between c-fos and Nrl.        
 
Inhibition of other molecules in the PI3 Kinase signaling cascade 
Based on our retinal explant culture experiments involving inhibition of Akt, it 
appears that the PI3K-Akt branch of the IGF-1 signaling pathway is important for survival of 
rod photoreceptors.  However, we did not exclude the possibility that IGF-1 may be acting 
through this pathway to increase rod differentiation.  Molecules further down in the PI3-
kinase pathway from Akt may be involved in the increase in rhodopsin expression following 
exposure to exogenous IGF-1 and could be investigated through various perturbation 
experiments using explant cultures.  One potential molecule is the mammalian target of 
rapamycin (mTOR).  Among other processes mTOR is involved in activating proteins 
involved in translation initiation.  IGF-1 stimulated differentiation in myocytes is associated 
with elevation of p70S6K through activation of mTOR (Coolican et al., 1997).  Retinal 
explants could be cultured with IGF-1 and mTOR/ p70 S6K inhibitor rapamycin and see if 
the increase in rhodopsin induced by IGF-1 can be reduced by inhibition of mTOR.   
Investigation of candidate genes identified through use of a rod seed network 
Through our approach to querying several large scale expression studies, we were 
able to identify a small number of candidate genes to investigate using experimental 
techniques.  There is evidence to suggest that two of the genes, Nr1d2 and RORalpha, may 
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act to enhance transcription of rod specific genes.  Binding assays could be preformed to look 
for protein-DNA interactions between these nuclear receptors and the promoter regions of 
rhodospin and Nrl.  A characterization of the protein expression patterns in the developing 
retina could be performed for all seven groups of genes identified as candidates to determine 
if they are expressed in developing or mature rod photoreceptors.  Each of the proposed links 
added to the original seed network could be investigated with knockout studies and other 
perturbations looking for altered expression of predicted downstream targets of these 
candidate genes.   
Concluding remarks 
 This dissertation demonstrates the power of combining informatics, tissue expression 
and in vitro experimental approaches.  We have shown that mining of large scale expression 
data using information specific to a biological event of interest, such as rod photoreceptor 
development, can generate candidate genes for further investigation.  Characterization of the 
expression patterns of these candidate genes will be a feasible way to obtain important 
information about their relevance to rod development.  Genes displaying expression patterns 
consistent with having a role in rod differentiation could be investigated further using 
experimental approaches such as the retinal explant culture system used in the studies 
described here.  Through this combined approach to investigating factors involved in rod 
development we may be able to more completely define the molecular network that can bias 
stem cells for use in treating diseases causing blindness.    
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Supp. Table 1: Gene in the datasets correlated with multiple seed genes.  Genes in the 
combined dataset which had high correlation with at least two seed genes in two of the five 
datasets are listed.  A total of 986 genes met this criteria and were considered for further 
analysis.  Genes are listed by their Unigene symbol.  The correlation values are shown for 
each individual dataset.  SAGE = SAGE data from whole retina [2]; MOE430.2.0 = 
Affymetrix microarray data from developing rod progenitors [9]; Mu74Av2_1 =  Affymetrix 
microarray data from whole retina [6]; Mu74Av2_2 = Affymetrix microarray data from 
whole retina [8]; cDNA microarray = cDNA microarray data from whole retina [10]      
 
Supp. Table 2: Several genes with known links to photoreceptors are highly correlated with 
multiple seed network genes.  Genes are listed by their Unigene symbol and name.  In 
addition, the seed genes with which the known photoreceptor related genes correlate and 



















Crx 0.764 0.690 0.684 0.000 0.000 0.713 Araf
Nrl 0.783 0.929 0.821 0.800 0.000 0.833 Araf
Rho 0.000 0.000 0.975 0.700 0.000 0.837 Araf
Nr2e3 0.827 0.000 0.821 0.000 0.000 0.824 Araf
Crx 0.887 0.000 0.667 0.000 0.000 0.777 Atp1b1
Nr2e3 0.729 0.000 0.700 0.000 0.000 0.715 Atp1b1
Nrl 0.913 0.000 0.700 0.000 0.000 0.806 Atp1b1
Rho 0.733 0.000 0.900 0.900 0.000 0.844 Atp1b1
Rho 0.732 0.000 0.900 1.000 0.934 0.892 Cst3
Crx 0.844 0.000 0.667 0.000 0.000 0.756 Cst3
Nr2e3 0.707 0.000 0.700 0.000 0.000 0.703 Cst3
Nrl 0.869 0.810 0.700 0.000 0.945 0.831 Cst3
Nrl 0.884 0.905 0.000 0.000 0.845 0.878 Dctn1
Rho 0.762 0.000 0.000 0.000 0.765 0.764 Dctn1
Crx 0.884 0.905 0.000 0.700 0.000 0.830 Dctn1
Chx10 0.000 0.000 0.667 0.700 0.806 0.724 Dctn1
Nrl 0.883 0.881 0.700 0.000 0.000 0.821 Eno2
Rho 0.714 0.000 0.900 0.900 0.000 0.838 Eno2
Crx 0.883 0.690 0.667 0.000 0.000 0.747 Eno2
Nr2e3 0.767 0.000 0.700 0.000 0.000 0.733 Eno2
Crx 0.000 0.881 0.667 0.900 0.000 0.816 Ext1
Rho 0.000 0.000 1.000 0.000 0.847 0.924 Ext1
Nr2e3 0.000 0.000 0.900 0.000 0.736 0.818 Ext1
Nrl 0.000 0.762 0.900 0.000 0.773 0.812 Ext1
Crx 0.909 0.905 0.000 1.000 0.000 0.938 Gnb3
Rb1 0.000 0.000 0.700 0.000 0.736 0.718 Gnb3
Nrl 0.897 0.905 -0.900 -0.700 0.918 0.224 Gnb3
Rho 0.744 0.000 -0.700 -0.800 0.948 0.048 Gnb3
Crx 0.824 0.000 0.667 0.000 0.000 0.746 Gngt1
Nr2e3 0.697 0.000 0.900 0.000 0.000 0.799 Gngt1
Nrl 0.902 0.000 0.900 0.000 0.926 0.909 Gngt1
Rho 0.901 0.000 1.000 0.000 0.979 0.960 Gngt1
Crx 0.000 0.786 0.667 0.000 0.000 0.726 Gria2
Nrl 0.000 0.786 0.900 0.000 0.773 0.819 Gria2
Rho 0.000 0.000 1.000 0.000 0.811 0.905 Gria2
Nr2e3 0.000 0.000 0.900 0.000 0.736 0.818 Gria2
Nr2e3 0.000 0.000 0.700 0.000 0.691 0.695 Hmgn1
Nrl 0.000 0.833 0.700 0.000 0.000 0.767 Hmgn1
Rho 0.000 0.000 0.900 1.000 0.000 0.950 Hmgn1
Crx 0.000 0.810 0.667 0.000 0.000 0.738 Hmgn1
Nr2e3 0.653 0.000 0.700 0.000 0.000 0.676 Ier3
Crx 0.745 0.833 0.667 0.000 0.000 0.749 Ier3
Rho 0.000 0.000 0.900 1.000 0.000 0.950 Ier3
Nrl 0.733 0.929 0.700 0.000 0.000 0.787 Ier3
Crx 0.000 0.881 0.667 0.000 0.000 0.774 Igj
cDNA Mean corSAGE Mu74Av2_1 MOE430.2.0 Mu74Av2_2
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Nr2e3 0.000 0.000 0.900 0.000 0.692 0.796 Igj
Nrl 0.000 0.952 0.900 0.900 0.651 0.851 Igj
Rho 0.000 0.000 1.000 0.000 0.758 0.879 Igj
Rho 0.728 0.000 0.900 0.900 0.000 0.843 Uhmk1
Nrl 0.809 0.898 0.700 0.000 0.664 0.768 Uhmk1
Nr2e3 0.834 0.000 0.700 0.000 0.000 0.767 Uhmk1
Crx 0.784 0.755 0.667 0.000 0.000 0.735 Uhmk1
Nr2e3 0.666 0.000 0.000 0.000 0.773 0.719 Klf9
Crx 0.666 0.946 0.000 0.000 0.000 0.806 Klf9
Nrl 0.729 0.874 0.000 0.000 0.855 0.819 Klf9
Rho 0.000 0.000 0.700 0.900 0.875 0.825 Klf9
Crx 0.810 0.762 0.821 0.000 0.000 0.798 Mdm1
Rho 0.888 0.000 0.900 0.000 0.000 0.894 Mdm1
Nr2e3 0.726 0.000 0.800 0.000 0.000 0.763 Mdm1
Nrl 0.874 0.000 0.800 0.000 0.000 0.837 Mdm1
Crx 0.000 0.690 0.821 0.000 0.000 0.756 Mod1
Chx10 0.842 0.000 0.000 0.000 0.752 0.797 Mod1
Nrl 0.000 0.881 0.800 0.000 0.945 0.875 Mod1
Rho 0.000 0.000 0.900 0.900 0.897 0.899 Mod1
Rho 0.826 0.000 0.900 0.000 0.961 0.896 Nrl
Nrl 1.000 1.000 1.000 1.000 1.000 1.000 Nrl
Nr2e3 0.777 0.000 1.000 0.000 0.000 0.889 Nrl
Crx 0.974 0.857 0.000 0.000 0.000 0.916 Nrl
Nrl 0.000 0.905 0.000 0.000 0.727 0.816 Oaz1
Crx 0.000 0.833 0.947 0.000 0.000 0.890 Oaz1
Rho 0.665 0.000 0.000 1.000 0.000 0.832 Oaz1
Rb1 0.000 0.000 0.667 0.000 0.718 0.693 Oaz1
Nrl 0.940 0.810 0.900 0.000 0.936 0.896 Pde6g
Crx 0.902 0.000 0.667 0.000 0.000 0.784 Pde6g
Rho 0.791 0.000 1.000 1.000 0.980 0.943 Pde6g
Nr2e3 0.708 0.000 0.900 0.000 0.000 0.804 Pde6g
Nrl 0.000 0.667 0.700 0.000 0.000 0.683 Ppp3r1
Rho 0.000 0.000 0.900 1.000 0.000 0.950 Ppp3r1
Nr2e3 0.670 0.000 0.700 0.000 0.000 0.685 Ppp3r1
Crx 0.000 0.810 0.667 0.000 0.000 0.738 Ppp3r1
Rho 0.659 0.000 0.900 0.900 0.000 0.820 Prom1
Nr2e3 0.850 0.000 0.800 0.000 0.000 0.825 Prom1
Nrl 0.832 0.905 0.800 0.000 0.000 0.845 Prom1
Crx 0.844 0.810 0.000 0.000 0.000 0.827 Prom1
Crx 0.895 0.000 0.667 0.000 0.000 0.781 Ptp4a3
Nrl 0.933 0.000 0.900 0.700 0.873 0.852 Ptp4a3
Rho 0.734 0.000 1.000 0.000 0.893 0.876 Ptp4a3
Nr2e3 0.676 0.000 0.900 0.000 0.700 0.759 Ptp4a3
Nr2e3 0.697 0.000 0.900 0.000 0.000 0.799 Rcvrn
Nrl 0.902 0.976 0.900 0.800 0.952 0.906 Rcvrn




















































Rho 0.901 0.000 1.000 0.700 0.991 0.898 Rcvrn
Crx 0.824 0.833 0.667 0.000 0.000 0.775 Rcvrn
Rho 0.826 0.000 1.000 1.000 0.975 0.950 Rom1
Crx 0.974 0.000 0.667 0.000 0.000 0.821 Rom1
Nrl 1.000 0.850 0.900 0.000 0.973 0.931 Rom1
Nr2e3 0.777 0.000 0.900 0.000 0.000 0.839 Rom1
Crx 0.886 0.976 0.000 0.000 0.000 0.931 Pdc
Rho 0.822 0.000 0.800 0.900 0.000 0.841 Pdc
Nrl 0.912 0.833 0.900 0.000 0.000 0.882 Pdc
Nr2e3 0.747 0.000 0.900 0.000 0.000 0.823 Pdc
Crx 0.886 0.810 0.821 0.000 0.000 0.839 Stx3
Nr2e3 0.747 0.000 0.800 0.000 0.827 0.791 Stx3
Nrl 0.912 0.857 0.800 0.800 0.000 0.842 Stx3
Rho 0.729 0.000 0.900 0.700 0.000 0.776 Stx3
Rho 0.898 0.000 0.900 0.900 0.000 0.899 Unc119
Nrl 0.960 0.810 0.700 0.000 0.000 0.823 Unc119
Crx 0.922 0.000 0.667 0.000 0.000 0.794 Unc119
Nr2e3 0.699 0.000 0.700 0.000 0.000 0.700 Unc119
Crx 0.803 0.857 0.821 0.000 0.000 0.827 Arih2
Rho 0.759 0.000 0.900 0.000 0.838 0.833 Arih2
Nr2e3 0.841 0.000 0.800 0.000 0.709 0.783 Arih2
Nrl 0.810 0.857 0.800 0.000 0.818 0.821 Arih2
Chx10 0.000 0.766 0.000 0.800 0.000 0.783 Psmb2
Crx 0.664 0.000 0.667 0.800 0.000 0.710 Psmb2
Rho 0.672 0.000 0.900 0.000 0.747 0.773 Psmb2
Nrl 0.708 0.000 0.700 0.000 0.673 0.693 Psmb2
Crx 0.652 0.857 0.667 0.000 0.000 0.725 D15Wsu75e
Nr2e3 0.703 0.000 0.700 0.000 0.000 0.701 D15Wsu75e
Nrl 0.677 0.929 0.700 0.800 0.836 0.788 D15Wsu75e
Rho 0.841 0.000 0.900 0.700 0.843 0.821 D15Wsu75e
Rho 0.772 0.000 0.900 0.700 0.000 0.791 Zfp385
Nr2e3 0.866 0.000 0.800 0.000 0.000 0.833 Zfp385
Crx 0.953 0.000 0.821 0.000 0.000 0.887 Zfp385
Nrl 0.947 0.810 0.800 0.800 0.000 0.839 Zfp385
Nrl 0.974 0.000 0.900 0.000 0.000 0.937 Cacna1f
Crx 0.955 0.000 0.667 0.000 0.000 0.811 Cacna1f
Nr2e3 0.708 0.000 0.900 0.000 0.000 0.804 Cacna1f
Rho 0.863 0.000 1.000 0.000 0.000 0.931 Cacna1f
Nrl 0.891 0.000 0.700 0.000 0.891 0.827 Scamp5
Rho 0.763 0.000 0.900 0.000 0.884 0.849 Scamp5
Nr2e3 0.000 0.000 0.700 0.000 0.682 0.691 Scamp5
Crx 0.878 0.000 0.667 0.000 0.000 0.773 Scamp5
Crx 0.700 0.000 0.667 0.000 0.000 0.683 Pex2
Nr2e3 0.000 0.000 0.700 0.000 0.745 0.723 Pex2
Rho 0.689 0.000 0.900 0.000 0.961 0.850 Pex2
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Nrl 0.777 0.000 0.700 0.000 0.909 0.795 Pex2
Crx 0.000 0.857 0.667 0.000 0.000 0.762 Trak1
Rho 0.000 0.000 0.900 0.900 0.834 0.878 Trak1
Nr2e3 0.000 0.000 0.700 0.000 0.764 0.732 Trak1
Nrl 0.000 0.857 0.700 0.000 0.773 0.777 Trak1
Rho 0.684 0.000 0.900 0.000 0.000 0.792 Mrps11
Nr2e3 0.874 0.000 1.000 0.000 0.000 0.937 Mrps11
Crx 0.676 0.814 0.000 0.900 0.000 0.797 Mrps11
Nrl 0.720 0.000 1.000 0.000 0.000 0.860 Mrps11
Nrl 0.731 0.905 0.700 0.800 0.000 0.784 2310061I04Rik
Rho 0.000 0.000 0.900 0.700 0.000 0.800 2310061I04Rik
Crx 0.731 0.810 0.667 0.000 0.000 0.736 2310061I04Rik
Nr2e3 0.797 0.000 0.700 0.000 0.000 0.748 2310061I04Rik
Nrl 0.762 0.667 0.000 0.000 0.764 0.731 Tmem30a
Crx 0.775 0.905 0.821 0.000 0.000 0.833 Tmem30a
Rho 0.000 0.000 0.000 0.900 0.793 0.846 Tmem30a
Rb1 0.000 0.000 0.800 0.000 0.691 0.745 Tmem30a
Crx 0.713 0.690 0.667 0.000 0.000 0.690 Reep6
Nrl 0.786 0.881 0.900 0.000 0.000 0.856 Reep6
Rho 0.764 0.000 1.000 0.900 0.000 0.888 Reep6
Nr2e3 0.000 0.000 0.900 0.000 0.691 0.795 Reep6
Rho 0.669 0.000 0.900 0.000 0.811 0.793 Bbs5
Nrl 0.717 0.000 0.700 0.000 0.827 0.748 Bbs5
Nr2e3 0.749 0.000 0.700 0.000 0.000 0.724 Bbs5
Crx 0.673 0.000 0.667 0.000 0.000 0.670 Bbs5
Nrl 0.912 0.000 0.700 0.000 0.000 0.806 Slc17a7
Rho 0.877 0.000 0.900 0.000 0.000 0.889 Slc17a7
Nr2e3 0.735 0.000 0.700 0.000 0.000 0.718 Slc17a7
Crx 0.842 0.000 0.667 0.000 0.000 0.754 Slc17a7
Crx 0.838 0.000 0.667 0.000 0.000 0.753 3322402L07Rik
Rho 0.662 0.000 1.000 0.000 0.000 0.831 3322402L07Rik
Nr2e3 0.775 0.000 0.900 0.000 0.000 0.837 3322402L07Rik
Nrl 0.864 0.000 0.900 0.000 0.000 0.882 3322402L07Rik
Rho 0.888 0.000 0.900 0.000 0.808 0.865 1700008G05Rik
Nrl 0.874 0.000 0.700 0.000 0.797 0.790 1700008G05Rik
Nr2e3 0.726 0.000 0.700 0.000 0.000 0.713 1700008G05Rik
Crx 0.810 0.000 0.667 0.000 0.000 0.739 1700008G05Rik
Rho 0.000 0.000 0.900 0.000 0.920 0.910 Atp6v0e2
Nr2e3 0.794 0.000 0.700 0.000 0.000 0.747 Atp6v0e2
Nrl 0.750 0.952 0.700 0.000 0.955 0.839 Atp6v0e2
Crx 0.738 0.881 0.667 0.000 0.000 0.762 Atp6v0e2
Crx 0.809 0.000 0.763 0.000 0.000 0.786 Rpgrip1
Nr2e3 0.797 0.000 0.872 0.000 0.000 0.834 Rpgrip1
Rho 0.000 0.000 0.975 0.000 0.980 0.977 Rpgrip1
Nrl 0.809 0.000 0.872 0.000 0.991 0.891 Rpgrip1
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Crx 0.824 0.000 0.667 0.000 0.000 0.746 Rdh12
Nr2e3 0.697 0.000 0.900 0.000 0.000 0.799 Rdh12
Rho 0.901 0.000 1.000 0.000 0.000 0.951 Rdh12
Nrl 0.902 0.000 0.900 0.000 0.000 0.901 Rdh12
Rho 0.764 0.000 0.700 0.700 0.858 0.756 Ptges2
Crx 0.686 0.000 0.821 0.000 0.000 0.753 Ptges2
Nrl 0.757 0.000 0.000 0.800 0.879 0.812 Ptges2
Nr2e3 0.744 0.000 0.000 0.000 0.715 0.730 Ptges2
Nrl 0.755 0.667 0.700 0.000 0.845 0.742 Stard7
Rho 0.850 0.000 0.900 0.000 0.825 0.858 Stard7
Nr2e3 0.000 0.000 0.700 0.000 0.691 0.695 Stard7
Crx 0.659 0.000 0.667 0.000 0.000 0.663 Stard7
Nrl 0.000 0.952 0.900 0.700 0.855 0.852 Rab28
Rho 0.000 0.000 1.000 0.800 0.870 0.890 Rab28
Nr2e3 0.000 0.000 0.900 0.000 0.718 0.809 Rab28
Crx 0.000 0.881 0.667 0.000 0.000 0.774 Rab28
Nr2e3 0.743 0.000 0.700 0.000 0.000 0.721
Crx 0.876 0.000 0.667 0.000 0.000 0.772
Rho 0.688 0.000 0.900 0.900 0.000 0.829
Nrl 0.883 0.000 0.700 0.000 0.000 0.791
Rho 0.884 0.000 1.000 0.000 0.000 0.942 AI875142
Nr2e3 0.721 0.000 0.900 0.000 0.000 0.811 AI875142
Nrl 0.863 0.000 0.900 0.000 0.000 0.881 AI875142
Crx 0.785 0.000 0.667 0.000 0.000 0.726 AI875142
Nr2e3 0.773 0.000 0.700 0.000 0.000 0.737 Fmip
Crx 0.653 0.000 0.667 0.000 0.000 0.660 Fmip
Rho 0.748 0.000 0.900 0.000 0.000 0.824 Fmip
Nrl 0.742 0.000 0.700 0.000 0.000 0.721 Fmip
Rb1 0.000 0.000 0.000 0.700 0.655 0.677 Brunol4
Nrl 0.833 0.000 0.000 0.000 0.836 0.835 Brunol4
Crx 0.795 0.000 0.821 0.000 0.000 0.808 Brunol4
Rho 0.751 0.000 0.000 0.000 0.879 0.815 Brunol4
Nr2e3 0.705 0.000 0.700 0.000 0.000 0.702 Laptm4b
Crx 0.818 0.690 0.000 0.000 0.000 0.754 Laptm4b
Nrl 0.862 0.881 0.700 0.000 0.000 0.814 Laptm4b
Rho 0.740 0.000 0.000 0.900 0.000 0.820 Laptm4b
Crx 0.787 0.000 0.667 0.000 0.000 0.727 Aipl1
Rho 0.791 0.000 0.900 0.000 0.980 0.890 Aipl1
Nr2e3 0.673 0.000 0.700 0.000 0.000 0.687 Aipl1
Nrl 0.851 0.000 0.700 0.000 0.964 0.838 Aipl1
Rho 0.860 0.000 0.900 0.000 0.779 0.846 Dscaml1
Nr2e3 0.740 0.000 0.800 0.000 0.000 0.770 Dscaml1
Crx 0.824 0.000 0.821 0.000 0.000 0.823 Dscaml1
Nrl 0.902 0.000 0.800 0.000 0.809 0.837 Dscaml1
Nrl 0.925 0.000 0.900 0.000 0.000 0.912 Man2a2
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Nr2e3 0.695 0.000 0.900 0.000 0.000 0.798 Man2a2
Crx 0.849 0.000 0.667 0.000 0.000 0.758 Man2a2
Rho 0.916 0.000 1.000 0.000 0.000 0.958 Man2a2
Nrl 0.792 0.000 0.900 0.000 0.855 0.849 Rapgef5
Crx 0.777 0.000 0.667 0.000 0.000 0.722 Rapgef5
Rho 0.810 0.000 1.000 0.000 0.920 0.910 Rapgef5
Nr2e3 0.000 0.000 0.900 0.000 0.682 0.791 Rapgef5
Crx 0.000 0.000 0.921 0.700 0.000 0.811 Wdtc1
Nr2e3 0.000 0.000 0.667 0.000 0.755 0.711 Wdtc1
Nrl 0.000 0.810 0.667 0.000 0.800 0.759 Wdtc1
Rho 0.000 0.000 0.821 0.000 0.724 0.773 Wdtc1
Rho 0.744 0.000 1.000 0.000 0.000 0.872 A330096I21Rik
Nrl 0.860 0.000 0.900 0.000 0.000 0.880 A330096I21Rik
Nr2e3 0.787 0.000 0.900 0.000 0.000 0.844 A330096I21Rik
Crx 0.822 0.000 0.667 0.000 0.000 0.745 A330096I21Rik
Nr2e3 0.700 0.000 0.700 0.000 0.000 0.700 Gramd1b
Nrl 0.789 0.000 0.700 0.000 0.000 0.744 Gramd1b
Crx 0.757 0.000 0.667 0.000 0.000 0.712 Gramd1b
Rho 0.780 0.000 0.900 0.000 0.000 0.840 Gramd1b
Nr2e3 0.699 0.000 0.872 0.000 0.000 0.785 Lrrc22
Nrl 0.910 0.000 0.872 0.000 0.000 0.891 Lrrc22
Crx 0.872 0.000 0.763 0.000 0.000 0.817 Lrrc22
Rho 0.789 0.000 0.975 0.000 0.000 0.882 Lrrc22
Nrl 0.844 0.000 0.900 0.000 0.900 0.881 A930011O12Rik
Nr2e3 0.838 0.000 0.900 0.000 0.727 0.822 A930011O12Rik
Rho 0.677 0.000 1.000 0.000 0.907 0.861 A930011O12Rik
Crx 0.832 0.000 0.667 0.000 0.000 0.749 A930011O12Rik
Rho 0.866 0.000 0.900 0.000 0.000 0.883 Hisppd2a
Nr2e3 0.725 0.000 0.700 0.000 0.000 0.712 Hisppd2a
Crx 0.939 0.000 0.667 0.000 0.000 0.803 Hisppd2a
Nrl 0.984 0.000 0.700 0.000 0.000 0.842 Hisppd2a
Rho 0.000 0.000 0.900 0.800 0.661 0.787 Nr1d2
Nr2e3 0.000 0.000 0.700 0.000 0.873 0.786 Nr1d2
Crx 0.000 0.810 0.667 0.000 0.000 0.738 Nr1d2
Nrl 0.000 0.667 0.700 0.700 0.664 0.683 Nr1d2
Rho 0.712 0.000 1.000 0.900 0.943 0.889 Abca4
Crx 0.000 0.690 0.667 0.000 0.000 0.679 Abca4
Nrl 0.000 0.881 0.900 0.000 0.982 0.921 Abca4
Rho 0.653 0.000 0.000 0.000 0.870 0.762 Acox1
Chx10 0.000 0.000 0.900 0.000 0.651 0.776 Acox1
Nrl 0.695 0.667 0.000 0.000 0.891 0.751 Acox1
Rho 0.000 0.000 0.700 0.000 0.820 0.760 Adam9
Crx 0.000 0.810 0.975 0.000 0.000 0.892 Adam9
Nrl 0.000 0.905 0.000 0.700 0.891 0.832 Adam9
Nrl 0.000 0.881 0.000 0.000 0.818 0.850 Adcy6
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Crx 0.000 0.786 0.821 0.000 0.000 0.803 Adcy6
Rho 0.000 0.000 0.700 0.000 0.911 0.806 Adcy6
Nrl 0.813 0.952 0.000 0.000 0.000 0.883 Aip
Rho 0.746 0.000 0.700 0.900 0.000 0.782 Aip
Crx 0.839 0.714 0.821 0.000 0.000 0.791 Aip
Rho 0.000 0.000 1.000 0.000 0.893 0.946 Akap1
Nrl 0.000 0.910 0.900 0.000 0.909 0.906 Akap1
Crx 0.000 0.898 0.667 0.000 0.000 0.783 Akap1
Rho 0.701 0.000 0.700 0.900 0.870 0.793 Aldoa
Crx 0.822 0.000 0.821 0.000 0.000 0.821 Aldoa
Nrl 0.822 0.000 0.000 0.000 0.864 0.843 Aldoa
Nrl 0.949 0.862 0.000 0.000 0.000 0.906 Amy1
Crx 0.936 0.659 0.763 0.000 0.000 0.786 Amy1
Rho 0.749 0.000 0.821 0.900 0.000 0.823 Amy1
Rho 0.000 0.000 0.900 0.000 0.770 0.835 Slc25a5
Nrl 0.000 0.714 0.700 0.000 0.736 0.717 Slc25a5
Crx 0.000 0.881 0.667 0.000 0.000 0.774 Slc25a5
Rho 0.000 0.000 0.900 0.000 0.938 0.919 Anxa7
Nrl 0.000 0.881 0.700 0.000 0.873 0.818 Anxa7
Crx 0.000 0.690 0.667 0.000 0.000 0.679 Anxa7
Crx 0.696 0.690 0.000 0.000 0.000 0.693 Ap2a2
Nrl 0.722 0.881 0.000 0.000 0.709 0.771 Ap2a2
Rho 0.678 0.000 0.700 1.000 0.711 0.772 Ap2a2
Crx 0.000 0.714 0.975 0.000 0.000 0.844 Aplp2
Nrl 0.000 0.714 0.000 0.700 0.718 0.711 Aplp2
Rho 0.663 0.000 0.000 0.800 0.711 0.724 Aplp2
Nrl 0.000 0.833 0.700 0.000 0.000 0.767 Arg2
Crx 0.000 0.810 0.667 0.000 0.000 0.738 Arg2
Rho 0.000 0.000 0.900 1.000 0.000 0.950 Arg2
Rho 0.726 0.000 0.000 0.700 0.815 0.747 Atp6v0c
Chx10 0.000 0.000 1.000 0.000 0.697 0.849 Atp6v0c
Nrl 0.894 0.850 0.000 0.800 0.855 0.850 Atp6v0c
Chx10 0.000 0.810 0.000 0.900 0.000 0.855 Phb2
Rb1 0.000 0.857 0.900 0.000 0.000 0.879 Phb2
Crx 0.000 0.000 0.718 0.900 0.000 0.809 Phb2
Crx 0.694 0.000 0.975 0.000 0.000 0.834 Bsg
Nrl 0.707 0.810 0.000 0.000 0.891 0.802 Bsg
Rho 0.000 0.000 0.000 1.000 0.806 0.903 Bsg
Crx 0.000 0.802 0.667 0.000 0.000 0.735 Cacnb2
Nrl 0.000 0.898 0.900 0.000 0.000 0.899 Cacnb2
Rho 0.000 0.000 1.000 1.000 0.000 1.000 Cacnb2
Crx 0.880 0.905 0.667 0.000 0.000 0.817 Car2
Rho 0.816 0.000 1.000 1.000 0.000 0.939 Car2
Nrl 0.905 0.905 0.900 0.000 0.000 0.903 Car2
Nrl 0.000 0.810 0.900 0.900 0.000 0.870 Casp7
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Crx 0.000 0.690 0.667 0.000 0.000 0.679 Casp7
Rho 0.000 0.000 1.000 0.000 0.651 0.826 Casp7
Nrl 0.715 0.000 0.000 0.800 0.755 0.757 Chgb
Nr2e3 0.765 0.000 0.000 0.000 0.655 0.710 Chgb
Rho 0.000 0.000 0.000 0.700 0.797 0.749 Chgb
Nrl 0.000 0.905 0.000 0.700 0.000 0.802 Clcn3
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Clcn3
Crx 0.000 0.905 0.821 0.000 0.000 0.863 Clcn3
Rho 0.000 0.000 0.700 0.800 0.866 0.789 Clock
Crx 0.000 0.786 0.821 0.000 0.000 0.803 Clock
Nrl 0.000 0.762 0.000 0.700 0.818 0.760 Clock
Rho 0.000 0.000 0.700 0.000 0.679 0.689 Clta
Chx10 0.000 0.000 0.000 0.900 0.888 0.894 Clta
Crx 0.000 0.690 0.821 0.900 0.000 0.804 Clta
Crx 0.832 0.000 0.821 0.000 0.000 0.826 Clu
Nrl 0.818 0.810 0.000 0.000 0.936 0.855 Clu
Rho 0.672 0.000 0.700 0.900 0.925 0.799 Clu
Rho 0.825 0.000 1.000 1.000 0.000 0.942 Cnga1
Crx 0.792 0.881 0.667 0.000 0.000 0.780 Cnga1
Nrl 0.823 0.952 0.900 0.000 0.000 0.892 Cnga1
Nrl 0.974 0.857 0.000 0.000 0.000 0.916 Crx
Crx 1.000 1.000 1.000 1.000 0.000 1.000 Crx
Rho 0.737 0.000 0.667 0.000 0.000 0.702 Crx
Crx 0.000 0.000 0.821 1.000 0.000 0.910 Ddb1
Rho 0.000 0.000 0.700 0.000 0.834 0.767 Ddb1
Nrl 0.000 0.810 0.000 0.000 0.818 0.814 Ddb1
Crx 0.679 0.000 0.667 0.000 0.000 0.673 Ddit3
Nrl 0.724 0.790 0.700 0.000 0.000 0.738 Ddit3
Nr2e3 0.794 0.000 0.700 0.000 0.000 0.747 Ddit3
Nr2e3 0.000 0.000 0.900 0.000 0.682 0.791 Dync1i1
Nrl 0.000 0.786 0.900 0.800 0.809 0.824 Dync1i1
Rho 0.000 0.000 0.800 0.700 0.834 0.778 Dync1i1
Rho 0.855 0.000 0.700 0.700 0.980 0.809 Dnm1
Nrl 0.947 0.833 0.000 0.800 0.964 0.886 Dnm1
Crx 0.909 0.000 0.821 0.000 0.000 0.865 Dnm1
Rb1 0.000 0.862 0.900 0.000 0.000 0.881 Eif4a1
Crx 0.000 0.000 0.718 0.800 0.000 0.759 Eif4a1
Chx10 0.693 0.000 0.000 0.800 0.000 0.747 Eif4a1
Nrl 0.842 0.833 0.800 1.000 0.000 0.869 Epb4.1l2
Nr2e3 0.735 0.000 0.800 0.000 0.000 0.768 Epb4.1l2
Crx 0.792 0.000 0.821 0.000 0.000 0.806 Epb4.1l2
Rb1 0.000 0.738 0.700 0.000 0.000 0.719 Epc1
Crx 0.000 0.000 0.872 0.800 0.000 0.836 Epc1
Chx10 0.000 0.000 0.000 0.800 0.870 0.835 Epc1
Nrl 0.000 0.905 0.000 0.700 0.000 0.802 Ephx2
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Crx 0.000 0.714 0.821 0.000 0.000 0.768 Ephx2
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Ephx2
Nrl 0.000 0.881 0.700 0.800 0.000 0.794 Eps8
Crx 0.000 0.690 0.667 0.000 0.000 0.679 Eps8
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Eps8
Crx 0.895 0.810 0.667 0.000 0.000 0.791 Gas6
Nrl 0.915 0.905 0.700 0.800 0.000 0.830 Gas6
Rho 0.742 0.000 0.900 0.700 0.000 0.781 Gas6
Rho 0.000 0.000 0.900 1.000 0.761 0.887 Rabac1
Nrl 0.694 0.976 0.700 0.000 0.773 0.786 Rabac1
Crx 0.713 0.905 0.667 0.000 0.000 0.762 Rabac1
Rho 0.000 0.000 0.000 0.700 0.907 0.803 Hagh
Nrl 0.000 0.881 0.000 0.800 0.864 0.848 Hagh
Crx 0.000 0.881 0.821 0.000 0.000 0.851 Hagh
Nrl 0.000 0.898 0.700 0.000 0.000 0.799 Gnat1
Rho 0.712 0.000 0.900 0.900 0.000 0.837 Gnat1
Crx 0.000 0.802 0.667 0.000 0.000 0.735 Gnat1
Crx 0.769 0.810 0.667 0.000 0.000 0.749 Gnb1
Rho 0.788 0.000 1.000 1.000 0.000 0.929 Gnb1
Nrl 0.832 0.905 0.900 0.000 0.000 0.879 Gnb1
Rho 0.000 0.000 0.900 0.700 0.900 0.833 Gnb5
Crx 0.000 0.690 0.667 0.000 0.000 0.679 Gnb5
Nrl 0.000 0.881 0.700 0.800 0.834 0.804 Gnb5
Crx 0.756 0.000 0.821 0.000 0.000 0.788 Gpi1
Nrl 0.781 0.786 0.000 0.700 0.864 0.783 Gpi1
Rho 0.000 0.000 0.700 0.800 0.861 0.787 Gpi1
Crx 0.671 0.857 0.821 0.000 0.000 0.783 Gpx4
Rho 0.796 0.000 0.700 0.000 0.888 0.795 Gpx4
Nrl 0.740 0.857 0.000 0.000 0.909 0.835 Gpx4
Rho 0.000 0.000 0.900 0.000 0.938 0.919 Gtf2h1
Nrl 0.000 0.000 0.700 0.000 0.873 0.786 Gtf2h1
Rb1 0.000 0.000 0.000 0.900 0.827 0.864 Gtf2h1
Rb1 0.000 0.000 0.000 0.700 0.836 0.768 Gtl3
Nrl 0.000 0.690 0.000 0.000 0.682 0.686 Gtl3
Crx 0.000 0.786 0.872 0.000 0.000 0.829 Gtl3
Rho 0.000 0.000 0.900 0.900 0.000 0.900 Guk1
Nrl 0.000 0.833 0.700 0.000 0.000 0.767 Guk1
Crx 0.000 0.905 0.667 0.000 0.000 0.786 Guk1
Nrl 0.000 0.881 0.800 0.700 0.682 0.766 Hcn1
Crx 0.000 0.690 0.821 0.000 0.000 0.756 Hcn1
Rho 0.000 0.000 0.900 0.800 0.692 0.797 Hcn1
Rho 0.720 0.000 0.000 0.900 0.952 0.857 Hdac5
Nrl 0.713 0.000 0.000 0.000 0.982 0.847 Hdac5
Crx 0.713 0.000 0.975 0.000 0.000 0.844 Hdac5
Rho 0.000 0.000 0.900 0.900 0.000 0.900 Hspa1b
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Crx 0.000 0.667 0.667 0.000 0.000 0.667 Hspa1b
Nrl 0.000 0.857 0.700 0.000 0.000 0.779 Hspa1b
Chx10 0.000 0.000 0.000 0.800 0.761 0.780 Hspa9a
Rb1 0.000 0.000 0.700 0.000 0.718 0.709 Hspa9a
Crx 0.000 0.000 0.872 0.800 0.000 0.836 Hspa9a
Crx 0.825 0.000 0.718 0.000 0.000 0.772 Itm2b
Rho 0.000 0.000 0.000 0.900 0.843 0.871 Itm2b
Nrl 0.788 0.810 0.000 0.000 0.891 0.829 Itm2b
Crx 0.000 0.714 0.667 0.000 0.000 0.691 Kcnab2
Rho 0.000 0.000 1.000 0.700 0.000 0.850 Kcnab2
Nrl 0.000 0.905 0.900 0.800 0.000 0.868 Kcnab2
Rho 0.000 0.000 0.975 0.700 0.902 0.859 Kcnb1
Crx 0.000 0.952 0.684 0.000 0.000 0.818 Kcnb1
Nrl 0.000 0.881 0.821 0.800 0.836 0.835 Kcnb1
Rho 0.000 0.000 0.821 0.000 0.802 0.811 Ktn1
Nr2e3 0.000 0.000 0.667 0.000 0.773 0.720 Ktn1
Nrl 0.000 0.000 0.667 0.000 0.718 0.693 Ktn1
Crx 0.000 0.810 0.821 0.000 0.000 0.815 Limk2
Nrl 0.000 0.810 0.000 0.900 0.764 0.824 Limk2
Rho 0.000 0.000 0.700 0.000 0.820 0.760 Limk2
Nrl 0.000 0.905 0.700 0.700 0.000 0.768 Phyh
Rho 0.000 0.000 0.900 0.800 0.000 0.850 Phyh
Crx 0.000 0.714 0.667 0.000 0.000 0.691 Phyh
Nr2e3 0.000 0.000 0.800 0.000 0.800 0.800 Lnx1
Nrl 0.000 0.905 0.800 0.800 0.000 0.835 Lnx1
Rho 0.000 0.000 0.900 0.700 0.674 0.758 Lnx1
Nrl 0.000 0.731 0.000 0.800 0.000 0.765 Slc3a2
Crx 0.000 0.671 0.975 0.000 0.000 0.823 Slc3a2
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Slc3a2
Rho 0.000 0.000 0.900 0.700 0.888 0.829 Myo6
Nrl 0.000 0.922 0.700 0.800 0.882 0.826 Myo6
Crx 0.000 0.826 0.667 0.000 0.000 0.747 Myo6
Nrl 0.735 0.810 0.700 0.000 0.918 0.791 Napb
Rho 0.710 0.000 0.900 0.900 0.970 0.870 Napb
Crx 0.761 0.000 0.667 0.000 0.000 0.714 Napb
Nrl 0.000 0.000 0.000 0.800 0.736 0.768 Nfe2l1
Crx 0.000 0.667 0.975 0.000 0.000 0.821 Nfe2l1
Rho 0.000 0.000 0.000 0.700 0.720 0.710 Nfe2l1
Nrl 0.901 0.000 0.000 0.000 0.827 0.864 Nfic
Nr2e3 0.927 0.000 0.000 0.000 0.673 0.800 Nfic
Rho 0.689 0.000 0.000 0.000 0.866 0.777 Nfic
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Nsf
Nrl 0.000 0.881 0.700 0.800 0.000 0.794 Nsf
Crx 0.000 0.690 0.667 0.000 0.000 0.679 Nsf
Nrl 0.000 0.857 0.700 0.000 0.000 0.779 Oat
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Rho 0.000 0.000 0.900 0.800 0.000 0.850 Oat
Crx 0.000 0.833 0.667 0.000 0.000 0.750 Oat
Neurod1 0.860 0.000 0.800 0.000 0.000 0.830 Sqstm1
Nrl 0.000 0.000 0.000 0.800 0.909 0.855 Sqstm1
Rho 0.000 0.000 0.000 0.700 0.879 0.790 Sqstm1
Rho 0.000 0.000 0.700 0.900 0.852 0.817 Hspa4l
Nrl 0.000 0.881 0.000 0.000 0.864 0.872 Hspa4l
Crx 0.000 0.690 0.821 0.000 0.000 0.756 Hspa4l
Rho 0.000 0.000 1.000 0.000 0.843 0.921 Pcaf
Nr2e3 0.000 0.000 0.900 0.000 0.882 0.891 Pcaf
Nrl 0.000 0.000 0.900 0.000 0.818 0.859 Pcaf
Rho 0.712 0.000 0.700 0.900 0.897 0.802 Pcp2
Crx 0.000 0.786 0.821 0.000 0.000 0.803 Pcp2
Nrl 0.000 0.881 0.000 0.000 0.909 0.895 Pcp2
Nrl 0.902 0.810 1.000 0.000 0.945 0.914 Pde6b
Nr2e3 0.697 0.000 1.000 0.000 0.000 0.849 Pde6b
Rho 0.901 0.000 0.900 1.000 0.897 0.925 Pde6b
Nrl 0.000 0.881 0.700 0.000 0.000 0.790 Pfkfb2
Crx 0.000 0.667 0.667 0.000 0.000 0.667 Pfkfb2
Rho 0.000 0.000 0.900 0.900 0.000 0.900 Pfkfb2
Crx 0.846 0.833 0.821 0.000 0.000 0.833 Pitpnm1
Nrl 0.878 0.905 0.000 0.000 0.891 0.891 Pitpnm1
Rho 0.805 0.000 0.700 0.000 0.852 0.786 Pitpnm1
Nrl 0.000 0.881 0.900 0.000 0.000 0.890 Pla2g1br
Rho 0.000 0.000 1.000 0.900 0.000 0.950 Pla2g1br
Crx 0.000 0.690 0.667 0.000 0.000 0.679 Pla2g1br
Nrl 0.000 0.952 0.700 0.000 0.000 0.826 Pla2g5
Crx 0.000 0.881 0.667 0.000 0.000 0.774 Pla2g5
Rho 0.000 0.000 0.900 0.900 0.000 0.900 Pla2g5
Crx 0.000 0.881 0.821 0.000 0.000 0.851 4-Sep
Nrl 0.000 0.952 0.000 0.800 0.664 0.805 4-Sep
Rho 0.000 0.000 0.000 0.700 0.679 0.689 4-Sep
Rho 0.679 0.000 0.700 0.000 0.911 0.763 Polb
Nrl 0.806 0.000 0.000 0.000 0.900 0.853 Polb
Crx 0.850 0.000 0.821 0.900 0.000 0.857 Polb
Crx 0.000 0.810 0.821 0.000 0.000 0.815 Pou2f1
Nrl 0.000 0.857 0.000 0.700 0.000 0.779 Pou2f1
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Pou2f1
Crx 0.914 0.762 0.975 0.000 0.000 0.883 Ppef2
Rho 0.755 0.000 0.700 0.000 0.000 0.728 Ppef2
Nrl 0.914 0.810 0.000 0.000 0.000 0.862 Ppef2
Nrl 0.674 0.690 0.000 0.800 0.864 0.757 Prkar1a
Crx 0.674 0.857 0.975 0.000 0.000 0.835 Prkar1a
Rho 0.000 0.000 0.000 0.700 0.788 0.744 Prkar1a
Nrl 0.818 0.810 0.000 0.700 0.918 0.811 Prnp
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Rho 0.000 0.000 0.700 0.800 0.852 0.784 Prnp
Crx 0.824 0.000 0.975 0.000 0.000 0.899 Prnp
Crx 0.000 0.000 0.718 0.800 0.000 0.759 Prpf4b
Chx10 0.000 0.667 0.000 0.800 0.000 0.733 Prpf4b
Rb1 0.000 0.857 0.900 0.000 0.000 0.879 Prpf4b
Chx10 0.689 0.000 0.800 0.000 0.715 0.735 Ptprd
Rho 0.000 0.000 0.000 0.800 0.870 0.835 Ptprd
Nrl 0.000 0.000 0.000 0.700 0.900 0.800 Ptprd
Rho 0.000 0.000 0.872 0.000 0.961 0.917 Rab3a
Nrl 0.000 0.000 0.667 0.000 0.918 0.793 Rab3a
Nr2e3 0.000 0.000 0.667 0.000 0.727 0.697 Rab3a
Crx 0.905 0.000 0.667 0.000 0.000 0.786 Rbp3
Rho 0.841 0.000 0.900 0.000 0.000 0.871 Rbp3
Nrl 0.956 0.000 0.700 0.000 0.000 0.828 Rbp3
Rho 0.000 0.000 0.800 0.900 0.820 0.840 Rlbp1
Nrl 0.000 0.881 0.900 0.000 0.818 0.866 Rlbp1
Nr2e3 0.000 0.000 0.900 0.000 0.673 0.786 Rlbp1
Rho 0.764 0.000 0.900 0.000 0.000 0.832 Rp1h
Nr2e3 0.783 0.000 1.000 0.000 0.000 0.892 Rp1h
Nrl 0.950 0.000 1.000 0.000 0.000 0.975 Rp1h
Crx 0.792 0.714 0.667 0.000 0.000 0.725 Rs1h
Rho 0.825 0.000 1.000 0.900 0.998 0.931 Rs1h
Nrl 0.823 0.714 0.900 0.000 0.955 0.848 Rs1h
Nrl 0.935 0.762 1.000 0.000 0.909 0.901 Sag
Nr2e3 0.724 0.000 1.000 0.000 0.000 0.862 Sag
Rho 0.818 0.000 0.900 0.900 0.970 0.897 Sag
Nrl 0.856 0.762 0.900 0.000 0.000 0.839 Scg2
Crx 0.898 0.000 0.667 0.000 0.000 0.783 Scg2
Rho 0.000 0.000 1.000 0.900 0.000 0.950 Scg2
Rho 0.000 0.000 0.900 1.000 0.000 0.950 Sdfr1
Nrl 0.797 0.905 0.700 0.000 0.000 0.800 Sdfr1
Crx 0.784 0.810 0.667 0.000 0.000 0.753 Sdfr1
Crx 0.000 0.762 0.821 0.000 0.000 0.791 Sgne1
Nrl 0.660 0.881 0.000 0.000 0.000 0.771 Sgne1
Rho 0.862 0.000 0.700 0.900 0.000 0.821 Sgne1
Nrl 0.717 0.000 0.000 1.000 0.000 0.858 Zfp106
Rho 0.655 0.000 0.700 0.000 0.000 0.678 Zfp106
Crx 0.761 0.000 0.821 0.000 0.000 0.791 Zfp106
Nrl 0.000 0.952 0.000 0.000 0.882 0.917 St6galnac2
Crx 0.000 0.714 0.821 0.000 0.000 0.768 St6galnac2
Rho 0.000 0.000 0.700 0.000 0.879 0.790 St6galnac2
Rho 0.000 0.000 0.000 0.900 0.770 0.835 Snap25
Crx 0.775 0.762 0.821 0.000 0.000 0.786 Snap25
Nrl 0.693 0.762 0.000 0.000 0.791 0.749 Snap25
Nrl 0.934 0.810 0.000 0.700 0.909 0.838 Snap91
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Crx 0.959 0.762 -0.821 -1.000 0.000 -0.025 Snap91
Rho 0.739 0.000 0.000 0.800 0.916 0.818 Snap91
Nrl 0.859 0.905 0.700 0.000 0.982 0.861 Stxbp1
Crx 0.834 0.714 0.000 0.000 0.000 0.774 Stxbp1
Rho 0.000 0.000 0.000 0.900 0.925 0.912 Stxbp1
Rho 0.953 0.000 0.000 0.700 0.893 0.849 Syp
Nr2e3 0.659 0.000 0.000 0.000 0.655 0.657 Syp
Nrl 0.917 0.000 0.000 0.800 0.936 0.885 Syp
Nrl 0.000 0.738 0.000 0.700 0.000 0.719 Syt1
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Syt1
Crx 0.000 0.738 0.821 0.000 0.000 0.779 Syt1
Nr2e3 0.000 0.000 0.900 0.000 0.800 0.850 Tef
Rho 0.000 0.000 0.700 0.000 0.811 0.755 Tef
Nrl 0.000 0.000 0.900 0.000 0.773 0.836 Tef
Nr2e3 0.688 0.000 0.000 0.000 0.664 0.676 Tsc22d1
Rho 0.000 0.000 0.000 0.800 0.738 0.769 Tsc22d1
Nrl 0.000 0.000 0.000 0.700 0.773 0.736 Tsc22d1
Rho 0.733 0.000 0.000 0.700 0.870 0.768 Timp3
Nr2e3 0.000 0.000 0.667 0.000 0.755 0.711 Timp3
Nrl 0.666 0.000 0.667 0.800 0.845 0.745 Timp3
Rho 0.000 0.000 0.900 0.900 0.843 0.881 Tspan7
Nr2e3 0.000 0.000 0.700 0.000 0.682 0.691 Tspan7
Nrl 0.000 0.810 0.700 0.000 0.827 0.779 Tspan7
Rho 0.000 0.000 0.900 0.900 0.834 0.878 Tnfaip3
Nrl 0.000 0.929 0.700 0.000 0.873 0.834 Tnfaip3
Crx 0.000 0.857 0.667 0.000 0.000 0.762 Tnfaip3
Crx 0.000 0.786 0.667 0.000 0.000 0.726 Traf3
Rb1 0.000 0.000 0.800 0.000 0.855 0.827 Traf3
Nrl 0.000 0.810 0.000 0.900 0.000 0.855 Traf3
Crx 0.000 0.810 0.975 0.000 0.000 0.892 Tob1
Rho 0.000 0.000 0.700 1.000 0.743 0.814 Tob1
Nrl 0.000 0.905 0.000 0.000 0.755 0.830 Tob1
Nrl 0.000 0.905 0.900 0.000 0.773 0.859 Tub
Rho 0.000 0.000 1.000 0.000 0.688 0.844 Tub
Crx 0.000 0.833 0.667 0.000 0.000 0.750 Tub
Crx 0.827 0.000 0.975 0.000 0.000 0.901 Tulp1
Nrl 0.883 0.833 0.000 0.000 0.991 0.903 Tulp1
Rho 0.832 0.000 0.000 0.900 0.970 0.901 Tulp1
Rho 0.000 0.000 0.000 0.700 0.847 0.774 Ube2a
Crx 0.000 0.826 0.921 0.000 0.000 0.874 Ube2a
Nrl 0.000 0.898 0.000 0.000 0.818 0.858 Ube2a
Nrl 0.699 0.000 0.000 0.000 0.882 0.791 Usp12
Crx 0.760 0.000 0.821 0.000 0.000 0.790 Usp12
Rho 0.000 0.000 0.700 0.000 0.938 0.819 Usp12
Nrl 0.000 0.905 0.800 0.700 0.918 0.831 Unc13b
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Rho 0.000 0.000 0.900 0.800 0.852 0.851 Unc13b
Crx 0.000 0.714 0.821 0.000 0.000 0.768 Unc13b
Crx 0.953 0.000 0.821 0.000 0.000 0.887 Usf2
Nr2e3 0.672 0.000 0.000 0.000 0.818 0.745 Usf2
Nrl 0.921 0.000 0.000 0.000 0.773 0.847 Usf2
Rho 0.000 0.000 0.700 0.900 0.989 0.863 Vamp2
Nrl 0.744 0.881 0.000 0.000 0.982 0.869 Vamp2
Crx 0.807 0.690 0.821 0.000 0.000 0.773 Vamp2
Crx 0.000 0.000 0.821 0.800 0.000 0.810 Vasp
Rb1 0.000 0.671 0.800 0.000 0.000 0.735 Vasp
Chx10 0.000 0.659 0.000 0.800 0.000 0.729 Vasp
Rho 0.000 0.000 0.000 0.800 0.688 0.744 Vcl
Nrl 0.000 0.952 0.000 0.700 0.709 0.787 Vcl
Crx 0.000 0.881 0.975 0.000 0.000 0.928 Vcl
Rho 0.863 0.000 0.000 0.000 0.779 0.821 Vdac1
Crx 0.915 0.000 0.667 0.000 0.000 0.791 Vdac1
Nrl 0.959 0.000 0.000 0.000 0.864 0.911 Vdac1
Crx 0.000 0.000 0.821 0.900 0.000 0.860 Lin7c
Chx10 0.000 0.000 0.000 0.900 0.738 0.819 Lin7c
Rb1 0.000 0.000 0.800 0.000 0.655 0.727 Lin7c
Rho 0.000 0.000 0.900 0.900 0.916 0.905 Vtn
Nrl 0.000 0.857 0.700 0.000 0.836 0.798 Vtn
Crx 0.000 0.667 0.667 0.000 0.000 0.667 Vtn
Crx 0.000 0.690 0.667 0.000 0.000 0.679 Wisp1
Rho 0.000 0.000 0.900 0.900 0.000 0.900 Wisp1
Nrl 0.000 0.881 0.700 0.000 0.000 0.790 Wisp1
Crx 0.000 0.000 0.718 0.700 0.000 0.709 Ercc5
Rb1 0.000 0.810 0.900 0.000 0.000 0.855 Ercc5
Chx10 0.000 0.738 0.000 0.700 0.000 0.719 Ercc5
Chx10 0.000 0.810 0.000 0.000 0.888 0.849 Zfp26
Rb1 0.000 0.000 0.800 0.900 0.000 0.850 Zfp26
Neurod1 0.000 0.000 0.900 0.700 0.000 0.800 Zfp26
Nrl 0.000 0.976 0.800 0.800 0.000 0.859 Impdh1
Crx 0.000 0.905 0.821 0.000 0.000 0.863 Impdh1
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Impdh1
Rho 0.000 0.000 0.700 0.000 0.897 0.799 Synj2bp
Crx 0.000 0.857 0.821 0.900 0.000 0.859 Synj2bp
Nrl 0.000 0.786 0.000 0.000 0.836 0.811 Synj2bp
Rho 0.810 0.000 0.000 0.900 0.738 0.816 Cadps
Nrl 0.723 0.881 0.000 0.000 0.791 0.798 Cadps
Chx10 0.000 0.000 0.900 0.000 0.651 0.776 Cadps
Rho 0.000 0.000 0.900 0.800 0.711 0.804 Azi2
Nr2e3 0.000 0.000 0.800 0.000 0.655 0.727 Azi2
Nrl 0.000 0.778 0.800 0.700 0.727 0.751 Azi2
Nr2e3 0.771 0.000 0.800 0.000 0.000 0.786 Plekhb1
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Nrl 0.825 0.000 0.800 0.000 0.900 0.842 Plekhb1
Rho 0.691 0.000 0.900 0.000 0.897 0.830 Plekhb1
Crx 0.659 0.000 0.821 0.900 0.000 0.793 Mrpl2
Rho 0.000 0.000 0.700 0.000 0.870 0.785 Mrpl2
Nrl 0.691 0.000 0.000 0.000 0.900 0.796 Mrpl2
Crx 0.000 0.762 0.667 0.000 0.000 0.714 D4Wsu53e
Rho 0.808 0.000 1.000 0.800 0.934 0.886 D4Wsu53e
Nrl 0.000 0.833 0.900 0.700 0.964 0.849 D4Wsu53e
Rb1 0.000 0.755 0.900 0.000 0.000 0.827 Prpf19
Crx 0.000 0.000 0.718 0.900 0.000 0.809 Prpf19
Chx10 0.000 0.898 0.000 0.900 0.000 0.899 Prpf19
Rho 0.000 0.000 0.900 0.900 0.957 0.919 Ndrg3
Nrl 0.000 0.952 0.700 0.000 0.909 0.854 Ndrg3
Crx 0.000 0.881 0.667 0.000 0.000 0.774 Ndrg3
Rho 0.000 0.000 0.700 1.000 0.724 0.808 Usp21
Crx 0.000 0.683 0.975 0.000 0.000 0.829 Usp21
Nrl 0.000 0.874 0.000 0.000 0.691 0.783 Usp21
Rho 0.852 0.000 0.000 0.000 0.866 0.859 Bin1
Crx 0.935 0.905 0.821 0.900 0.000 0.890 Bin1
Nrl 0.928 0.786 0.000 0.000 0.818 0.844 Bin1
Nrl 0.000 0.881 0.000 0.700 0.673 0.751 Atp11a
Crx 0.000 0.690 0.921 0.000 0.000 0.806 Atp11a
Rho 0.697 0.000 0.667 0.800 0.000 0.721 Atp11a
Nrl 0.000 0.833 0.700 0.800 0.000 0.778 Polg2
Crx 0.000 0.810 0.667 0.000 0.000 0.738 Polg2
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Polg2
Nr2e3 0.000 0.000 0.700 0.000 0.755 0.727 D2Ertd435e
Nrl 0.000 0.000 0.700 0.000 0.718 0.709 D2Ertd435e
Rho 0.000 0.000 0.900 0.000 0.724 0.812 D2Ertd435e
Nr2e3 0.000 0.000 0.900 0.000 0.664 0.782 D1Ertd161e
Rho 0.000 0.000 1.000 0.800 0.838 0.879 D1Ertd161e
Nrl 0.000 0.000 0.900 0.700 0.782 0.794 D1Ertd161e
Crx 0.000 0.690 0.821 0.000 0.000 0.756 D8Ertd594e
Nrl 0.000 0.881 0.000 0.800 0.000 0.840 D8Ertd594e
Rho 0.000 0.000 0.700 0.700 0.000 0.700 D8Ertd594e
Rho 0.720 0.000 0.700 0.900 0.000 0.773 Ahi1
Nrl 0.667 0.738 0.000 0.000 0.000 0.702 Ahi1
Crx 0.680 0.738 0.975 0.000 0.000 0.797 Ahi1
Rho 0.000 0.000 0.700 0.000 0.724 0.712 Nucb2
Nrl 0.000 0.833 0.000 0.000 0.709 0.771 Nucb2
Crx 0.000 0.976 0.821 0.000 0.000 0.898 Nucb2
Crx 0.797 0.000 0.667 0.000 0.000 0.732 Clpp
Nrl 0.822 0.000 0.000 0.000 0.718 0.770 Clpp
Rho 0.654 0.000 0.000 0.700 0.747 0.701 Clpp
Nrl 0.000 0.690 0.000 0.700 0.000 0.695 Copg
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Nr2e3 0.700 0.000 0.000 0.000 0.655 0.678 Copg
Otx2 0.762 0.000 0.700 0.000 0.000 0.731 Copg
Crx 0.000 0.833 0.872 0.000 0.000 0.853 Azin1
Rho 0.000 0.000 0.000 0.800 0.806 0.803 Azin1
Nrl 0.000 0.738 0.000 0.700 0.755 0.731 Azin1
Nrl 0.000 0.000 0.900 0.000 0.782 0.841 Hs3st3b1
Rho 0.000 0.000 1.000 0.000 0.861 0.931 Hs3st3b1
Nr2e3 0.000 0.000 0.900 0.000 0.809 0.855 Hs3st3b1
Chx10 0.000 0.881 0.000 0.900 0.000 0.890 Eif3s7
Crx 0.000 0.000 0.718 0.900 0.000 0.809 Eif3s7
Rb1 0.000 0.810 0.900 0.000 0.000 0.855 Eif3s7
Nrl 0.000 0.810 0.700 0.000 0.000 0.755 Tspan5
Crx 0.000 0.690 0.667 0.000 0.000 0.679 Tspan5
Rho 0.000 0.000 0.900 1.000 0.000 0.950 Tspan5
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Arl3
Nrl 0.000 0.905 0.700 0.800 0.000 0.802 Arl3
Crx 0.000 0.810 0.667 0.000 0.000 0.738 Arl3
Rho 0.718 0.000 1.000 1.000 0.000 0.906 Csda
Crx 0.713 0.690 0.667 0.000 0.000 0.690 Csda
Nrl 0.740 0.881 0.900 0.000 0.000 0.840 Csda
Crx 0.762 0.905 0.718 0.000 0.000 0.795 Ctsf
Rho 0.838 0.000 0.000 0.700 0.000 0.769 Ctsf
Nrl 0.838 0.976 0.000 0.800 0.000 0.871 Ctsf
Nrl 0.000 0.810 0.700 0.000 0.682 0.730 Socs5
Rho 0.000 0.000 0.900 0.700 0.679 0.760 Socs5
Crx 0.000 0.667 0.667 0.000 0.000 0.667 Socs5
Crx 0.000 0.874 0.667 0.000 0.000 0.771 Mbnl1
Nrl 0.683 0.886 0.700 0.000 0.855 0.781 Mbnl1
Rho 0.000 0.000 0.900 0.900 0.897 0.899 Mbnl1
Crx 0.673 0.000 0.821 0.000 0.000 0.747 Slc12a5
Rho 0.000 0.000 0.900 0.000 0.843 0.871 Slc12a5
Nrl 0.654 0.833 0.800 0.000 0.773 0.765 Slc12a5
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Gabarapl1
Crx 0.000 0.714 0.821 0.000 0.000 0.768 Gabarapl1
Nrl 0.000 0.905 0.000 0.800 0.000 0.852 Gabarapl1
Rb1 0.000 0.905 0.000 0.000 0.709 0.807 Fbxo3
Rho 0.000 0.000 0.000 0.700 0.925 0.812 Fbxo3
Nrl 0.000 0.000 0.000 0.800 0.873 0.836 Fbxo3
Nrl 0.000 0.881 0.700 0.000 0.000 0.790 Rhot1
Rho 0.790 0.000 0.900 0.900 0.000 0.863 Rhot1
Crx 0.000 0.690 0.667 0.000 0.000 0.679 Rhot1
Crx 0.000 0.659 0.821 0.000 0.000 0.740 Cope
Nrl 0.000 0.695 0.000 0.000 0.709 0.702 Cope
Rb1 0.000 0.000 0.800 0.000 0.691 0.745 Cope
Nrl 0.000 0.000 0.900 0.000 0.755 0.827 Foxj2
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Nr2e3 0.000 0.000 0.900 0.000 0.700 0.800 Foxj2
Rho 0.000 0.000 1.000 0.000 0.733 0.867 Foxj2
Nrl 0.000 0.000 0.700 0.000 0.709 0.705 Abhd6
Nr2e3 0.000 0.000 0.700 0.000 0.900 0.800 Abhd6
Rho 0.000 0.000 0.900 0.000 0.788 0.844 Abhd6
Neurod1 0.831 0.000 0.700 0.000 0.000 0.766 Ypel3
Rb1 0.000 0.000 0.900 0.700 0.000 0.800 Ypel3
Otx2 0.836 0.000 0.900 0.000 0.000 0.868 Ypel3
Rho 0.726 0.000 0.000 0.000 0.721 0.724 Grina
Nrl 0.850 0.857 0.000 0.000 0.683 0.797 Grina
Crx 0.838 0.000 0.921 0.000 0.000 0.879 Grina
Nrl 0.000 0.905 0.900 0.800 0.873 0.869 1810015C04Rik
Crx 0.000 0.833 0.667 0.000 0.000 0.750 1810015C04Rik
Rho 0.000 0.000 1.000 0.700 0.811 0.837 1810015C04Rik
Rho 0.000 0.000 0.900 0.900 0.000 0.900 1810009A15Rik
Crx 0.686 0.810 0.667 0.000 0.000 0.721 1810009A15Rik
Nrl 0.673 0.905 0.700 0.000 0.000 0.759 1810009A15Rik
Rho 0.656 0.000 0.000 0.000 0.825 0.740 Ergic3
Crx 0.686 0.000 0.000 0.800 0.000 0.743 Ergic3
Nrl 0.705 0.762 0.000 0.000 0.809 0.759 Ergic3
Crx 0.000 0.000 0.821 0.800 0.000 0.810 Stoml2
Chx10 0.000 0.000 0.000 0.800 0.674 0.737 Stoml2
Rb1 0.000 0.786 0.800 0.000 0.000 0.793 Stoml2
Nr2e3 0.000 0.000 0.700 0.000 0.764 0.732 4432406C05Rik
Rho 0.000 0.000 0.900 0.000 0.847 0.874 4432406C05Rik
Nrl 0.000 0.000 0.700 0.000 0.900 0.800 4432406C05Rik
Nrl 0.659 0.000 0.000 0.000 0.718 0.688 4733401H18Rik
Crx 0.715 0.000 0.821 0.000 0.000 0.768 4733401H18Rik
Rho 0.000 0.000 0.700 0.000 0.702 0.701 4733401H18Rik
Crx 0.697 0.000 0.667 0.000 0.000 0.682 Grtp1
Nrl 0.683 0.000 0.700 0.000 0.791 0.725 Grtp1
Rho 0.000 0.000 0.900 0.000 0.838 0.869 Grtp1
Rho 0.000 0.000 0.000 0.800 0.829 0.815 Sdha
Crx 0.000 0.786 0.975 0.000 0.000 0.880 Sdha
Nrl 0.000 0.881 0.000 0.700 0.864 0.815 Sdha
Nrl 0.000 0.905 0.000 0.000 0.809 0.857 Ssbp2
Crx 0.000 0.810 0.821 0.000 0.000 0.815 Ssbp2
Rho 0.000 0.000 0.700 0.900 0.806 0.802 Ssbp2
Nr2e3 0.000 0.000 0.800 0.000 0.818 0.809 Rbm7
Rho 0.000 0.000 0.900 0.000 0.747 0.824 Rbm7
Nrl 0.000 0.000 0.800 0.000 0.782 0.791 Rbm7
Crx 0.000 0.738 0.000 0.700 0.000 0.719 2210018M03Rik
Nrl 0.000 0.857 0.700 0.000 0.000 0.779 2210018M03Rik
Nr2e3 0.000 0.000 0.700 0.000 0.936 0.818 2210018M03Rik
Nrl 0.000 0.898 0.000 0.700 0.000 0.799 Smarca2
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Rho 0.000 0.000 0.700 0.800 0.000 0.750 Smarca2
Crx 0.000 0.671 0.821 0.000 0.000 0.746 Smarca2
Crx 0.000 0.000 0.718 0.700 0.000 0.709 Smc6l1
Chx10 0.000 0.714 0.000 0.700 0.000 0.707 Smc6l1
Rb1 0.000 0.929 0.900 0.000 0.000 0.914 Smc6l1
Nrl 0.827 0.000 0.000 0.000 0.845 0.836 Bbs2
Rho 0.936 0.000 0.700 0.000 0.834 0.823 Bbs2
Crx 0.768 0.000 0.821 0.000 0.000 0.794 Bbs2
Nrl 0.838 0.000 0.700 0.000 0.945 0.828 4930583H14Rik
Rho 0.762 0.000 0.900 0.000 0.925 0.862 4930583H14Rik
Crx 0.819 0.000 0.667 0.000 0.000 0.743 4930583H14Rik
Nrl 0.000 0.881 0.000 0.800 0.000 0.840 1200015F23Rik
Crx 0.000 0.690 0.821 0.000 0.000 0.756 1200015F23Rik
Rho 0.000 0.000 0.700 0.700 0.000 0.700 1200015F23Rik
Rho 0.815 0.000 0.000 0.000 0.861 0.838 Tmem66
Nrl 0.771 0.667 0.000 0.000 0.855 0.764 Tmem66
Crx 0.665 0.810 0.000 0.000 0.000 0.737 Tmem66
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Atpbd1c
Nrl 0.000 0.881 0.000 0.700 0.000 0.790 Atpbd1c
Crx 0.000 0.690 0.821 0.000 0.000 0.756 Atpbd1c
Chx10 0.000 0.000 0.000 1.000 0.679 0.839 Ndufb10
Crx 0.000 0.000 0.821 1.000 0.000 0.910 Ndufb10
Rho 0.000 0.000 0.700 0.000 0.724 0.712 Ndufb10
Crx 0.740 0.000 0.872 0.800 0.000 0.804 Syf2
Chx10 0.000 0.000 0.000 0.800 0.779 0.790 Syf2
Neurod1 0.811 0.881 0.000 0.000 0.000 0.846 Syf2
Nrl 0.000 0.000 0.900 0.000 0.782 0.841 1110020G09Rik
Rho 0.000 0.000 1.000 0.000 0.802 0.901 1110020G09Rik
Nr2e3 0.000 0.000 0.900 0.000 0.655 0.777 1110020G09Rik
Nrl 0.845 0.000 0.000 0.800 0.791 0.812 Trp53inp2
Crx 0.864 0.000 0.821 0.000 0.000 0.842 Trp53inp2
Rho 0.000 0.000 0.700 0.700 0.743 0.714 Trp53inp2
Nrl 0.000 0.000 1.000 0.000 0.736 0.868 1110034C04Rik
Nr2e3 0.000 0.000 1.000 0.000 0.655 0.827 1110034C04Rik
Rho 0.000 0.000 0.900 0.000 0.733 0.817 1110034C04Rik
Rho 0.000 0.000 0.000 0.700 0.888 0.794 1110038D17Rik
Nrl 0.000 0.000 0.000 0.800 0.882 0.841 1110038D17Rik
Crx 0.000 0.857 0.975 0.000 0.000 0.916 1110038D17Rik
Crx 0.879 0.738 0.821 0.000 0.000 0.813 1190005I06Rik
Nrl 0.873 0.833 0.000 0.800 0.000 0.835 1190005I06Rik
Rho 0.747 0.000 0.700 0.700 0.000 0.716 1190005I06Rik
Nrl 0.000 0.738 0.000 0.700 0.836 0.758 Hbld2
Rho 0.000 0.000 0.700 0.800 0.870 0.790 Hbld2
Crx 0.000 0.857 0.975 0.000 0.000 0.916 Hbld2
Crx 0.000 0.857 0.821 0.000 0.000 0.839 Ascc1
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Nrl 0.000 0.929 0.000 0.700 0.000 0.814 Ascc1
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Ascc1
Nr2e3 0.790 0.000 1.000 0.000 0.000 0.895 Dyrk2
Nrl 0.828 0.000 1.000 0.000 0.000 0.914 Dyrk2
Rho 0.733 0.000 0.900 0.000 0.000 0.816 Dyrk2
Rho 0.000 0.000 0.700 0.000 0.856 0.778 Dym
Crx 0.000 0.667 0.821 0.000 0.000 0.744 Dym
Nrl 0.000 0.857 0.000 0.900 0.882 0.880 Dym
Neurod1 0.766 0.000 0.700 0.000 0.000 0.733 Tm2d2
Nrl 0.919 0.905 0.000 0.000 0.000 0.912 Tm2d2
Crx 0.919 0.976 0.000 0.000 0.000 0.948 Tm2d2
Crx 0.681 0.000 0.667 0.000 0.000 0.674 Bbs7
Nrl 0.653 0.000 0.900 0.000 0.973 0.842 Bbs7
Rho 0.000 0.000 1.000 0.000 0.934 0.967 Bbs7
Crx 0.841 0.690 0.975 0.000 0.000 0.836 Fbxo9
Rho 0.772 0.000 0.700 1.000 0.000 0.824 Fbxo9
Nrl 0.886 0.881 0.000 0.000 0.000 0.883 Fbxo9
Nr2e3 0.000 0.000 0.700 0.000 0.709 0.705 Optn
Nrl 0.000 0.000 0.700 0.000 0.918 0.809 Optn
Rho 0.000 0.000 0.900 0.000 0.925 0.912 Optn
Nrl 0.000 0.000 0.900 0.000 0.873 0.886 Synpr
Nr2e3 0.000 0.000 0.900 0.000 0.718 0.809 Synpr
Rho 0.000 0.000 1.000 0.000 0.920 0.960 Synpr
Crx 0.842 0.000 0.821 0.000 0.000 0.831 Mms19l
Nrl 0.779 0.690 0.000 0.000 0.764 0.744 Mms19l
Rho 0.000 0.000 0.700 0.000 0.784 0.742 Mms19l
Nrl 0.000 0.868 0.000 0.800 0.000 0.834 2510002A14Rik
Crx 0.000 0.663 0.821 0.000 0.000 0.742 2510002A14Rik
Rho 0.000 0.000 0.700 0.700 0.000 0.700 2510002A14Rik
Nrl 0.000 0.857 0.000 0.800 0.000 0.829 Pdia5
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Pdia5
Crx 0.000 0.667 0.821 0.000 0.000 0.744 Pdia5
Rho 0.000 0.000 0.700 0.000 0.834 0.767 Adipor1
Nrl 0.800 0.000 0.000 0.000 0.855 0.827 Adipor1
Crx 0.850 0.000 0.821 0.000 0.000 0.836 Adipor1
Crx 0.865 0.929 0.821 0.700 0.000 0.829 Txndc1
Nrl 0.915 0.857 0.000 0.000 0.000 0.886 Txndc1
Rho 0.876 0.000 0.700 0.000 0.000 0.788 Txndc1
Crx 0.000 0.671 0.667 0.000 0.000 0.669 2900006A08Rik
Nrl 0.000 0.898 0.700 0.000 0.000 0.799 2900006A08Rik
Rho 0.000 0.000 0.900 0.900 0.000 0.900 2900006A08Rik
Crx 0.000 0.905 0.667 0.000 0.000 0.786 Ppp2r2b
Rho 0.000 0.000 1.000 0.000 0.752 0.876 Ppp2r2b
Nrl 0.000 0.667 0.900 0.000 0.736 0.768 Ppp2r2b
Crx 0.792 0.000 0.667 0.000 0.000 0.730 Cabp4
cDNA Mean corSAGE Mu74Av2_1 MOE430.2.0 Mu74Av2_2
 
 128 




Rho 0.825 0.000 0.900 0.000 0.000 0.863 Cabp4
Nrl 0.823 0.000 0.700 0.000 0.000 0.762 Cabp4
Rb1 0.000 0.000 0.718 0.000 0.736 0.727 Atp6v1d
Nrl 0.000 0.000 0.000 1.000 0.909 0.955 Atp6v1d
Chx10 0.000 0.000 0.667 0.000 0.765 0.716 Atp6v1d
Crx 0.737 0.000 0.667 0.000 0.000 0.702 4930430E16Rik
Rho 0.000 0.000 1.000 0.000 0.970 0.985 4930430E16Rik
Nrl 0.751 0.000 0.900 0.000 0.918 0.856 4930430E16Rik
Neurod1 0.863 0.000 0.000 0.700 0.000 0.782 Cltb
Otx2 0.730 0.000 0.900 0.000 0.000 0.815 Cltb
Rb1 0.000 0.714 0.000 0.900 0.000 0.807 Cltb
Rho 0.768 0.000 0.900 0.000 0.884 0.851 4933406E20Rik
Nrl 0.726 0.000 0.700 0.000 0.945 0.791 4933406E20Rik
Crx 0.694 0.000 0.667 0.000 0.000 0.681 4933406E20Rik
Crx 0.000 0.874 0.667 0.000 0.000 0.771 Ppa2
Nrl 0.000 0.719 0.900 0.000 0.891 0.836 Ppa2
Rho 0.000 0.000 1.000 0.000 0.920 0.960 Ppa2
Nrl 0.000 0.000 0.000 0.700 0.909 0.805 Gns
Rb1 0.000 0.000 0.900 0.000 0.691 0.795 Gns
Rho 0.000 0.000 0.000 0.800 0.879 0.840 Gns
Rho 0.000 0.000 0.900 0.000 0.793 0.846 Phf14
Nrl 0.000 0.000 0.700 0.000 0.782 0.741 Phf14
Nr2e3 0.000 0.000 0.700 0.000 0.655 0.677 Phf14
Nrl 0.808 0.000 1.000 0.000 0.827 0.878 Samd7
Nr2e3 0.846 0.000 1.000 0.000 0.000 0.923 Samd7
Rho 0.000 0.000 0.900 0.000 0.788 0.844 Samd7
Rho 0.000 0.000 0.900 0.700 0.000 0.800 6530401D17Rik
Nrl 0.000 0.833 0.700 0.800 0.000 0.778 6530401D17Rik
Crx 0.000 0.976 0.667 0.000 0.000 0.822 6530401D17Rik
Crx 0.900 0.000 0.821 0.000 0.000 0.861 Slc38a3
Rho 0.873 0.000 0.700 0.000 0.980 0.851 Slc38a3
Nrl 0.945 0.000 0.000 0.000 0.964 0.954 Slc38a3
Nrl 0.000 0.659 0.000 0.000 0.827 0.743 Unc84a
Crx 0.000 0.874 0.000 0.800 0.000 0.837 Unc84a
Rb1 0.000 0.000 0.900 0.000 0.773 0.836 Unc84a
Crx 0.000 0.667 0.821 0.000 0.000 0.744 Tmem50b
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Tmem50b
Nrl 0.000 0.857 0.800 0.800 0.736 0.798 Tmem50b
Crx 0.000 0.000 0.947 0.900 0.000 0.924 Brd8
Rb1 0.000 0.000 0.667 0.000 0.736 0.702 Brd8
Chx10 0.000 0.000 0.000 0.900 0.656 0.778 Brd8
Rho 0.659 0.000 1.000 0.000 0.000 0.829 Slc25a12
Crx 0.652 0.000 0.667 0.000 0.000 0.659 Slc25a12
Nrl 0.680 0.000 0.900 0.000 0.000 0.790 Slc25a12
Chx10 0.000 0.667 0.000 0.900 0.000 0.783 Cstf2t
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Crx 0.000 0.000 0.872 0.900 0.000 0.886 Cstf2t
Rb1 0.000 0.881 0.700 0.000 0.000 0.790 Cstf2t
Nrl 0.947 0.000 0.000 0.000 0.973 0.960 Elovl4
Rho 0.707 0.000 0.700 0.000 0.989 0.798 Elovl4
Crx 0.935 0.000 0.821 0.000 0.000 0.878 Elovl4
Otx2 0.679 0.000 0.900 0.000 0.000 0.790 Maged1
Chx10 0.000 0.786 0.000 0.800 0.000 0.793 Maged1
Rb1 0.000 0.857 0.900 0.000 0.000 0.879 Maged1
Rho 0.000 0.000 0.975 0.000 0.825 0.900 Tmem62
Nr2e3 0.000 0.000 0.821 0.000 0.655 0.738 Tmem62
Nrl 0.000 0.000 0.821 0.900 0.782 0.834 Tmem62
Nrl 0.000 0.000 0.700 0.000 0.709 0.705 Hadha
Nr2e3 0.000 0.000 0.700 0.000 0.855 0.777 Hadha
Rho 0.000 0.000 0.900 0.000 0.661 0.780 Hadha
Crx 0.000 0.905 0.821 0.000 0.000 0.863 AW112037
Nrl 0.683 0.905 0.000 0.800 0.000 0.796 AW112037
Rho 0.681 0.000 0.700 0.700 0.000 0.694 AW112037
Nr2e3 0.000 0.000 0.800 0.000 0.729 0.764 AI481772
Nrl 0.000 0.000 0.800 0.000 0.888 0.844 AI481772
Rho 0.000 0.000 0.900 0.000 0.945 0.923 AI481772
Rho 0.000 0.000 0.900 0.000 0.961 0.931 Dnm3
Nrl 0.000 0.000 0.700 0.000 0.918 0.809 Dnm3
Nr2e3 0.000 0.000 0.700 0.000 0.727 0.714 Dnm3
Nrl 0.812 0.833 0.900 0.800 0.000 0.836 Sncb
Nr2e3 0.652 0.000 0.900 0.000 0.000 0.776 Sncb
Rho 0.000 0.000 0.800 0.700 0.000 0.750 Sncb
Rho 0.000 0.000 1.000 0.800 0.000 0.900 Rexo2
Crx 0.000 0.786 0.667 0.000 0.000 0.726 Rexo2
Nrl 0.000 0.833 0.900 0.700 0.000 0.811 Rexo2
Rho 0.000 0.000 0.900 0.700 0.000 0.800 AI462493
Nrl 0.000 0.905 0.700 0.800 0.000 0.802 AI462493
Crx 0.000 0.810 0.667 0.000 0.000 0.738 AI462493
Nrl 0.000 0.905 0.700 0.000 0.000 0.802 Vps37c
Crx 0.000 0.810 0.667 0.000 0.000 0.738 Vps37c
Rho 0.000 0.000 0.900 0.900 0.000 0.900 Vps37c
Nrl 0.813 0.000 0.000 0.900 0.845 0.853 Scamp1
Rho 0.000 0.000 0.700 0.000 0.779 0.740 Scamp1
Crx 0.883 0.000 0.821 0.000 0.000 0.852 Scamp1
Nrl 0.720 0.810 1.000 0.000 0.927 0.864 Camk2d
Nr2e3 0.696 0.000 1.000 0.000 0.000 0.848 Camk2d
Rho 0.847 0.000 0.900 1.000 0.916 0.916 Camk2d
Nr2e3 0.000 0.000 0.900 0.000 0.718 0.809 Slco4a1
Nrl 0.000 0.000 0.900 0.000 0.891 0.895 Slco4a1
Rho 0.000 0.000 1.000 0.000 0.952 0.976 Slco4a1
Nrl 0.000 0.905 0.900 0.000 0.000 0.902 Blvra
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Rho 0.000 0.000 1.000 0.700 0.000 0.850 Blvra
Crx 0.000 0.810 0.667 0.000 0.000 0.738 Blvra
Nr2e3 0.794 0.000 0.800 0.000 0.000 0.797 Pcdh21
Rho 0.659 0.000 0.900 0.000 0.852 0.803 Pcdh21
Nrl 0.850 0.000 0.800 0.000 0.864 0.838 Pcdh21
Nr2e3 0.000 0.000 0.900 0.000 0.736 0.818 Bmf
Rho 0.000 0.000 0.800 0.000 0.838 0.819 Bmf
Nrl 0.000 0.000 0.900 0.000 0.791 0.845 Bmf
Rb1 0.000 0.000 0.975 0.000 0.809 0.892 Bat5
Rho 0.000 0.000 0.000 0.700 0.980 0.840 Bat5
Nrl 0.000 0.857 0.000 0.800 0.936 0.865 Bat5
Nrl 0.000 0.738 0.000 0.700 0.655 0.698 Mcfd2
Rho 0.000 0.000 0.667 0.800 0.000 0.733 Mcfd2
Crx 0.000 0.810 1.000 0.000 0.000 0.905 Mcfd2
Rho 0.000 0.000 0.900 0.000 0.943 0.922 Ankrd33
Crx 0.859 0.000 0.667 0.000 0.000 0.763 Ankrd33
Nrl 0.824 0.000 0.700 0.000 0.982 0.835 Ankrd33
Crx 0.834 0.000 0.975 0.000 0.000 0.905 Kbtbd7
Rho 0.000 0.000 0.700 0.000 0.834 0.767 Kbtbd7
Nrl 0.792 0.000 0.000 0.000 0.827 0.810 Kbtbd7
Nrl 0.000 0.838 0.821 0.700 0.000 0.786 Arfgef1
Crx 0.000 0.671 0.684 0.000 0.000 0.677 Arfgef1
Rho 0.000 0.000 0.975 0.800 0.000 0.887 Arfgef1
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Mapre2
Nrl 0.000 0.976 0.000 0.700 0.000 0.838 Mapre2
Crx 0.000 0.905 0.821 0.000 0.000 0.863 Mapre2
Crx 0.737 0.000 0.667 0.000 0.000 0.702 Rho
Nrl 0.826 0.000 0.900 0.000 0.961 0.896 Rho
Rho 1.000 0.000 1.000 1.000 1.000 1.000 Rho
Rho 0.721 0.000 0.900 0.000 0.000 0.810 Rhot2
Crx 0.757 0.000 0.667 0.000 0.000 0.712 Rhot2
Nrl 0.808 0.000 0.700 0.000 0.000 0.754 Rhot2
Rho 0.000 0.000 0.700 0.900 0.825 0.808 Cerk
Nrl 0.000 0.905 0.000 0.000 0.864 0.884 Cerk
Crx 0.000 0.714 0.821 0.000 0.000 0.768 Cerk
Rho 0.000 0.000 0.700 0.000 0.820 0.760 Svil
Crx 0.000 0.826 0.975 0.000 0.000 0.901 Svil
Nrl 0.000 0.802 0.000 0.000 0.791 0.797 Svil
Rho 0.825 0.000 0.900 0.900 0.000 0.875 Pde6a
Crx 0.792 0.667 0.667 0.000 0.000 0.709 Pde6a
Nrl 0.823 0.857 0.700 0.000 0.664 0.761 Pde6a
Rho 0.000 0.000 1.000 0.000 0.934 0.967 Ndufs2
Crx 0.000 0.743 0.667 0.000 0.000 0.705 Ndufs2
Nrl 0.000 0.000 0.900 0.000 0.873 0.886 Ndufs2
Rho 0.000 0.000 0.700 1.000 0.952 0.884 Plekhb2
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Nrl 0.000 0.881 0.000 0.000 0.955 0.918 Plekhb2
Crx 0.000 0.690 0.821 0.000 0.000 0.756 Plekhb2
Crx 0.792 0.000 0.667 0.000 0.000 0.730 Mpp4
Rho 0.825 0.000 0.900 0.000 0.000 0.863 Mpp4
Nrl 0.823 0.000 0.700 0.000 0.000 0.762 Mpp4
Nrl 0.000 0.000 0.000 0.800 0.800 0.800 Ndufs1
Crx 0.000 0.731 0.975 0.000 0.000 0.853 Ndufs1
Rho 0.000 0.000 0.700 0.700 0.861 0.754 Ndufs1
Nr2e3 0.000 0.000 0.700 0.000 0.664 0.682 Camk1d
Nrl 0.000 0.000 0.700 0.000 0.945 0.823 Camk1d
Rho 0.000 0.000 0.900 0.000 0.952 0.926 Camk1d
Nrl 0.000 0.738 0.000 0.000 0.827 0.783 Camsap1
Crx 0.000 0.738 0.921 0.000 0.000 0.830 Camsap1
Rho 0.000 0.000 0.667 0.000 0.825 0.746 Camsap1
Nrl 0.000 0.905 0.700 0.800 0.927 0.833 Slc25a25
Crx 0.000 0.810 0.667 0.000 0.000 0.738 Slc25a25
Rho 0.000 0.000 0.900 0.700 0.943 0.848 Slc25a25
Rho 0.000 0.000 0.900 0.800 0.000 0.850 Zdhhc5
Crx 0.000 0.929 0.667 0.000 0.000 0.798 Zdhhc5
Nrl 0.000 0.857 0.700 0.700 0.000 0.752 Zdhhc5
Crx 0.657 0.000 0.667 0.800 0.000 0.708 Pias3
Rho 0.000 0.000 0.700 0.000 0.897 0.799 Pias3
Nrl 0.657 0.000 0.000 0.000 0.891 0.774 Pias3
Rho 0.000 0.000 0.900 0.700 0.879 0.826 Rap1gds1
Nrl 0.000 0.810 0.700 0.800 0.827 0.784 Rap1gds1
Nr2e3 0.000 0.000 0.700 0.000 0.673 0.686 Rap1gds1
Rho 0.790 0.000 0.718 0.000 0.000 0.754 Samd11
Nr2e3 0.916 0.000 0.821 0.000 0.000 0.868 Samd11
Nrl 0.897 0.000 0.821 0.000 0.000 0.859 Samd11
Rho 0.876 0.000 0.700 0.000 0.000 0.788 Trafd1
Crx 0.893 0.881 0.821 0.000 0.000 0.865 Trafd1
Nrl 0.937 0.881 0.000 0.000 0.000 0.909 Trafd1
Rho 0.779 0.000 0.700 0.000 0.966 0.815 Atp1a3
Nrl 0.981 0.000 0.000 0.000 0.964 0.972 Atp1a3
Crx 0.956 0.000 0.667 0.000 0.000 0.811 Atp1a3
Nr2e3 0.739 0.000 1.000 0.000 0.000 0.869 D430042O09Rik
Rho 0.806 0.000 0.900 0.000 0.000 0.853 D430042O09Rik
Nrl 0.927 0.000 1.000 0.000 0.000 0.963 D430042O09Rik
Crx 0.792 0.000 0.667 0.000 0.000 0.730 Txnl6
Nrl 0.823 0.000 0.900 0.000 0.000 0.862 Txnl6
Rho 0.825 0.000 1.000 0.000 0.000 0.913 Txnl6
Nrl 0.823 0.000 0.900 0.000 0.845 0.856 BC016201
Rho 0.825 0.000 1.000 0.000 0.861 0.895 BC016201
Crx 0.792 0.000 0.667 0.000 0.000 0.730 BC016201
Rho 0.719 0.000 0.700 0.000 0.820 0.746 Dmxl2
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Crx 0.696 0.000 0.667 0.000 0.000 0.682 Dmxl2
Nrl 0.771 0.000 0.000 0.000 0.864 0.818 Dmxl2
Nrl 0.000 0.738 0.000 0.700 0.755 0.731 Tnpo1
Crx 0.000 0.762 0.821 0.000 0.000 0.791 Tnpo1
Rho 0.000 0.000 0.700 0.800 0.724 0.741 Tnpo1
Nr2e3 0.000 0.000 0.667 0.000 0.715 0.691 AI118078
Rho 0.000 0.000 0.667 0.000 0.845 0.756 AI118078
Nrl 0.000 0.881 0.667 0.000 0.784 0.777 AI118078
Nrl 0.656 0.000 0.800 0.700 0.000 0.719 Gphn
Nr2e3 0.750 0.000 0.800 0.000 0.000 0.775 Gphn
Crx 0.750 0.719 0.000 0.000 0.000 0.734 Gphn
Crx 0.000 0.000 0.667 0.900 0.000 0.783 Epb4.1
Nrl 0.000 0.000 0.700 0.000 0.870 0.785 Epb4.1
Rho 0.000 0.000 0.900 0.000 0.856 0.878 Epb4.1
Crx 0.683 0.000 0.667 0.000 0.000 0.675 Klhl18
Rho 0.753 0.000 1.000 0.000 0.779 0.844 Klhl18
Nrl 0.740 0.000 0.900 0.000 0.873 0.838 Klhl18
Rho 0.000 0.000 0.000 0.700 0.784 0.742 Pigs
Crx 0.000 0.857 0.821 0.000 0.000 0.839 Pigs
Nrl 0.000 1.000 0.000 0.800 0.845 0.882 Pigs
Crx 0.000 0.667 0.821 0.000 0.000 0.744 Jmjd1b
Nrl 0.000 0.857 0.000 0.700 0.655 0.737 Jmjd1b
Rho 0.000 0.000 0.700 0.800 0.661 0.720 Jmjd1b
Nr2e3 0.000 0.000 0.900 0.000 0.718 0.809 9030227G01Rik
Nrl 0.000 0.000 0.900 0.000 0.773 0.836 9030227G01Rik
Rho 0.000 0.000 1.000 0.000 0.843 0.921 9030227G01Rik
Nrl 0.000 0.000 1.000 0.000 0.945 0.973 A330068P14Rik
Nr2e3 0.000 0.000 1.000 0.000 0.764 0.882 A330068P14Rik
Rho 0.000 0.000 0.900 0.000 0.920 0.910 A330068P14Rik
Nrl 0.683 0.000 0.000 0.000 0.873 0.778 Abca2
Nr2e3 0.689 0.000 0.000 0.000 0.718 0.704 Abca2
Nrl 0.000 0.667 0.000 0.700 0.000 0.683 Ak3l1
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Ak3l1
Rho 0.000 0.000 0.700 0.000 0.838 0.769 Akp2
Nrl 0.000 0.857 0.000 0.900 0.791 0.849 Akp2
Rho 0.714 0.000 0.700 0.900 0.000 0.771 Aldoc
Crx 0.841 0.000 0.821 0.000 0.000 0.831 Aldoc
Rho 0.000 0.000 0.000 0.800 0.743 0.771 Anp32a
Nrl 0.000 0.000 0.000 0.700 0.709 0.705 Anp32a
Rho 0.757 0.000 0.000 0.700 0.000 0.729 Slc25a4
Nrl 0.675 0.905 0.000 0.800 0.000 0.793 Slc25a4
Rho 0.000 0.000 0.000 0.700 0.724 0.712 Anxa5
Nrl 0.000 0.762 0.000 0.800 0.745 0.769 Anxa5
Rho 0.906 0.000 1.000 0.000 0.838 0.915 Ap1b1
Nrl 0.670 0.810 0.900 0.000 0.845 0.806 Ap1b1
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Crx 0.000 0.786 0.000 0.700 0.000 0.743 Ap2m1
Chx10 0.000 0.000 0.900 0.700 0.000 0.800 Ap2m1
Nrl 0.000 0.738 0.000 0.000 0.727 0.733 Ap3s2
Crx 0.000 0.000 0.821 0.900 0.000 0.860 Ap3s2
Nrl 0.883 0.762 0.000 0.000 0.691 0.779 Apoe
Rho 0.832 0.000 0.000 0.900 0.738 0.823 Apoe
Rho 0.000 0.000 0.000 0.900 0.870 0.885 Aqp1
Nrl 0.000 0.874 0.000 0.000 0.782 0.828 Aqp1
Nrl 0.000 0.786 0.900 0.000 0.000 0.843 Aqp4
Rho 0.000 0.000 0.700 0.900 0.000 0.800 Aqp4
Chx10 0.000 0.695 0.000 0.800 0.000 0.747 Arf1
Crx 0.779 0.000 0.872 0.800 0.000 0.817 Arf1
Nrl 0.733 0.738 0.000 0.000 0.000 0.736 Atf4
Crx 0.740 0.738 0.000 1.000 0.000 0.826 Atf4
Crx 0.779 0.000 0.000 0.800 0.000 0.789 Neurod4
Neurod1 0.892 0.000 0.900 0.000 0.000 0.896 Neurod4
Rho 0.000 0.000 0.975 0.000 0.852 0.913 Atp1a1
Nrl 0.000 0.000 0.872 0.000 0.836 0.854 Atp1a1
Nrl 0.897 0.922 0.000 0.000 0.000 0.910 Atp1b2
Crx 0.872 0.826 0.000 0.000 0.000 0.849 Atp1b2
Rho 0.000 0.000 0.700 0.900 0.000 0.800 Atp2a2
Crx 0.000 0.810 0.821 0.000 0.000 0.815 Atp2a2
Crx 0.000 0.000 0.821 0.900 0.000 0.860 Atp5j
Rb1 0.000 0.690 0.800 0.000 0.000 0.745 Atp5j
Rho 0.000 0.000 0.700 0.900 0.000 0.800 Atp6v1a
Crx 0.000 0.762 0.821 0.000 0.000 0.791 Atp6v1a
Crx 0.000 0.810 0.821 0.000 0.000 0.815 Atp6v1b2
Nrl 0.000 0.905 0.000 0.700 0.000 0.802 Atp6v1b2
Rb1 0.000 0.762 0.900 0.000 0.000 0.831 Atpif1
Crx 0.000 0.000 0.667 0.900 0.000 0.783 Atpif1
Crx 0.000 0.000 0.718 0.800 0.000 0.759 Hnrpd
Rb1 0.000 0.714 0.900 0.000 0.000 0.807 Hnrpd
Rb1 0.000 0.000 0.700 0.900 0.000 0.800 Bag1
Neurod1 0.817 0.000 0.000 0.700 0.000 0.758 Bag1
Nrl 0.000 0.000 0.000 1.000 0.845 0.923 Bcl2l2
Rho 0.000 0.000 0.700 0.000 0.929 0.815 Bcl2l2
Nrl 0.000 0.714 0.000 0.700 0.745 0.720 Bnip3
Rho 0.000 0.000 0.000 0.800 0.761 0.780 Bnip3
Rho 0.000 0.000 0.821 0.667 0.000 0.744 Bpgm
Crx 0.000 0.790 0.763 0.000 0.000 0.777 Bpgm
Rb1 0.000 0.762 0.000 0.700 0.000 0.731 Btg1
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 Btg1
Otx2 0.779 0.000 0.718 0.000 0.000 0.749 Btg2
Rb1 0.000 0.786 0.667 0.000 0.000 0.726 Btg2
Rho 0.000 0.000 0.000 0.700 0.870 0.785 Calb2
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Nrl 0.000 0.881 0.000 0.800 0.873 0.851 Calb2
Rho 0.719 0.000 0.800 0.000 0.925 0.815 Camk2g
Nrl 0.744 0.000 0.900 0.000 0.918 0.854 Camk2g
Rb1 0.000 0.905 0.700 0.700 0.000 0.768 Cask
Neurod1 0.000 0.667 0.000 0.900 0.000 0.783 Cask
Rb1 0.000 0.833 0.000 0.700 0.000 0.767 Cd24a
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 Cd24a
Neurod1 0.923 0.000 0.000 1.000 0.000 0.961 Scarb2
Otx2 0.756 0.000 0.900 0.000 0.000 0.828 Scarb2
Rho 0.000 0.000 0.000 0.700 0.683 0.692 Cd59a
Nrl 0.000 0.000 0.000 0.800 0.664 0.732 Cd59a
Rho 0.000 0.000 0.000 0.700 0.788 0.744 Cd9
Nrl 0.000 0.738 0.000 0.800 0.809 0.782 Cd9
Crx 0.000 0.810 0.921 0.000 0.000 0.865 Cdk5
Rho 0.000 0.000 0.667 0.900 0.000 0.783 Cdk5
Rho 0.000 0.000 0.900 0.900 0.000 0.900 Cdr2
Nrl 0.000 0.731 0.700 0.000 0.000 0.715 Cdr2
Neurod1 0.000 0.833 0.000 0.900 0.000 0.867 Cetn3
Rb1 0.000 0.000 0.700 0.700 0.000 0.700 Cetn3
Nrl 0.000 0.000 0.000 0.800 0.727 0.764 Cfh
Rho 0.000 0.000 0.000 0.700 0.738 0.719 Cfh
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Cflar
Nrl 0.000 0.000 0.900 0.800 0.000 0.850 Cflar
Nrl 0.709 0.000 0.000 0.000 0.800 0.754 Cirbp
Crx 0.778 0.719 0.000 0.000 0.000 0.748 Cirbp
Rho 0.000 0.000 1.000 0.000 0.916 0.958 Ckmt1
Nrl 0.000 0.000 0.900 0.000 0.936 0.918 Ckmt1
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Tpp1
Nrl 0.000 0.762 0.000 0.800 0.000 0.781 Tpp1
Nrl 0.000 0.000 0.700 0.000 0.909 0.805 Hps3
Rho 0.000 0.000 0.900 0.000 0.925 0.912 Hps3
Nrl 0.000 0.000 0.821 0.000 0.764 0.792 Col4a3
Rho 0.000 0.000 0.667 0.000 0.806 0.737 Col4a3
Nrl 0.675 0.833 0.900 0.700 0.000 0.777 Cpe
Rho 0.720 0.000 1.000 0.800 0.000 0.840 Cpe
Nrl 0.840 0.667 0.000 0.000 0.000 0.754 Cplx1
Crx 0.828 0.881 0.000 0.000 0.000 0.854 Cplx1
Rho 0.000 0.000 0.700 0.900 0.770 0.790 Cpox
Nrl 0.000 0.667 0.000 0.000 0.673 0.670 Cpox
Nrl 0.000 0.970 0.900 0.000 0.000 0.935 Cpt1a
Nr2e3 0.720 0.000 0.900 0.000 0.000 0.810 Cpt1a
Rho 0.000 0.000 0.900 0.800 0.961 0.887 Cradd
Nrl 0.000 0.000 0.700 0.700 0.973 0.791 Cradd
Rho 0.000 0.000 0.700 0.800 0.651 0.717 Cryab
Nrl 0.000 0.000 0.000 0.700 0.673 0.686 Cryab
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Rb1 0.000 0.000 0.800 0.700 0.000 0.750 Cspg6
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 Cspg6
Crx 0.883 0.810 0.667 0.000 0.000 0.786 Ctbp2
Nrl 0.851 0.833 0.000 0.900 0.918 0.876 Ctbp2
Nrl 0.000 0.833 0.700 0.000 0.000 0.767 Ctsb
Rho 0.684 0.000 0.000 0.700 0.000 0.692 Ctsb
Nrl 0.000 0.833 0.000 0.000 0.900 0.867 Ctsl
Rho 0.000 0.000 0.000 0.900 0.897 0.899 Ctsl
Crx 0.000 0.000 0.667 1.000 0.000 0.833 Daxx
Chx10 0.000 0.000 0.000 1.000 0.843 0.921 Daxx
Nrl 0.784 0.000 0.000 0.000 0.655 0.719 Dbp
Rho 0.851 0.000 0.000 0.900 0.688 0.813 Dbp
Rho 0.000 0.000 0.000 0.700 0.966 0.833 Dct
Nrl 0.000 0.833 0.000 0.800 0.918 0.851 Dct
Neurod1 0.000 0.000 0.700 0.900 0.000 0.800 Ddost
Rb1 0.000 0.786 0.900 0.700 0.000 0.795 Ddost
Nrl 0.000 0.762 0.700 0.800 0.000 0.754 Degs1
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Degs1
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Dhh
Nrl 0.000 0.000 1.000 0.800 0.000 0.900 Dhh
Rho 0.000 0.000 0.900 0.700 0.733 0.778 Dlgh1
Nrl 0.000 0.000 0.700 0.800 0.727 0.742 Dlgh1
Nrl 0.000 0.833 0.700 0.000 0.955 0.829 Dlgh4
Rho 0.000 0.000 0.900 0.000 0.970 0.935 Dlgh4
Crx 0.000 0.738 0.975 0.000 0.000 0.856 Dmd
Rho 0.000 0.000 0.700 0.000 0.770 0.735 Dmd
Nrl 0.000 0.802 0.000 0.800 0.909 0.837 Drd2
Rho 0.000 0.000 0.000 0.700 0.893 0.796 Drd2
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Drd4
Nrl 0.000 0.898 0.000 0.800 0.000 0.849 Drd4
Nrl 0.000 0.762 0.700 0.000 0.718 0.727 Dtnb
Rho 0.000 0.000 0.900 0.000 0.779 0.840 Dtnb
Nrl 0.734 0.000 0.000 0.000 0.764 0.749 Sparcl1
Rho 0.000 0.000 0.000 0.900 0.670 0.785 Sparcl1
Crx 0.000 0.000 0.821 0.700 0.000 0.760 Eif2ak3
Chx10 0.000 0.000 0.000 0.700 0.875 0.787 Eif2ak3
Chx10 0.768 0.000 0.000 0.000 0.761 0.765 Scye1
Rb1 0.000 0.786 0.000 0.000 0.809 0.797 Scye1
Rho 0.000 0.000 0.900 0.700 0.938 0.846 Stom
Nrl 0.000 0.833 1.000 0.800 0.900 0.883 Stom
Chx10 0.000 0.000 0.667 0.000 0.661 0.664 Evl
Neurod1 0.000 0.000 0.872 0.800 0.000 0.836 Evl
Nrl 0.733 0.905 0.000 0.000 0.000 0.819 Fkbp8
Crx 0.720 0.905 0.000 0.000 0.000 0.813 Fkbp8
Nrl 0.000 0.000 0.000 0.800 0.891 0.845 Lpin1
cDNA Mean corSAGE Mu74Av2_1 MOE430.2.0 Mu74Av2_2
 
 136 




Rho 0.000 0.000 0.700 0.700 0.834 0.745 Lpin1
Neurod1 0.757 0.000 0.667 0.000 0.000 0.712 Flot1
Nrl 0.880 0.810 0.000 0.000 0.000 0.845 Flot1
Nrl 0.000 0.833 0.000 0.700 0.000 0.767 Fth1
Crx 0.000 0.976 0.667 0.000 0.000 0.822 Fth1
Chx10 0.000 0.000 0.000 0.800 0.661 0.730 Slc37a4
Crx 0.000 0.786 0.821 0.800 0.000 0.802 Slc37a4
Rho 0.000 0.000 0.800 0.900 0.000 0.850 Gabra1
Nrl 0.000 0.814 0.900 0.000 0.000 0.857 Gabra1
Nrl 0.000 0.810 0.000 0.700 0.864 0.791 Gabrg2
Rho 0.000 0.000 0.000 0.800 0.916 0.858 Gabrg2
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Gabrr1
Nrl 0.000 0.755 0.800 0.800 0.000 0.785 Gabrr1
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Gabrr2
Nrl 0.000 0.690 0.000 0.700 0.000 0.695 Gabrr2
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Gad1
Nrl 0.000 0.881 0.000 0.700 0.000 0.790 Gad1
Rb1 0.000 0.976 0.800 0.000 0.000 0.888 Gart
Crx 0.000 0.000 0.821 0.800 0.000 0.810 Gart
Rho 0.000 0.000 0.900 0.000 0.788 0.844 Usp15
Nrl 0.000 0.000 1.000 0.000 0.864 0.932 Usp15
Chx10 0.000 0.000 0.000 0.900 0.670 0.785 Mrps33
Crx 0.000 0.000 0.667 0.900 0.000 0.783 Mrps33
Nrl 0.000 0.857 1.000 0.000 0.782 0.880 B4galt1
Rho 0.000 0.000 0.900 0.900 0.825 0.875 B4galt1
Crx 0.000 0.952 0.667 0.000 0.000 0.810 Gja9
Nrl 0.000 0.881 0.900 0.000 0.000 0.890 Gja9
Rho 0.000 0.000 0.900 0.000 0.852 0.876 Gls
Nrl 0.000 0.000 0.700 0.000 0.827 0.764 Gls
Neurod1 0.699 0.000 0.700 0.000 0.000 0.700 Glud1
Rb1 0.000 0.000 0.900 0.700 0.755 0.785 Glud1
Nrl 0.699 0.833 0.000 0.900 0.791 0.806 Slc6a9
Rho 0.688 0.000 0.000 0.000 0.825 0.756 Slc6a9
Rho 0.704 0.000 0.000 0.900 0.925 0.843 Gnao1
Nrl 0.850 0.000 0.000 0.000 0.918 0.884 Gnao1
Rho 0.000 0.000 0.000 0.900 0.952 0.926 Gnat2
Nrl 0.000 0.898 0.000 0.000 0.927 0.913 Gnat2
Crx 0.000 0.929 0.667 0.000 0.000 0.798 Gnaz
Nrl 0.000 0.929 0.700 0.000 0.000 0.814 Gnaz
Chx10 0.000 0.000 0.700 0.800 0.000 0.750 Gnb2
Neurod1 0.000 0.714 0.700 0.000 0.000 0.707 Gnb2
Nrl 0.000 0.000 0.700 0.000 0.927 0.814 Got1
Rho 0.000 0.000 0.900 0.000 0.916 0.908 Got1
Nrl 0.000 0.000 0.700 0.000 0.891 0.795 Got2
Rho 0.000 0.000 0.900 0.000 0.852 0.876 Got2
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Nr2e3 0.838 0.000 0.700 0.000 0.000 0.769 Gpam
Nrl 0.000 0.881 0.700 0.900 0.000 0.827 Gpam
Rb1 0.000 0.000 0.700 0.000 0.845 0.773 Grb2
Chx10 0.000 0.667 0.000 0.000 0.743 0.705 Grb2
Rho 0.885 0.000 0.000 0.000 0.788 0.836 Gpr162
Nrl 0.801 0.000 0.000 0.000 0.791 0.796 Gpr162
Nrl 0.000 0.905 0.900 0.900 0.727 0.858 Grm8
Rho 0.000 0.000 0.700 0.000 0.806 0.753 Grm8
Chx10 0.784 0.000 0.000 0.700 0.000 0.742 Hspa5
Crx 0.000 0.000 0.667 0.700 0.000 0.683 Hspa5
Nrl 0.000 0.857 0.900 0.000 0.000 0.879 Gsg1
Rho 0.000 0.000 0.800 0.900 0.000 0.850 Gsg1
Rho 0.000 0.000 0.900 0.000 0.724 0.812 Gss
Nrl 0.000 0.000 1.000 0.000 0.682 0.841 Gss
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Gstp1
Nrl 0.000 0.857 0.000 0.800 0.000 0.829 Gstp1
Neurod1 0.000 0.000 0.700 0.900 0.000 0.800 Trip12
Rb1 0.000 0.000 0.900 0.700 0.000 0.800 Trip12
Nrl 0.000 0.738 0.000 0.000 0.727 0.733 Gtpbp1
Neurod1 0.701 0.000 0.000 0.700 0.000 0.701 Gtpbp1
Rho 0.712 0.000 0.700 0.800 0.943 0.789 Guca1a
Nrl 0.000 0.810 0.000 0.700 0.936 0.815 Guca1a
Nrl 0.840 0.810 0.000 0.800 0.000 0.816 Hgs
Neurod1 0.765 0.000 0.800 0.000 0.000 0.782 Hgs
Rho 0.000 0.000 1.000 1.000 0.861 0.954 Hif1a
Nrl 0.000 0.762 0.900 0.000 0.809 0.824 Hif1a
Rho 0.000 0.000 0.900 0.000 0.856 0.878 Hipk3
Nrl 0.000 0.000 0.800 0.000 0.791 0.795 Hipk3
Crx 0.000 0.000 0.718 0.800 0.000 0.759 Prmt1
Chx10 0.000 0.762 0.000 0.800 0.000 0.781 Prmt1
Crx 0.000 0.000 0.947 0.800 0.000 0.874 Elavl1
Rb1 0.000 0.659 0.667 0.000 0.000 0.663 Elavl1
Crx 0.000 0.850 0.667 0.000 0.000 0.759 Ifngr1
Nrl 0.000 0.695 0.900 0.000 0.000 0.797 Ifngr1
Nr2e3 0.000 0.000 0.700 0.000 0.700 0.700 Isgf3g
Rho 0.000 0.000 0.900 0.000 0.665 0.783 Isgf3g
Crx 0.000 0.683 0.000 1.000 0.000 0.841 Isl1
Chx10 0.000 0.000 0.800 1.000 0.000 0.900 Isl1
Rho 0.000 0.000 1.000 0.000 0.770 0.885 Jag1
Nrl 0.000 0.000 0.900 0.000 0.664 0.782 Jag1
Nrl 0.000 0.976 0.000 0.900 0.000 0.938 Jak1
Crx 0.000 0.905 0.821 0.000 0.000 0.863 Jak1
Nrl 0.000 0.000 0.800 0.000 0.873 0.836 Kcnc1
Rho 0.000 0.000 0.900 0.000 0.934 0.917 Kcnc1
Nrl 0.000 0.833 0.800 0.000 0.973 0.869 Kcnma1
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Rho 0.000 0.000 0.900 0.900 0.961 0.920 Kcnma1
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Kif2a
Nrl 0.000 0.738 0.900 0.700 0.000 0.779 Kif2a
Rho 0.788 0.000 0.000 0.000 0.815 0.802 Kif21b
Nrl 0.757 0.000 0.000 0.000 0.836 0.796 Kif21b
Rho 0.000 0.000 0.900 0.000 0.897 0.899 Kif3b
Nrl 0.000 0.000 0.700 0.000 0.836 0.768 Kif3b
Crx 0.000 0.000 0.667 0.800 0.000 0.733 Kns2
Rb1 0.000 0.000 0.900 0.000 0.664 0.782 Kns2
Neurod1 0.650 0.000 0.700 0.000 0.000 0.675 Ldha
Crx 0.000 0.786 0.000 0.900 0.000 0.843 Ldha
Nrl 0.000 0.762 0.000 0.000 0.773 0.767 Lhx3
Chx10 0.000 0.000 0.700 0.900 0.000 0.800 Lhx3
Nrl 0.723 0.000 0.000 0.000 0.845 0.784 Mxd1
Crx 0.669 0.000 0.667 0.000 0.000 0.668 Mxd1
Rb1 0.000 0.814 0.872 0.000 0.000 0.843 Smad1
Chx10 0.000 0.695 0.000 0.800 0.000 0.747 Smad1
Crx 0.000 0.833 0.975 0.000 0.000 0.904 Ccndbp1
Rho 0.000 0.000 0.700 0.900 0.000 0.800 Ccndbp1
Crx 0.000 0.786 0.975 0.000 0.000 0.880 Mak
Nrl 0.000 0.714 0.000 0.000 0.964 0.839 Mak
Crx 0.000 0.000 0.718 0.800 0.000 0.759 Mark3
Rb1 0.000 0.857 0.900 0.000 0.855 0.871 Mark3
Rho 0.000 0.000 0.800 0.700 0.000 0.750 Mc1r
Nrl 0.000 0.000 0.900 0.800 0.000 0.850 Mc1r
Nrl 0.000 0.738 0.821 0.000 0.000 0.779 Abcc1
Crx 0.000 0.833 0.684 0.000 0.000 0.759 Abcc1
Rb1 0.000 0.000 0.000 0.900 0.745 0.823 Mef2d
Rho 0.000 0.000 0.700 0.000 0.975 0.837 Mef2d
Rb1 0.000 0.000 0.700 0.000 0.764 0.732 Gtl2
Otx2 0.658 0.000 0.800 0.000 0.000 0.729 Gtl2
Crx 0.000 0.000 0.975 0.800 0.000 0.887 Meis1
Chx10 0.000 0.000 0.000 0.800 0.661 0.730 Meis1
Chx10 0.000 0.714 0.000 1.000 0.000 0.857 Rab8a
Crx 0.000 0.000 0.667 1.000 0.000 0.833 Rab8a
Rho 0.728 0.000 0.000 0.000 0.966 0.847 Mmp24
Nrl 0.651 0.000 0.000 0.000 0.936 0.794 Mmp24
Nrl 0.000 0.810 0.000 0.700 0.000 0.755 Cited2
Crx 0.000 0.762 0.872 0.000 0.000 0.817 Cited2
Nrl 0.663 0.833 0.000 0.000 0.909 0.802 Mtap4
Rho 0.757 0.000 0.000 0.900 0.925 0.861 Mtap4
Chx10 0.693 0.000 0.000 0.800 0.000 0.747 Laptm4a
Crx 0.000 0.000 0.872 0.800 0.000 0.836 Laptm4a
Rb1 0.000 0.000 0.800 0.700 0.000 0.750 Mxi1
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 Mxi1
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Nrl 0.000 0.886 0.000 0.900 0.000 0.893 Nap1l2
Crx 0.000 0.778 0.821 0.000 0.000 0.800 Nap1l2
Rb1 0.000 0.000 0.800 0.700 0.000 0.750 Nnt
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 Nnt
Nrl 0.000 0.833 0.900 0.000 0.000 0.867 Npc1
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Npc1
Otx2 0.831 0.000 0.718 0.000 0.000 0.774 Npdc1
Neurod1 0.000 0.000 0.718 0.700 0.000 0.709 Npdc1
Crx 0.000 0.000 0.872 0.700 0.000 0.786 Nsd1
Chx10 0.657 0.000 0.000 0.700 0.000 0.678 Nsd1
Nrl 0.000 0.000 0.000 0.900 0.927 0.914 Nsg2
Rho 0.000 0.000 0.700 0.000 0.925 0.812 Nsg2
Nrl 0.000 0.786 0.000 0.800 0.691 0.759 Ogdh
Rho 0.000 0.000 0.700 0.700 0.720 0.707 Ogdh
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Pcbp2
Nrl 0.000 0.833 0.000 0.700 0.000 0.767 Pcbp2
Rho 0.763 0.000 0.900 0.700 0.000 0.788 Pcp4
Nrl 0.859 0.000 0.800 0.800 0.000 0.820 Pcp4
Crx 0.000 0.000 0.872 0.800 0.000 0.836 Pdcd6
Rb1 0.000 0.714 0.700 0.000 0.000 0.707 Pdcd6
Rho 0.000 0.000 0.700 0.000 0.911 0.806 Pdha1
Nrl 0.000 0.000 0.000 0.900 0.882 0.891 Pdha1
Nrl 0.000 0.000 0.000 0.800 0.718 0.759 Per2
Rho 0.000 0.000 0.000 0.700 0.692 0.696 Per2
Nrl 0.000 0.833 0.700 0.800 0.682 0.754 Pfkl
Rho 0.000 0.000 0.900 0.700 0.733 0.778 Pfkl
Chx10 0.000 0.000 0.900 0.900 0.000 0.900 Pfn2
Crx 0.714 0.000 0.000 0.900 0.000 0.807 Pfn2
Nrl 0.000 0.786 0.000 0.800 0.891 0.826 Pkm2
Rho 0.000 0.000 0.000 0.700 0.829 0.765 Pkm2
Nrl 0.000 0.714 0.900 0.700 0.909 0.806 Prkca
Rho 0.000 0.000 1.000 0.000 0.861 0.931 Prkca
Nrl 0.864 0.000 0.000 0.800 0.000 0.832 Prkcb1
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Prkcb1
Nrl 0.000 0.810 0.667 0.700 0.727 0.726 Prkce
Rho 0.000 0.000 0.872 0.800 0.000 0.836 Prkce
Rho 0.000 0.000 0.900 0.000 0.665 0.783 Prkcm
Nrl 0.000 0.000 0.800 0.900 0.000 0.850 Prkcm
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Prkcz
Nrl 0.000 0.826 0.000 0.800 0.000 0.813 Prkcz
Nrl 0.000 0.786 0.000 0.900 0.000 0.843 Pkd1
Crx 0.690 0.000 0.821 0.000 0.000 0.755 Pkd1
Nrl 0.824 0.786 0.000 0.800 0.782 0.798 Pld3
Rho 0.000 0.000 0.000 0.700 0.834 0.767 Pld3
Nrl 0.000 0.881 0.000 0.800 0.818 0.833 Prkar1b
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Rho 0.000 0.000 0.000 0.700 0.856 0.778 Prkar1b
Rho 0.796 0.000 0.000 0.900 0.938 0.878 Rds
Nrl 0.997 0.810 0.000 0.000 0.945 0.917 Rds
Nrl 0.709 0.000 0.000 0.900 0.855 0.821 Psap
Rho 0.901 0.000 0.000 0.000 0.820 0.861 Psap
Neurod1 0.000 0.000 0.700 0.900 0.000 0.800 Psmc1
Rb1 0.000 0.000 0.900 0.800 0.000 0.850 Psmc1
Nrl 0.771 0.810 0.000 0.900 0.000 0.827 Ptgds
Crx 0.674 0.000 0.975 0.000 0.000 0.824 Ptgds
Rho 0.000 0.000 0.900 0.800 0.000 0.850 Ptpns1
Nrl 0.000 0.000 1.000 0.700 0.000 0.850 Ptpns1
Nrl 0.000 0.000 0.000 0.800 0.864 0.832 Ptprk
Rho 0.000 0.000 0.000 0.700 0.852 0.776 Ptprk
Chx10 0.000 0.000 0.000 0.900 0.656 0.778 Ptpro
Neurod1 0.000 0.833 0.900 0.000 0.000 0.867 Ptpro
Nrl 0.000 0.810 0.000 0.000 0.982 0.896 Pura
Rho 0.000 0.000 0.700 0.000 0.916 0.808 Pura
Crx 0.000 0.810 0.872 0.000 0.000 0.841 Pxmp3
Rb1 0.000 0.000 0.700 0.800 0.000 0.750 Pxmp3
Rho 0.000 0.000 0.000 0.700 0.724 0.712 Rab4b
Nrl 0.000 0.802 0.000 0.800 0.782 0.795 Rab4b
Nrl 0.000 0.714 0.000 0.000 0.927 0.821 Rab7
Neurod1 0.689 0.000 0.800 0.000 0.000 0.745 Rab7
Rb1 0.000 0.762 0.000 0.900 0.000 0.831 Rad21
Neurod1 0.000 0.000 1.000 0.700 0.000 0.850 Rad21
Rho 0.000 0.000 0.000 0.900 0.852 0.876 Rasgrf1
Nrl 0.000 0.810 0.000 0.000 0.764 0.787 Rasgrf1
Crx 0.000 0.874 0.921 0.000 0.000 0.898 Rbbp6
Rb1 0.000 0.000 0.718 0.700 0.000 0.709 Rbbp6
Crx 0.000 0.000 0.718 0.900 0.000 0.809 Rbmx
Rb1 0.000 0.714 0.900 0.000 0.000 0.807 Rbmx
Rb1 0.000 0.929 0.700 0.000 0.000 0.814 Rdx
Chx10 0.000 0.714 0.000 0.800 0.000 0.757 Rdx
Crx 0.000 0.690 0.872 0.000 0.000 0.781 Rag1ap1
Nrl 0.000 0.881 0.000 0.700 0.000 0.790 Rag1ap1
Rho 0.000 0.000 1.000 0.900 0.000 0.950 Rit2
Nrl 0.000 0.850 0.900 0.000 0.000 0.875 Rit2
Nrl 0.000 0.886 0.000 0.900 0.000 0.893 Rora
Crx 0.000 0.778 0.821 0.000 0.000 0.800 Rora
Nrl 0.000 0.810 0.700 0.000 0.000 0.755 Dhrs3
Rho 0.000 0.000 0.900 0.900 0.000 0.900 Dhrs3
Crx 0.000 0.000 0.975 0.800 0.000 0.887 Rxrip110
Chx10 0.000 0.000 0.000 0.800 0.852 0.826 Rxrip110
Neurod1 0.825 0.881 0.000 0.000 0.000 0.853 12/1/2006
Nr2e3 0.772 0.000 0.000 0.000 0.700 0.736 12/1/2006
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Rho 0.000 0.000 0.900 0.000 0.743 0.821 Atxn1
Nrl 0.000 0.000 0.700 0.000 0.800 0.750 Atxn1
Nrl 0.765 0.000 0.000 0.000 0.691 0.728 Clec11a
Rho 0.666 0.000 0.000 0.000 0.720 0.693 Clec11a
Chx10 0.000 0.000 0.000 0.700 0.797 0.749 Stmn3
Nrl 0.684 0.000 0.000 0.000 0.682 0.683 Stmn3
Nrl 0.000 0.762 0.800 0.000 0.736 0.766 Scn1a
Rho 0.000 0.000 0.900 0.900 0.797 0.866 Scn1a
Rb1 0.000 0.000 0.000 0.700 0.745 0.723 Sez6
Nrl 0.689 0.000 0.000 0.000 0.882 0.785 Sez6
Nrl 0.000 0.810 0.821 0.800 0.000 0.810 Sh3gl2
Rho 0.000 0.000 0.975 0.700 0.000 0.837 Sh3gl2
Otx2 0.796 0.000 0.700 0.000 0.000 0.748 Sin3b
Rb1 0.000 0.790 0.700 0.000 0.000 0.745 Sin3b
Nrl 0.000 0.786 0.700 0.000 0.000 0.743 Slc16a1
Rho 0.712 0.000 0.900 0.900 0.000 0.837 Slc16a1
Nrl 0.000 0.690 0.000 0.000 0.882 0.786 Slc1a1
Rb1 0.000 0.000 0.000 1.000 0.700 0.850 Slc1a1
Crx 0.000 0.000 0.711 0.700 0.000 0.705 Slc31a1
Chx10 0.000 0.857 0.000 0.700 0.000 0.779 Slc31a1
Nrl 0.000 0.000 0.700 0.000 0.745 0.723 Slc31a2
Rho 0.000 0.000 0.900 0.000 0.779 0.840 Slc31a2
Nrl 0.000 0.000 0.000 0.800 0.845 0.823 Smpd1
Rho 0.000 0.000 0.000 0.700 0.884 0.792 Smpd1
Otx2 0.661 0.000 0.800 0.000 0.000 0.730 Ncor2
Rb1 0.000 0.786 0.700 0.700 0.000 0.729 Ncor2
Crx 0.000 0.000 0.718 0.800 0.000 0.759 Sms
Rb1 0.000 0.667 0.900 0.000 0.000 0.783 Sms
Rb1 0.000 0.000 0.900 0.900 0.000 0.900 Eftud2
Neurod1 0.000 0.000 0.700 1.000 0.000 0.850 Eftud2
Crx 0.000 0.000 0.821 0.700 0.000 0.760 Son
Rho 0.000 0.000 0.700 0.000 0.670 0.685 Son
Otx2 0.804 0.000 0.800 0.000 0.000 0.802 Sox4
Rb1 0.000 0.786 0.700 0.000 0.000 0.743 Sox4
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 Spin
Rb1 0.000 0.738 0.800 0.700 0.000 0.746 Spin
Rho 0.000 0.000 0.000 0.800 0.688 0.744 Spna2
Nrl 0.000 0.927 0.000 0.000 0.709 0.818 Spna2
Rho 0.000 0.000 0.000 0.900 0.884 0.892 Spnb2
Nrl 0.000 0.738 0.000 0.000 0.900 0.819 Spnb2
Rho 0.692 0.000 0.000 0.700 0.870 0.754 Spop
Nrl 0.676 0.000 0.000 0.800 0.891 0.789 Spop
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 Ssrp1
Rb1 0.000 0.833 0.900 0.000 0.000 0.867 Ssrp1
Crx 0.000 0.667 0.872 0.000 0.000 0.769 Stag2
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Nrl 0.000 0.690 0.000 0.700 0.000 0.695 Stag2
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Sucla2
Nrl 0.000 0.714 0.000 0.800 0.000 0.757 Sucla2
Rb1 0.000 0.000 0.900 0.900 0.000 0.900 Supt5h
Neurod1 0.000 0.000 0.700 1.000 0.000 0.850 Supt5h
Nrl 0.000 0.000 0.700 0.000 0.864 0.782 Sdc4
Rho 0.000 0.000 0.900 0.000 0.943 0.922 Sdc4
Nrl 0.000 0.690 0.800 0.000 0.000 0.745 Syngr1
Crx 0.000 0.714 0.821 0.000 0.000 0.768 Syngr1
Crx 0.000 0.000 0.667 0.800 0.000 0.733 Taldo1
Rb1 0.000 0.690 0.000 0.000 0.773 0.732 Taldo1
Rho 0.000 0.000 0.900 0.800 0.000 0.850 Tank
Nrl 0.000 0.000 1.000 0.700 0.000 0.850 Tank
Nrl 0.699 0.833 0.000 0.000 0.864 0.799 Slc6a6
Rho 0.000 0.000 0.000 0.900 0.879 0.890 Slc6a6
Rho 0.000 0.000 0.900 0.000 0.761 0.830 Tex261
Nrl 0.000 0.762 1.000 0.000 0.791 0.851 Tex261
Crx 0.000 0.000 0.872 0.900 0.000 0.886 Tfdp1
Rb1 0.000 0.905 0.700 0.000 0.000 0.802 Tfdp1
Crx 0.000 0.881 0.975 0.000 0.000 0.928 Timm44
Rho 0.000 0.000 0.700 0.900 0.000 0.800 Timm44
Rho 0.000 0.000 0.000 0.800 0.970 0.885 Timp2
Nrl 0.000 0.000 0.000 0.700 0.955 0.827 Timp2
Rho 0.000 0.000 1.000 0.000 0.834 0.917 Tjp2
Nrl 0.000 0.000 0.900 0.000 0.818 0.859 Tjp2
Rb1 0.000 0.857 0.900 0.000 0.000 0.879 Tln1
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 Tln1
Rho 0.000 0.000 0.000 0.700 0.934 0.817 Tnfsf12
Nrl 0.000 0.810 0.000 0.800 0.855 0.821 Tnfsf12
Crx 0.000 0.000 0.821 0.700 0.000 0.760 Top1
Rb1 0.000 0.738 0.800 0.000 0.673 0.737 Top1
Crx 0.000 0.833 0.921 0.000 0.000 0.877 Nr2c1
Nrl 0.000 0.810 0.000 0.900 0.000 0.855 Nr2c1
Nrl 0.000 0.000 1.000 0.700 0.000 0.850 Trpc4
Rho 0.000 0.000 0.900 0.800 0.000 0.850 Trpc4
Nrl 0.856 0.810 0.900 0.900 0.000 0.866 Ttr
Crx 0.898 0.000 0.667 0.000 0.000 0.783 Ttr
Rho 0.000 0.000 0.700 0.700 0.952 0.784 U2af1-rs1
Nrl 0.000 0.905 0.000 0.800 0.964 0.889 U2af1-rs1
Neurod1 0.693 0.000 0.800 0.000 0.000 0.747 Ube2e3
Chx10 0.000 0.000 0.700 0.900 0.000 0.800 Ube2e3
Rb1 0.000 0.000 0.900 0.000 0.745 0.823 Ube1x
Nrl 0.000 0.810 0.000 0.700 0.000 0.755 Ube1x
Nrl 0.000 0.000 0.667 0.000 0.664 0.665 Utx
Rho 0.000 0.000 0.667 0.000 0.706 0.687 Utx
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Rho 0.000 0.000 0.900 0.000 0.897 0.899 Vldlr
Nrl 0.000 0.810 0.700 0.000 0.855 0.788 Vldlr
Rho 0.000 0.000 0.700 0.900 0.000 0.800 Vmp
Crx 0.000 0.690 0.821 0.000 0.000 0.756 Vmp
Nrl 0.000 0.762 0.700 0.000 0.000 0.731 Wbp4
Crx 0.000 0.762 0.667 0.000 0.000 0.714 Wbp4
Rho 0.000 0.000 0.000 0.900 0.916 0.908 Xbp1
Nrl 0.000 0.833 0.000 0.000 0.836 0.835 Xbp1
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 Ywhaq
Rb1 0.000 0.786 0.000 1.000 0.000 0.893 Ywhaq
Crx 0.000 0.000 0.821 0.800 0.000 0.810 Zfp207
Chx10 0.000 0.000 0.000 0.800 0.706 0.753 Zfp207
Crx 0.000 0.000 0.667 0.900 0.000 0.783 Zfp62
Rb1 0.000 0.714 0.800 0.000 0.000 0.757 Zfp62
Nr2e3 0.660 0.000 0.000 0.000 0.673 0.666 Amfr
Rb1 0.000 0.000 1.000 0.700 0.000 0.850 Amfr
Nrl 0.000 0.881 0.000 0.000 0.927 0.904 C1ql1
Rho 0.000 0.000 0.000 1.000 0.929 0.965 C1ql1
Rho 0.000 0.000 0.000 0.900 0.747 0.824 Car14
Nrl 0.000 0.833 0.000 0.000 0.773 0.803 Car14
Crx 0.000 0.000 0.718 0.900 0.000 0.809 Cfdp1
Rb1 0.000 0.690 0.900 0.000 0.000 0.795 Cfdp1
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Clca3
Nrl 0.000 0.000 0.900 0.800 0.000 0.850 Clca3
Nr2e3 0.000 0.000 0.700 0.000 0.818 0.759 Dlgh2
Nrl 0.000 0.000 0.700 0.000 0.818 0.759 Dlgh2
Crx 0.680 0.000 0.821 0.000 0.000 0.750 Mta2
Nrl 0.705 0.833 0.000 0.000 0.700 0.746 Mta2
Nrl 0.777 0.000 1.000 0.000 0.000 0.889 Nr2e3
Nr2e3 1.000 0.000 1.000 0.000 1.000 1.000 Nr2e3
Rho 0.000 0.000 0.000 0.900 0.943 0.922 Pacsin1
Nrl 0.000 0.810 0.000 0.000 0.964 0.887 Pacsin1
Crx 0.000 0.000 0.684 0.900 0.000 0.792 Papss1
Rb1 0.000 0.714 0.872 0.000 0.000 0.793 Papss1
Rb1 0.000 0.762 0.000 1.000 0.000 0.881 Dazap2
Neurod1 0.000 0.000 1.000 0.900 0.000 0.950 Dazap2
Nrl 0.000 0.000 0.000 0.700 0.827 0.764 Rnf13
Rho 0.000 0.000 0.000 0.800 0.843 0.821 Rnf13
Nrl 0.000 0.000 0.700 0.000 0.836 0.768 Srp54
Rho 0.000 0.000 0.900 0.000 0.856 0.878 Srp54
Neurod1 0.000 0.690 0.700 0.700 0.000 0.697 Tlk2
Chx10 0.000 0.000 0.700 0.000 0.692 0.696 Tlk2
Rho 0.000 0.000 0.000 1.000 0.829 0.915 Clcn7
Nrl 0.000 0.905 0.000 0.000 0.745 0.825 Clcn7
Rho 0.000 0.000 0.700 0.000 0.733 0.717 Rfwd2
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Nrl 0.000 0.000 0.900 0.000 0.718 0.809 Rfwd2
Nrl 0.000 0.000 0.700 0.000 0.691 0.695 Esrrb
Rho 0.806 0.000 0.900 0.000 0.747 0.818 Esrrb
Rho 0.000 0.000 0.000 0.700 0.779 0.740 Map2k1
Nrl 0.000 0.000 0.000 0.800 0.709 0.755 Map2k1
Neurod1 0.000 0.683 0.000 0.800 0.000 0.741 Map3k1
Nr2e3 0.000 0.000 0.700 0.000 0.800 0.750 Map3k1
Rho 0.000 0.000 0.000 0.800 0.888 0.844 Mapk14
Nrl 0.000 0.000 0.000 0.700 0.900 0.800 Mapk14
Rb1 0.000 0.762 0.800 0.000 0.000 0.781 Psma5
Crx 0.000 0.000 0.821 1.000 0.000 0.910 Psma5
Rb1 0.000 0.786 0.900 0.000 0.000 0.843 Psmb3
Crx 0.000 0.000 0.718 0.900 0.000 0.809 Psmb3
Nrl 0.000 0.738 0.000 0.000 0.945 0.842 Slc27a1
Crx 0.000 0.667 0.975 0.000 0.000 0.821 Slc27a1
Rb1 0.000 0.762 0.900 0.900 0.000 0.854 Zfp260
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 Zfp260
Nrl 0.000 0.786 0.000 0.000 0.955 0.870 Cul3
Rho 0.000 0.000 0.700 1.000 0.961 0.887 Cul3
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Ncdn
Nrl 0.000 0.833 0.000 0.800 0.000 0.817 Ncdn
Rb1 0.000 0.738 0.900 0.000 0.000 0.819 Cops5
Neurod1 0.000 0.714 0.700 0.000 0.000 0.707 Cops5
Neurod1 0.000 0.810 0.000 0.900 0.000 0.855 Pclo
Rb1 0.000 0.000 1.000 1.000 0.891 0.964 Pclo
Neurod1 0.000 0.000 0.700 0.800 0.000 0.750 Casp8ap2
Rb1 0.000 0.714 0.900 0.000 0.000 0.807 Casp8ap2
Neurod1 0.000 0.762 0.700 0.000 0.000 0.731 Cops6
Rb1 0.000 0.762 0.900 0.000 0.000 0.831 Cops6
Nrl 0.000 0.000 0.700 0.000 0.782 0.741 Mecr
Rho 0.000 0.000 0.900 0.000 0.834 0.867 Mecr
Nrl 0.000 0.881 0.667 0.000 0.655 0.734 Ppp2r5c
Rho 0.000 0.000 0.821 0.000 0.661 0.741 Ppp2r5c
Crx 0.000 0.000 0.718 0.900 0.000 0.809 AA536749
Chx10 0.000 0.000 0.000 0.900 0.697 0.799 AA536749
Nrl 0.696 0.000 0.000 0.000 0.727 0.712 Serinc3
Crx 0.659 0.762 0.000 0.000 0.000 0.710 Serinc3
Nrl 0.000 0.905 0.975 0.900 0.827 0.902 Vsnl1
Rho 0.000 0.000 0.975 0.000 0.907 0.941 Vsnl1
Rho 0.000 0.000 0.975 1.000 0.000 0.987 Pla2g7
Nrl 0.000 0.952 0.975 0.000 0.000 0.964 Pla2g7
Nrl 0.000 0.762 0.000 0.700 0.000 0.731 Dnajb9
Crx 0.000 0.762 0.872 0.000 0.000 0.817 Dnajb9
Crx 0.000 0.000 0.711 0.800 0.000 0.755 Mrpl17
Chx10 0.000 0.000 0.000 0.800 0.729 0.764 Mrpl17
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Nrl 0.000 0.833 0.821 0.800 0.945 0.850 Ihpk1
Rho 0.000 0.000 0.667 0.700 0.961 0.776 Ihpk1
Nrl 0.675 0.810 0.900 0.000 0.845 0.808 D6Wsu176e
Rho 0.843 0.000 1.000 0.900 0.815 0.890 D6Wsu176e
Rb1 0.000 0.786 0.900 0.000 0.000 0.843 D3Ucla1
Crx 0.000 0.000 0.718 0.800 0.000 0.759 D3Ucla1
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Pcsk1n
Nrl 0.000 0.833 0.000 0.800 0.000 0.817 Pcsk1n
Crx 0.812 0.881 0.000 0.000 0.000 0.846 Hist1h1c
Nrl 0.844 0.786 0.000 0.000 0.000 0.815 Hist1h1c
Chx10 0.657 0.826 0.000 0.900 0.000 0.794 Mapk6
Rb1 0.000 0.898 0.900 0.000 0.000 0.899 Mapk6
Crx 0.000 0.755 0.821 0.000 0.000 0.788 Fbxl3
Rho 0.000 0.000 0.700 1.000 0.000 0.850 Fbxl3
Nrl 0.000 0.000 0.700 0.000 0.861 0.781 Orc3l
Rho 0.000 0.000 0.900 0.000 0.868 0.884 Orc3l
Rho 0.000 0.000 0.700 0.000 0.920 0.810 Rnf10
Crx 0.000 0.000 0.821 0.700 0.000 0.760 Rnf10
Neurod1 0.000 0.000 0.900 0.700 0.000 0.800 Uble1b
Rb1 0.000 0.881 0.800 0.000 0.000 0.840 Uble1b
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 H2afz
Rb1 0.000 0.762 0.000 0.700 0.000 0.731 H2afz
Nrl 0.000 0.929 0.000 0.900 0.000 0.914 Cdk2ap2
Crx 0.000 0.929 0.821 0.000 0.000 0.875 Cdk2ap2
Rho 0.000 0.000 0.000 0.800 0.802 0.801 D8Ertd354e
Nrl 0.000 0.762 0.000 0.700 0.818 0.760 D8Ertd354e
Rb1 0.000 0.000 0.800 0.000 0.664 0.732 D4Ertd196e
Nrl 0.000 0.000 0.000 0.900 0.936 0.918 D4Ertd196e
Nrl 0.000 0.000 0.000 0.800 0.927 0.864 Tax1bp1
Rho 0.000 0.000 0.700 0.700 0.938 0.779 Tax1bp1
Rho 0.000 0.000 0.000 0.700 0.706 0.703 Ccdc56
Nrl 0.000 0.934 0.000 0.800 0.673 0.802 Ccdc56
Nrl 0.000 0.000 0.700 0.000 0.755 0.727 D12Ertd551e
Nr2e3 0.000 0.000 0.700 0.000 0.755 0.727 D12Ertd551e
Nrl 0.000 0.000 0.000 0.900 0.655 0.777 Zwint
Rho 0.675 0.000 0.000 0.000 0.706 0.691 Zwint
Rho 0.000 0.000 0.700 0.800 0.651 0.717 Rufy3
Nrl 0.000 0.000 0.000 0.700 0.682 0.691 Rufy3
Nrl 0.000 0.905 0.700 0.900 0.000 0.835 D2Bwg0891e
Crx 0.000 0.810 0.667 0.000 0.000 0.738 D2Bwg0891e
Neurod1 0.799 0.000 0.700 0.000 0.000 0.749 Cdipt
Nrl 0.000 0.905 0.000 0.900 0.655 0.820 Cdipt
Nrl 0.000 0.810 0.000 0.000 0.782 0.796 Usp2
Rho 0.000 0.000 0.700 0.900 0.843 0.814 Usp2
Nrl 0.000 0.000 0.900 0.800 0.000 0.850 Stk39
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Rho 0.000 0.000 1.000 0.700 0.661 0.787 Stk39
Crx 0.000 0.000 0.821 0.700 0.000 0.760 Tsnax
Rho 0.000 0.000 0.700 0.000 0.692 0.696 Tsnax
Rb1 0.000 0.000 0.900 0.000 0.755 0.827 Blcap
Crx 0.000 0.000 0.718 0.900 0.000 0.809 Blcap
Chx10 0.000 0.000 0.000 0.800 0.879 0.840 Cks1b
Rb1 0.000 0.833 0.000 0.000 0.700 0.767 Cks1b
Nrl 0.000 0.810 0.800 0.000 0.000 0.805 Gucy1b3
Rho 0.000 0.000 0.900 1.000 0.000 0.950 Gucy1b3
Rho 0.000 0.000 0.872 0.900 0.000 0.886 Rassf5
Nrl 0.000 0.881 0.975 0.000 0.000 0.928 Rassf5
Rho 0.000 0.000 0.000 0.900 0.847 0.874 Chst2
Nrl 0.000 0.786 0.000 0.000 0.773 0.779 Chst2
Nrl 0.000 0.857 0.800 0.000 0.000 0.829 Mtmr7
Rho 0.000 0.000 0.900 0.900 0.000 0.900 Mtmr7
Crx 0.762 0.000 0.763 0.000 0.000 0.763 Gabbr1
Nrl 0.762 0.000 0.000 0.800 0.000 0.781 Gabbr1
Nrl 0.000 0.833 0.700 0.700 0.000 0.744 Crlf3
Rho 0.000 0.000 0.900 0.800 0.000 0.850 Crlf3
Nrl 0.000 0.000 1.000 0.000 0.764 0.882 Nfat5
Rho 0.000 0.000 0.900 0.000 0.692 0.796 Nfat5
Rb1 0.000 0.000 0.700 1.000 0.000 0.850 Wdr45
Neurod1 0.000 0.738 0.000 0.900 0.000 0.819 Wdr45
Rho 0.701 0.000 0.700 1.000 0.000 0.800 Praf2
Crx 0.000 0.881 0.821 0.000 0.000 0.851 Praf2
Crx 0.000 0.898 0.821 0.000 0.000 0.860 Dscr1
Nrl 0.000 0.755 0.000 0.700 0.000 0.727 Dscr1
Crx 0.000 0.738 0.975 0.000 0.000 0.856 Fnbp4
Rho 0.000 0.000 0.700 0.000 0.843 0.771 Fnbp4
Rho 0.000 0.000 0.700 0.000 0.770 0.735 Ift20
Nrl 0.000 0.000 0.900 0.000 0.773 0.836 Ift20
Nrl 0.000 0.881 0.000 0.000 0.884 0.882 Snx12
Crx 0.000 0.786 0.975 0.000 0.000 0.880 Snx12
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 D1Bwg0491e
Rb1 0.000 0.000 0.900 0.900 0.000 0.900 D1Bwg0491e
Rho 0.000 0.000 0.821 0.700 0.000 0.760 Ramp3
Nrl 0.000 0.000 0.667 0.800 0.000 0.733 Ramp3
Crx 0.000 0.000 0.872 0.700 0.000 0.786 Ddx21
Rb1 0.000 0.855 0.700 0.000 0.000 0.778 Ddx21
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 Hnrph2
Rb1 0.000 0.000 0.900 0.900 0.000 0.900 Hnrph2
Nrl 0.000 0.000 0.700 0.700 0.000 0.700 Styx
Rho 0.000 0.000 0.900 0.800 0.000 0.850 Styx
Rb1 0.000 0.719 0.900 0.000 0.827 0.815 Eif3s8
Chx10 0.000 0.886 0.000 0.900 0.000 0.893 Eif3s8
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Chx10 0.000 0.000 0.000 1.000 0.665 0.833 Dnajc7
Crx 0.000 0.000 0.975 1.000 0.000 0.987 Dnajc7
Nrl 0.000 0.881 0.000 0.900 0.673 0.818 Ivd
Crx 0.000 0.881 0.975 0.000 0.000 0.928 Ivd
Crx 0.849 0.826 0.000 0.000 0.000 0.838 Tmem59
Nrl 0.798 0.683 0.000 0.000 0.000 0.740 Tmem59
Rho 0.000 0.000 0.700 0.000 0.702 0.701 Stx5a
Crx 0.000 0.000 0.821 0.900 0.000 0.860 Stx5a
Nrl 0.000 0.810 0.000 0.000 0.982 0.896 Pfkp
Rho 0.000 0.000 0.700 0.900 0.961 0.854 Pfkp
Nrl 0.000 0.786 0.000 0.000 0.891 0.838 Rsn
Rho 0.000 0.000 0.700 0.000 0.884 0.792 Rsn
Crx 0.000 0.000 0.667 0.900 0.000 0.783 Rbx1
Chx10 0.748 0.000 0.000 0.900 0.000 0.824 Rbx1
Crx 0.000 0.690 0.975 0.000 0.000 0.833 Pias1
Nrl 0.000 0.881 0.000 0.700 0.000 0.790 Pias1
Rho 0.000 0.000 0.000 0.700 0.743 0.721 Rps6ka4
Nrl 0.000 0.857 0.000 0.800 0.855 0.837 Rps6ka4
Crx 0.000 0.714 0.000 0.700 0.000 0.707
Chx10 0.000 0.000 0.700 0.700 0.000 0.700
Nrl 0.000 0.850 0.667 0.000 0.000 0.759 Frap1
Rho 0.000 0.000 0.821 0.900 0.000 0.860 Frap1
Nrl 0.000 0.667 0.000 0.800 0.000 0.733 Rnf14
Crx 0.000 0.905 0.821 0.000 0.000 0.863 Rnf14
Rho 0.000 0.000 0.900 0.000 0.774 0.837 Lmbr1
Nrl 0.000 0.690 0.700 0.700 0.736 0.707 Lmbr1
Rho 0.000 0.000 0.667 0.000 0.913 0.790 Sfrs4
Nrl 0.000 0.810 0.000 0.000 0.897 0.854 Sfrs4
Nrl 0.000 0.000 0.700 0.000 0.955 0.827 Ttyh1
Nr2e3 0.000 0.000 0.700 0.000 0.718 0.709 Ttyh1
Nrl 0.734 0.786 0.000 0.000 0.000 0.760 Ptplad1
Crx 0.669 0.738 0.000 0.000 0.000 0.703 Ptplad1
Nrl 0.834 0.000 0.700 0.000 0.000 0.767 Nap1l5
Crx 0.856 0.000 0.667 0.000 0.000 0.761 Nap1l5
Chx10 0.671 0.000 0.000 0.900 0.000 0.785 Cri1
Crx 0.000 0.667 0.000 0.900 0.000 0.783 Cri1
Crx 0.000 0.762 0.667 0.000 0.000 0.714 Hibadh
Rho 0.000 0.000 0.700 0.900 0.000 0.800 Hibadh
Rho 0.000 0.000 0.700 0.000 0.752 0.726 Slc4a8
Nrl 0.000 0.000 0.900 0.000 0.700 0.800 Slc4a8
Nrl 0.000 0.833 0.000 0.800 0.891 0.841 Slc22a17
Rho 0.000 0.000 0.000 0.700 0.879 0.790 Slc22a17
Neurod1 0.000 0.000 1.000 0.900 0.000 0.950 0610012D09Rik
Rb1 0.000 0.833 0.000 0.700 0.000 0.767 0610012D09Rik
Nrl 0.737 0.000 0.000 0.000 0.718 0.727 Pcbp3
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Crx 0.724 0.000 0.821 0.000 0.000 0.772 Pcbp3
Crx 0.000 0.000 0.718 1.000 0.000 0.859 Rbm8a
Rb1 0.000 0.857 0.900 0.000 0.000 0.879 Rbm8a
Nrl 0.816 0.000 0.800 0.000 0.000 0.808 Sv2a
Rho 0.860 0.000 0.900 0.000 0.000 0.880 Sv2a
Nrl 0.000 0.833 0.000 0.800 0.936 0.857 Itm2c
Rho 0.000 0.000 0.700 0.700 0.879 0.760 Itm2c
Crx 0.000 0.850 0.821 0.700 0.000 0.790 Mrps10
Chx10 0.000 0.000 0.000 0.700 0.651 0.676 Mrps10
Rho 0.000 0.000 0.000 0.700 0.793 0.746 Arl6ip5
Nrl 0.000 0.000 0.000 0.800 0.845 0.823 Arl6ip5
Rho 0.759 0.000 0.000 0.900 0.000 0.829 Ndfip1
Chx10 0.000 0.000 0.700 0.000 0.811 0.755 Ndfip1
Rho 0.877 0.000 0.000 0.000 0.884 0.880 Clstn1
Nrl 0.884 0.000 0.000 0.000 0.918 0.901 Clstn1
Crx 0.000 0.857 0.000 0.900 0.000 0.879 Mrpl54
Nrl 0.000 0.857 0.000 0.000 0.845 0.851 Mrpl54
Rho 0.000 0.000 0.872 0.900 0.000 0.886 0610010O12Rik
Nrl 0.000 0.762 0.872 0.000 0.000 0.817 0610010O12Rik
Rb1 0.000 0.810 0.000 0.000 0.655 0.732 0610041E09Rik
Neurod1 0.000 0.690 0.800 0.000 0.000 0.745 0610041E09Rik
Rb1 0.000 0.675 0.900 0.000 0.000 0.787 Chchd6
Neurod1 0.000 0.735 0.700 0.000 0.000 0.717 Chchd6
Chx10 0.000 0.000 0.000 0.900 0.715 0.808 Ndufa9
Crx 0.000 0.000 0.975 0.900 0.000 0.937 Ndufa9
Rho 0.000 0.000 0.000 0.800 0.920 0.860 Tmed3
Nrl 0.000 0.714 0.000 0.700 0.855 0.756 Tmed3
Rb1 0.000 0.714 0.800 0.000 0.000 0.757 1110005A23Rik
Crx 0.000 0.000 0.821 0.800 0.000 0.810 1110005A23Rik
Nrl 0.000 0.000 0.872 0.000 0.809 0.841 1110018J18Rik
Rho 0.000 0.000 0.975 0.000 0.897 0.936 1110018J18Rik
Nrl 0.857 0.000 0.700 0.000 0.000 0.778 Ccdc72
Nr2e3 0.788 0.000 0.700 0.000 0.000 0.744 Ccdc72
Crx 0.830 0.000 0.667 0.000 0.000 0.748 1500011B03Rik
Nrl 0.765 0.000 0.900 0.000 0.000 0.833 1500011B03Rik
Neurod1 0.000 0.833 0.700 0.000 0.000 0.767 1810020E01Rik
Rb1 0.000 0.714 0.900 0.000 0.000 0.807 1810020E01Rik
Nrl 0.000 0.000 0.000 0.700 0.864 0.782 Atp6v1c1
Rho 0.000 0.000 0.667 0.800 0.925 0.797 Atp6v1c1
Chx10 0.000 0.000 0.700 0.000 0.802 0.751 Cyc1
Neurod1 0.000 0.786 0.800 0.000 0.000 0.793 Cyc1
Crx 0.000 0.738 0.821 0.000 0.000 0.779 Anp32e
Nrl 0.000 0.738 0.800 0.900 0.000 0.813 Anp32e
Crx 0.000 0.905 0.821 0.000 0.000 0.863 3110001A13Rik
Rho 0.000 0.000 0.700 0.900 0.000 0.800 3110001A13Rik
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Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 5730410I19Rik
Rb1 0.000 0.790 0.900 0.900 0.000 0.863 5730410I19Rik
Crx 0.000 0.810 0.821 0.000 0.000 0.815 Hiatl1
Rho 0.000 0.000 0.700 0.900 0.000 0.800 Hiatl1
Chx10 0.000 0.000 0.900 0.900 0.000 0.900 5730494M16Rik
Crx 0.000 0.719 0.000 0.900 0.000 0.809 5730494M16Rik
Rho 0.000 0.000 0.000 0.800 0.929 0.865 Them2
Nrl 0.000 0.000 0.000 0.700 0.909 0.805 Them2
Rb1 0.000 0.000 0.900 0.000 0.900 0.900 Vps28
Rho 0.000 0.000 0.000 1.000 0.811 0.905 Vps28
Chx10 0.798 0.000 0.000 0.800 0.000 0.799 Prpf38b
Crx 0.000 0.000 0.975 0.800 0.000 0.887 Prpf38b
Crx 0.000 0.833 0.975 0.000 0.000 0.904 Txndc14
Nrl 0.000 0.976 0.000 0.900 0.000 0.938 Txndc14
Rho 0.000 0.000 0.700 0.900 0.000 0.800 2310050N11Rik
Crx 0.000 0.786 0.821 0.000 0.000 0.803 2310050N11Rik
Otx2 0.812 0.000 0.718 0.000 0.000 0.765 Slc25a23
Neurod1 0.735 0.000 0.718 0.000 0.000 0.726 Slc25a23
Nrl 0.000 0.000 0.900 0.000 0.773 0.836 D16Ertd472e
Rho 0.000 0.000 0.700 0.000 0.879 0.790 D16Ertd472e
Rb1 0.000 0.778 0.900 0.000 0.000 0.839 2610204K14Rik
Crx 0.000 0.000 0.718 0.800 0.000 0.759 2610204K14Rik
Neurod1 0.000 0.690 0.800 0.000 0.000 0.745 2700085E05Rik
Chx10 0.000 0.000 0.700 0.700 0.000 0.700 2700085E05Rik
Rb1 0.000 0.810 0.000 0.900 0.000 0.855 Zfp422
Neurod1 0.000 0.000 0.900 1.000 0.000 0.950 Zfp422
Rho 0.000 0.000 0.900 0.000 0.651 0.776 Lass4
Nrl 0.000 0.000 0.700 0.000 0.736 0.718 Lass4
Crx 0.684 0.000 0.821 0.000 0.000 0.752 Agtpbp1
Rho 0.000 0.000 0.700 0.000 0.834 0.767 Agtpbp1
Rb1 0.000 0.762 0.700 0.000 0.000 0.731 Parp6
Neurod1 0.000 0.714 0.000 0.700 0.000 0.707 Parp6
Crx 0.000 0.690 0.684 0.000 0.000 0.687 Tbc1d23
Rb1 0.000 0.000 0.872 0.000 0.700 0.786 Tbc1d23
Nrl 0.000 0.714 0.872 0.000 0.000 0.793 1110007L15Rik
Crx 0.000 0.810 0.763 0.000 0.000 0.786 1110007L15Rik
Rho 0.000 0.000 1.000 0.000 0.843 0.921 Slc25a37
Nrl 0.000 0.000 0.900 0.000 0.882 0.891 Slc25a37
Rho 0.000 0.000 0.800 0.900 0.000 0.850 Rgs8
Nrl 0.000 0.690 0.900 0.000 0.000 0.795 Rgs8
Nrl 0.000 0.000 0.000 0.700 0.727 0.714 1200015A19Rik
Rho 0.000 0.000 0.000 0.800 0.733 0.767 1200015A19Rik
Crx 0.000 0.000 0.975 0.800 0.000 0.887 Ubxd2
Chx10 0.000 0.000 0.000 0.800 0.733 0.767 Ubxd2
Nrl 0.000 0.000 0.700 0.800 0.000 0.750 Idh3a
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Rho 0.000 0.000 0.900 0.700 0.000 0.800 Idh3a
Crx 0.000 0.838 0.821 0.000 0.000 0.830 Dnajb11
Nrl 0.000 0.766 0.000 1.000 0.000 0.883 Dnajb11
Crx 0.752 0.000 0.821 0.000 0.000 0.787 1500011K16Rik
Rho 0.728 0.000 0.700 0.000 0.000 0.714 1500011K16Rik
Rb1 0.000 0.786 0.821 0.000 0.000 0.803 Rbm13
Crx 0.000 0.000 0.816 0.700 0.000 0.758 Rbm13
Rb1 0.000 0.762 0.900 0.000 0.000 0.831 2510049I19Rik
Crx 0.000 0.000 0.718 0.900 0.000 0.809 2510049I19Rik
Nrl 0.000 0.000 0.900 0.000 0.882 0.891 5330410G16Rik
Rho 0.712 0.000 0.700 0.000 0.943 0.785 5330410G16Rik
Crx 0.000 0.000 0.718 0.900 0.000 0.809 Sugt1
Rb1 0.000 0.762 0.900 0.000 0.000 0.831 Sugt1
Chx10 0.000 0.667 0.000 0.900 0.000 0.783 2410195B05Rik
Crx 0.000 0.000 0.667 0.900 0.000 0.783 2410195B05Rik
Rho 0.000 0.000 0.000 0.800 0.697 0.749 Hist1h2bc
Nrl 0.000 0.762 0.000 0.700 0.700 0.721 Hist1h2bc
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 Tm9sf2
Rb1 0.000 0.000 0.800 1.000 0.000 0.900 Tm9sf2
Neurod1 0.000 0.000 0.800 1.000 0.000 0.900 9430080K19Rik
Rb1 0.000 0.762 0.000 0.900 0.000 0.831 9430080K19Rik
Rho 0.000 0.000 0.900 0.000 0.911 0.906 Inoc1
Nrl 0.000 0.000 1.000 0.000 0.873 0.936 Inoc1
Crx 0.000 0.000 0.718 0.800 0.000 0.759 Nola1
Rb1 0.000 0.786 0.900 0.000 0.000 0.843 Nola1
Crx 0.756 0.000 0.000 0.900 0.000 0.828 Ndufa5
Neurod1 0.689 0.952 0.000 0.000 0.000 0.821 Ndufa5
Nrl 0.876 0.000 0.900 0.000 0.000 0.888 AI846148
Rho 0.781 0.000 0.800 0.000 0.000 0.791 AI846148
Rho 0.000 0.000 0.872 1.000 0.000 0.936 Rpa1
Nrl 0.000 0.810 0.667 0.000 0.000 0.738 Rpa1
Rho 0.673 0.000 0.900 0.000 0.943 0.839 Rab14
Nrl 0.000 0.000 0.700 0.000 0.909 0.805 Rab14
Crx 0.000 0.000 0.821 0.700 0.000 0.760 1110007M04Rik
Rho 0.000 0.000 0.700 0.000 0.966 0.833 1110007M04Rik
Rb1 0.000 0.000 0.700 0.000 0.691 0.695 1110011C06Rik
Nrl 0.663 0.000 0.000 0.000 0.809 0.736 1110011C06Rik
Crx 0.000 0.000 0.816 0.800 0.000 0.808 Elac2
Rb1 0.000 0.000 0.821 0.000 0.682 0.751 Elac2
Nrl 0.000 0.755 0.975 0.000 0.000 0.865 Fndc1
Rho 0.000 0.000 0.821 0.900 0.000 0.860 Fndc1
Rb1 0.000 0.000 0.900 1.000 0.000 0.950 Hnrpul2
Neurod1 0.787 0.000 0.000 0.900 0.000 0.844 Hnrpul2
Rb1 0.000 0.683 0.900 0.000 0.000 0.791 2610031L17Rik
Crx 0.000 0.000 0.718 0.700 0.000 0.709 2610031L17Rik
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Crx 0.924 0.000 0.667 0.000 0.000 0.795 1500016O10Rik
Nrl 0.892 0.000 0.900 0.000 0.000 0.896 1500016O10Rik
Rho 0.000 0.000 0.700 0.800 0.866 0.789 Cdan1
Nrl 0.000 0.786 0.000 0.700 0.791 0.759 Cdan1
Rho 0.000 0.000 0.900 0.000 0.836 0.868 Nol11
Nrl 0.000 0.000 0.700 0.000 0.815 0.758 Nol11
Nrl 0.000 0.000 1.000 0.000 0.873 0.936 Rhebl1
Rho 0.000 0.000 0.900 0.000 0.925 0.912 Rhebl1
Neurod1 0.000 0.762 0.700 0.000 0.000 0.731 2610009E16Rik
Chx10 0.000 0.000 0.700 0.900 0.000 0.800 2610009E16Rik
Neurod1 0.809 0.000 0.000 0.700 0.000 0.754 Zfp688
Crx 0.656 0.786 0.000 0.000 0.000 0.721 Zfp688
Crx 0.000 0.000 0.718 0.800 0.000 0.759 Gtpbp4
Rb1 0.000 0.738 0.900 0.000 0.000 0.819 Gtpbp4
Rho 0.000 0.000 0.975 0.800 0.000 0.887 2310001H12Rik
Nrl 0.000 0.000 0.872 0.700 0.000 0.786 2310001H12Rik
Nrl 0.000 0.000 0.800 0.000 0.809 0.805 2300002D11Rik
Rho 0.000 0.000 0.900 0.000 0.770 0.835 2300002D11Rik
Crx 0.000 0.000 0.718 0.900 0.000 0.809 2310061I09Rik
Rb1 0.000 0.690 0.900 0.000 0.000 0.795 2310061I09Rik
Nrl 0.000 0.000 0.821 0.000 0.700 0.760 Lrch3
Rho 0.000 0.000 0.667 0.000 0.756 0.712 Lrch3
Neurod1 0.000 0.810 0.700 0.000 0.000 0.755 Ndufab1
Rb1 0.000 0.000 0.900 0.000 0.836 0.868 Ndufab1
Rho 0.000 0.000 0.700 0.000 0.825 0.762 5730469M10Rik
Nrl 0.000 0.690 0.000 0.700 0.855 0.748 5730469M10Rik
Crx 0.000 0.000 0.821 0.700 0.000 0.760 Zc3h11a
Rho 0.000 0.000 0.700 0.000 0.651 0.676 Zc3h11a
Neurod1 0.878 0.000 0.667 0.000 0.000 0.772 Trak2
Chx10 0.000 0.000 0.821 0.800 0.000 0.810 Trak2
Rb1 0.000 0.786 0.900 1.000 0.000 0.895 4933424N09Rik
Neurod1 0.000 0.000 0.700 0.900 0.000 0.800 4933424N09Rik
Crx 0.790 0.000 0.667 0.000 0.000 0.729 5530400B01Rik
Rho 0.664 0.000 0.700 0.000 0.000 0.682 5530400B01Rik
Crx 0.749 0.000 0.975 0.000 0.000 0.862 Smug1
Nrl 0.775 0.000 0.000 0.000 0.673 0.724 Smug1
Rb1 0.000 0.810 0.800 0.000 0.000 0.805 Cul2
Crx 0.000 0.000 0.821 0.700 0.000 0.760 Cul2
Crx 0.000 0.000 0.872 0.800 0.000 0.836 Gtf3c2
Rb1 0.000 0.952 0.700 0.000 0.000 0.826 Gtf3c2
Nrl 0.715 0.000 0.700 0.000 0.000 0.708 Tmem24
Crx 0.762 0.000 0.667 0.000 0.000 0.714 Tmem24
Rb1 0.000 0.000 0.900 0.000 0.709 0.805 2400003N08Rik
Crx 0.000 0.850 0.718 0.000 0.000 0.784 2400003N08Rik
Nrl 0.000 0.667 0.000 0.900 0.836 0.801 Snx10
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Crx 0.000 0.905 0.975 0.000 0.000 0.940 Snx10
Rho 0.000 0.000 0.700 0.800 0.000 0.750 Cyb5r1
Nrl 0.000 0.786 0.000 0.700 0.000 0.743 Cyb5r1
Nrl 0.000 0.786 0.000 0.000 0.664 0.725 Pgm2
Chx10 0.000 0.000 0.000 0.900 0.829 0.865 Pgm2
Rho 0.000 0.000 1.000 0.800 0.815 0.872 Nsun4
Nrl 0.000 0.000 0.900 0.700 0.764 0.788 Nsun4
Rho 0.000 0.000 0.700 0.900 0.000 0.800 Tspyl4
Crx 0.000 0.690 0.821 0.000 0.000 0.756 Tspyl4
Crx 0.000 0.000 0.718 0.900 0.000 0.809 2610507B11Rik
Chx10 0.716 0.683 0.000 0.900 0.843 0.785 2610507B11Rik
Rho 0.000 0.000 0.900 0.000 0.961 0.931 Zfp655
Nrl 0.000 0.000 0.800 0.000 0.909 0.855 Zfp655
Crx 0.000 0.881 0.000 0.900 0.000 0.890 Zfp444
Nrl 0.000 0.786 0.000 0.000 0.773 0.779 Zfp444
Nrl 0.000 0.000 0.900 0.000 0.764 0.832 Dnajc6
Rho 0.000 0.000 1.000 0.000 0.838 0.919 Dnajc6
Rb1 0.000 0.714 0.800 1.000 0.000 0.838 Hnrpll
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 Hnrpll
Crx 0.000 0.000 0.975 0.900 0.000 0.937 Zfp306
Chx10 0.000 0.000 0.000 0.900 0.861 0.881 Zfp306
Nrl 0.000 0.762 0.000 0.000 0.682 0.722 Dhx30
Crx 0.000 0.714 0.000 0.900 0.000 0.807 Dhx30
Rho 0.000 0.000 0.900 0.000 0.724 0.812 2900006F19Rik
Nrl 0.000 0.000 1.000 0.000 0.691 0.845 2900006F19Rik
Nrl 0.000 0.000 0.800 0.000 0.755 0.777 2900076A07Rik
Rho 0.000 0.000 0.900 0.000 0.779 0.840 2900076A07Rik
Nrl 0.000 0.000 0.700 0.000 0.827 0.764 2900064A13Rik
Rho 0.000 0.000 0.900 0.000 0.916 0.908 2900064A13Rik
Rb1 0.000 0.667 0.900 0.000 0.000 0.783 Golph4
Nrl 0.000 0.000 0.000 0.700 0.736 0.718 Golph4
Crx 0.000 0.881 0.667 0.000 0.000 0.774 1700040I03Rik
Nrl 0.000 0.000 0.000 0.900 0.855 0.877 1700040I03Rik
Nrl 0.000 0.000 0.800 0.000 0.682 0.741 1110034G24Rik
Rho 0.000 0.000 0.900 0.000 0.720 0.810 1110034G24Rik
Nrl 0.000 0.000 0.700 0.000 0.782 0.741 Whrn
Rho 0.000 0.000 0.900 0.000 0.834 0.867 Whrn
Rho 0.000 0.000 1.000 0.000 0.870 0.935 Herc3
Nrl 0.000 0.000 0.900 0.000 0.855 0.877 Herc3
Rb1 0.000 0.690 0.700 0.700 0.655 0.686 4121402D02Rik
Neurod1 0.000 0.714 0.000 0.900 0.000 0.807 4121402D02Rik
Rho 0.000 0.000 0.900 0.000 0.868 0.884 4632404H12Rik
Nrl 0.000 0.000 0.700 0.000 0.788 0.744 4632404H12Rik
Crx 0.000 0.786 0.975 0.000 0.000 0.880 Rnf6
Nrl 0.000 0.000 0.000 0.700 0.791 0.745 Rnf6
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Rho 0.000 0.000 0.700 0.900 0.870 0.823 Sec14l1
Nrl 0.000 0.810 0.000 0.000 0.791 0.800 Sec14l1
Nrl 0.000 0.000 0.900 0.000 0.800 0.850 Osbp2
Rho 0.712 0.000 1.000 0.000 0.770 0.827 Osbp2
Crx 0.685 0.000 0.975 0.800 0.000 0.820 3732413I11Rik
Rho 0.000 0.000 0.700 0.000 0.756 0.728 3732413I11Rik
Rb1 0.000 0.833 0.900 0.000 0.655 0.796 Hnrpr
Neurod1 0.000 0.000 0.700 0.800 0.000 0.750 Hnrpr
Rho 0.000 0.000 0.800 0.000 0.943 0.872 4932417H02Rik
Nrl 0.000 0.000 0.900 0.000 0.882 0.891 4932417H02Rik
Nrl 0.000 0.000 0.700 0.000 0.673 0.686 Cds1
Rho 0.712 0.000 0.900 0.000 0.000 0.806 Cds1
Nrl 0.000 0.000 0.000 0.700 0.818 0.759 Pcf11
Rho 0.000 0.000 0.000 0.800 0.852 0.826 Pcf11
Rb1 0.000 0.000 0.900 0.700 0.000 0.800 Atp13a2
Neurod1 0.000 0.000 0.700 0.900 0.000 0.800 Atp13a2
Rho 0.000 0.000 1.000 0.000 0.970 0.985 4930519N16Rik
Nrl 0.000 0.000 0.900 0.000 0.945 0.923 4930519N16Rik
Rho 0.000 0.000 0.900 1.000 0.802 0.901 Etnk1
Nrl 0.000 0.000 0.700 0.000 0.764 0.732 Etnk1
Crx 0.000 0.719 0.718 0.000 0.000 0.718
Nrl 0.000 0.707 0.000 0.900 0.000 0.803
Neurod1 0.000 0.881 0.000 0.900 0.000 0.890 Jarid1b
Rho 0.000 0.000 0.667 0.000 0.829 0.748 Jarid1b
Crx 0.762 0.000 0.684 0.000 0.000 0.723 2210403N09Rik
Nrl 0.715 0.000 0.821 0.000 0.000 0.768 2210403N09Rik
Rho 0.000 0.000 0.900 0.000 0.925 0.912 3010001F23Rik
Nrl 0.000 0.000 0.700 0.000 0.909 0.805 3010001F23Rik
Nrl 0.658 0.000 0.900 0.000 0.855 0.804 Cul5
Rho 0.000 0.000 0.700 0.000 0.861 0.781 Cul5
Nrl 0.000 0.000 0.900 0.000 0.809 0.855 4930431B11Rik
Rho 0.000 0.000 1.000 0.000 0.870 0.935 4930431B11Rik
Nrl 0.000 0.714 0.000 0.700 0.000 0.707 Tmem49
Crx 0.000 0.881 0.789 0.000 0.000 0.835 Tmem49
Nrl 0.000 0.000 0.667 0.700 0.809 0.725 Las1l
Rho 0.000 0.000 0.821 0.000 0.870 0.845 Las1l
Nrl 0.000 0.000 0.900 0.000 0.800 0.850 6430590I03Rik
Rho 0.000 0.000 0.800 0.000 0.806 0.803 6430590I03Rik
Nrl 0.000 0.000 0.800 0.000 0.845 0.823 Atp11b
Rho 0.825 0.000 0.900 0.000 0.811 0.845 Atp11b
Rb1 0.000 0.000 0.700 0.000 0.673 0.686 Commd9
Nrl 0.000 0.000 0.000 0.700 0.836 0.768 Commd9
Rho 0.000 0.000 0.821 0.900 0.000 0.860 Srxn1
Nrl 0.000 0.810 0.667 0.000 0.000 0.738 Srxn1
Chx10 0.000 0.000 0.000 0.900 0.784 0.842 Arpc2
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Rb1 0.000 0.898 0.821 0.000 0.000 0.860 Arpc2
Rho 0.000 0.000 0.900 0.000 0.829 0.865 2410131K14Rik
Nrl 0.000 0.000 0.700 0.000 0.736 0.718 2410131K14Rik
Rho 0.000 0.000 0.700 0.800 0.000 0.750 0610016J10Rik
Nrl 0.000 0.000 0.000 0.700 0.655 0.677 0610016J10Rik
Rho 0.000 0.000 0.700 0.000 0.820 0.760 B3gat1
Nrl 0.785 0.000 0.000 0.000 0.845 0.815 B3gat1
Rb1 0.000 0.810 0.800 0.000 0.000 0.805 Rbm17
Crx 0.000 0.000 0.821 0.900 0.000 0.860 Rbm17
Nrl 0.000 0.000 0.900 0.000 0.736 0.818 2210418O10Rik
Rho 0.000 0.000 0.700 0.000 0.811 0.755 2210418O10Rik
Rho 0.000 0.000 0.900 0.900 0.916 0.905 Atg16l1
Nrl 0.000 0.000 0.700 0.000 0.927 0.814 Atg16l1
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 Arid2
Rb1 0.000 0.000 0.900 0.900 0.000 0.900 Arid2
Chx10 0.000 0.874 0.000 0.900 0.000 0.887 2810433D01Rik
Crx 0.000 0.000 0.763 0.900 0.000 0.832 2810433D01Rik
Nr2e3 0.000 0.000 0.700 0.000 0.673 0.686 Rnf170
Nrl 0.000 0.000 0.700 0.000 0.827 0.764 Rnf170
Neurod1 0.683 0.000 0.700 0.000 0.000 0.691 A330103N21Rik
Otx2 0.737 0.000 0.900 0.000 0.000 0.818 A330103N21Rik
Rb1 0.000 0.707 0.975 0.000 0.000 0.841 Eif3s1
Crx 0.000 0.000 0.658 0.800 0.000 0.729 Eif3s1
Rho 0.000 0.000 1.000 0.000 0.806 0.903 Zfp623
Nrl 0.000 0.000 0.900 0.000 0.827 0.864 Zfp623
Crx 0.000 0.000 0.821 0.900 0.000 0.860 Dlst
Chx10 0.000 0.683 0.000 0.900 0.000 0.791 Dlst
Nrl 0.000 0.743 0.000 0.900 0.000 0.821 Ublcp1
Crx 0.000 0.850 0.667 0.000 0.000 0.759 Ublcp1
Nrl 0.000 0.707 0.000 0.800 0.691 0.733 Lrba
Rho 0.000 0.000 0.000 0.700 0.747 0.724 Lrba
Crx 0.000 0.952 0.667 0.000 0.000 0.810 Senp3
Nrl 0.000 0.810 0.900 0.700 0.000 0.803 Senp3
Chx10 0.000 0.000 0.000 0.900 0.779 0.840 Dusp12
Crx 0.000 0.000 0.872 0.900 0.000 0.886 Dusp12
Chx10 0.000 0.719 0.000 0.000 0.834 0.776 Ankrd17
Rb1 0.000 0.695 0.000 0.700 0.000 0.697 Ankrd17
Crx 0.723 0.000 0.000 1.000 0.000 0.861 Wdr6
Neurod1 0.920 0.000 0.700 0.000 0.000 0.810 Wdr6
Rho 0.000 0.000 0.000 0.900 0.770 0.835 Dpp7
Nrl 0.000 0.826 0.000 0.000 0.800 0.813 Dpp7
Rho 0.000 0.000 1.000 0.700 0.000 0.850 Nedd4l
Nrl 0.000 0.786 0.900 0.800 0.000 0.829 Nedd4l
Nrl 0.000 0.766 0.821 0.000 0.000 0.794 Slmap
Rho 0.000 0.000 0.975 0.900 0.000 0.937 Slmap
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Crx 0.000 0.898 0.816 0.000 0.000 0.857 Gabarapl2
Nrl 0.000 0.731 0.000 0.900 0.000 0.815 Gabarapl2
Rho 0.678 0.000 0.000 0.000 0.834 0.756 Dock2
Nrl 0.784 0.000 0.000 0.000 0.855 0.819 Dock2
Nrl 0.000 0.000 0.800 0.000 0.736 0.768 Slc4a10
Rho 0.000 0.000 0.900 0.000 0.670 0.785 Slc4a10
Neurod1 0.000 0.000 1.000 0.700 0.000 0.850 C78339
Rb1 0.000 0.000 0.000 0.900 0.745 0.823 C78339
Chx10 0.697 0.000 0.000 0.800 0.000 0.748 Lrrc59
Rb1 0.000 0.707 0.700 0.000 0.000 0.703 Lrrc59
Nrl 0.000 0.000 0.700 0.000 0.836 0.768 Ehd4
Rho 0.000 0.000 0.900 0.000 0.861 0.881 Ehd4
Nrl 0.000 0.833 0.000 0.000 0.736 0.785 C230093N12Rik
Rb1 0.000 0.000 0.667 0.000 0.727 0.697 C230093N12Rik
Rho 0.000 0.000 0.700 0.800 0.934 0.811 E130013N09Rik
Nrl 0.000 0.000 0.000 0.700 0.909 0.805 E130013N09Rik
Rho 0.827 0.000 1.000 0.000 0.000 0.913 Tdrd7
Nrl 0.680 0.000 0.900 0.000 0.000 0.790 Tdrd7
Nrl 0.000 0.857 0.700 0.800 0.900 0.814 Mapre3
Rho 0.000 0.000 0.900 0.700 0.916 0.839 Mapre3
Chx10 0.000 0.000 0.800 0.900 0.000 0.850 Cd276
Crx 0.000 0.667 0.000 0.900 0.000 0.783 Cd276
Nrl 0.000 0.850 0.000 0.800 0.000 0.825 Tcta
Crx 0.000 0.958 0.975 0.000 0.000 0.966 Tcta
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Slc6a15
Nrl 0.000 0.000 0.700 0.800 0.000 0.750 Slc6a15
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 Usp52
Rb1 0.000 0.000 0.900 0.900 0.000 0.900 Usp52
Rb1 0.000 0.738 0.900 0.000 0.000 0.819 Pwp1
Crx 0.000 0.000 0.718 0.800 0.000 0.759 Pwp1
Rho 0.000 0.000 0.700 0.000 0.829 0.765 Fbxw11
Rb1 0.000 0.000 0.000 0.900 0.682 0.791 Fbxw11
Rho 0.000 0.000 0.000 0.700 0.797 0.749 Pnpo
Nrl 0.000 0.905 0.000 0.000 0.800 0.852 Pnpo
Nrl 0.000 0.000 0.000 0.800 0.818 0.809 Cuedc1
Rho 0.000 0.000 0.000 0.700 0.843 0.771 Cuedc1
Chx10 0.000 0.000 0.000 0.900 0.916 0.908 Rtn1
Rb1 0.000 0.905 0.700 0.000 0.000 0.802 Rtn1
Rho 0.000 0.000 1.000 0.000 0.980 0.990 Synj1
Nrl 0.000 0.000 0.900 0.000 0.927 0.914 Synj1
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 Rnf44
Rb1 0.000 0.000 0.900 0.900 0.000 0.900 Rnf44
Neurod1 0.000 0.738 0.700 0.000 0.000 0.719 Ankrd28
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Rb1 0.000 0.810 0.900 0.000 0.000 0.855 Ankrd28
Nrl 0.000 0.000 0.800 0.000 0.736 0.768 Phr1
Rho 0.000 0.000 0.900 0.000 0.825 0.862 Phr1
Rho 0.000 0.000 0.900 0.000 0.897 0.899 Prickle1
Nrl 0.000 0.000 0.700 0.000 0.945 0.823 Prickle1
Nrl 0.000 0.833 0.000 0.000 0.655 0.744 Gbf1
Rho 0.000 0.000 0.821 0.000 0.679 0.750 Gbf1
Nrl 0.000 0.000 0.700 0.000 0.682 0.691 Guca1b
Rho 0.000 0.000 0.900 0.000 0.733 0.817 Guca1b
Crx 0.000 0.738 0.000 0.700 0.000 0.719 Arl2bp
Chx10 0.000 0.000 0.667 0.700 0.706 0.691 Arl2bp
Nrl 0.000 0.905 0.000 0.900 0.882 0.896 Mylk
Crx 0.000 0.810 0.667 0.000 0.000 0.738 Mylk
Chx10 0.000 0.707 0.000 0.900 0.000 0.803 Sfrs9
Crx 0.000 0.000 0.718 0.900 0.000 0.809 Sfrs9
Nrl 0.000 0.671 0.000 0.700 0.818 0.730 Napa
Rho 0.000 0.000 0.000 0.800 0.838 0.819 Napa
Nrl 0.000 0.000 0.900 0.000 0.845 0.873 Ubxd6
Rho 0.000 0.000 0.700 0.000 0.861 0.781 Ubxd6
Rho 0.000 0.000 0.000 0.700 0.656 0.678 Pttg1ip
Nrl 0.000 0.000 0.000 0.800 0.773 0.786 Pttg1ip
Crx 0.000 0.810 0.821 0.000 0.000 0.815 Rarsl
Rb1 0.000 0.000 0.800 0.700 0.000 0.750 Rarsl
Chx10 0.000 0.000 0.700 0.800 0.000 0.750 Glo1
Neurod1 0.000 0.738 0.800 0.000 0.000 0.769 Glo1
Rho 0.000 0.000 0.900 0.000 0.761 0.830 H47
Nrl 0.000 0.000 0.700 0.000 0.782 0.741 H47
Rho 0.781 0.000 0.000 0.900 0.934 0.872 Adarb1
Nrl 0.838 0.810 0.000 0.000 0.918 0.855 Adarb1
Crx 0.000 0.000 0.718 0.900 0.000 0.809 Etfa
Rb1 0.000 0.714 0.900 0.000 0.709 0.774 Etfa
Rho 0.734 0.000 0.000 0.000 0.825 0.779 Cds2
Nrl 0.711 0.786 0.000 0.000 0.864 0.787 Cds2
Rho 0.932 0.000 0.000 0.700 0.000 0.816 Acaa1a
Nrl 0.853 0.000 0.000 0.800 0.000 0.827 Acaa1a
Crx 0.719 0.929 0.718 0.000 0.000 0.789 Atp6v0b
Nrl 0.790 0.929 0.000 1.000 0.000 0.906 Atp6v0b
Nrl 0.000 0.000 0.700 0.000 0.845 0.773 Ddhd1
Rho 0.000 0.000 0.900 0.900 0.911 0.904 Ddhd1
Nrl 0.720 0.000 0.000 0.000 0.664 0.692 Pop5
Nr2e3 0.659 0.000 0.000 0.000 0.700 0.680 Pop5
Nrl 0.000 0.000 0.900 0.800 0.000 0.850 Pip5k2c
Rho 0.000 0.000 1.000 0.700 0.000 0.850 Pip5k2c
Rho 0.000 0.000 0.975 0.000 0.838 0.906 Elmo2
Nrl 0.000 0.000 0.821 0.000 0.864 0.842 Elmo2
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Nr2e3 0.000 0.000 0.700 0.000 0.827 0.764 Hpcal4
Nrl 0.000 0.667 0.700 0.000 0.000 0.683 Hpcal4
Nrl 0.000 0.000 0.900 0.000 0.945 0.923 Arr3
Rho 0.000 0.000 1.000 0.000 0.989 0.994 Arr3
Rb1 0.000 0.000 0.900 1.000 0.000 0.950 Atp13a1
Neurod1 0.000 0.000 0.700 0.900 0.000 0.800 Atp13a1
Rho 0.000 0.000 1.000 0.000 0.925 0.962 Crb1
Nrl 0.000 0.000 0.900 0.000 0.945 0.923 Crb1
Rho 0.000 0.000 0.667 0.700 0.916 0.761 Galnt10
Nrl 0.000 0.810 0.667 0.800 0.855 0.783 Galnt10
Nrl 0.000 0.810 0.700 0.800 0.000 0.770 Hspa1a
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Hspa1a
Neurod1 0.957 0.000 0.900 0.000 0.000 0.928 1500031H01Rik
Otx2 0.675 0.000 0.700 0.000 0.000 0.688 1500031H01Rik
Rho 0.000 0.000 0.900 0.000 0.957 0.928 BC034090
Nrl 0.000 0.000 1.000 0.000 0.909 0.955 BC034090
Nrl 0.000 0.833 0.900 0.000 0.000 0.867 Gm1
Rho 0.000 0.000 1.000 0.700 0.000 0.850 Gm1
Rb1 0.000 0.667 0.900 0.900 0.000 0.822 D15Ertd621e
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 D15Ertd621e
Nr2e3 0.702 0.000 0.000 0.000 0.700 0.701 Nomo1
Nrl 0.765 0.000 0.000 0.000 0.745 0.755 Nomo1
Crx 0.000 0.000 0.718 0.800 0.000 0.759 BC002199
Rb1 0.000 0.857 0.900 0.000 0.000 0.879 BC002199
Nrl 0.000 0.000 0.000 0.700 0.818 0.759 Inpp5a
Rho 0.000 0.000 0.000 0.800 0.806 0.803 Inpp5a
Crx 0.000 0.810 0.821 0.000 0.000 0.815 Sh3bgrl2
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Sh3bgrl2
Rho 0.000 0.000 0.800 0.900 0.936 0.879 A930031D07Rik
Nrl 0.000 0.905 0.900 0.000 0.870 0.892 A930031D07Rik
Nrl 0.000 0.000 0.821 0.000 0.791 0.806 Cdkl3
Rho 0.000 0.000 0.718 0.000 0.870 0.794 Cdkl3
Rho 0.759 0.000 0.900 0.000 0.925 0.861 Slc24a1
Nrl 0.000 0.000 0.700 0.000 0.927 0.814 Slc24a1
Nrl 0.000 0.000 0.800 0.000 0.864 0.832 Scgn
Rho 0.000 0.000 0.900 0.000 0.943 0.922 Scgn
Neurod1 0.000 0.659 0.667 0.000 0.000 0.663 Zcchc6
Rb1 0.000 0.683 0.821 0.000 0.000 0.752 Zcchc6
Nrl 0.000 0.000 0.000 0.700 0.918 0.809 Sidt2
Rho 0.000 0.000 0.000 0.800 0.916 0.858 Sidt2
Rho 0.795 0.000 0.700 0.900 0.000 0.798 1110067D22Rik
Crx 0.660 0.000 0.975 0.000 0.000 0.817 1110067D22Rik
Rb1 0.000 0.000 0.872 0.900 0.000 0.886 Flcn
Neurod1 0.829 0.000 0.000 0.700 0.000 0.764 Flcn
Crx 0.717 0.905 0.821 0.700 0.000 0.786 Spag7
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Nrl 0.711 0.714 0.000 0.000 0.000 0.713 Spag7
Nrl 0.000 0.000 0.821 0.000 0.891 0.856 Ggnbp2
Rho 0.000 0.000 0.667 0.000 0.916 0.791 Ggnbp2
Crx 0.000 0.000 0.667 0.900 0.000 0.783 Wdr50
Chx10 0.000 0.738 0.000 0.900 0.000 0.819 Wdr50
Nrl 0.000 0.000 0.700 0.000 0.664 0.682 Pde8b
Nr2e3 0.000 0.000 0.700 0.000 0.691 0.695 Pde8b
Neurod1 0.000 0.000 0.700 0.800 0.000 0.750 Btf3
Rb1 0.000 0.738 0.900 0.000 0.000 0.819 Btf3
Nrl 0.000 0.810 0.900 0.900 0.000 0.870 Slc4a7
Crx 0.000 0.952 0.667 0.000 0.000 0.810 Slc4a7
Rb1 0.000 0.738 0.900 0.900 0.000 0.846 3/6/2006
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 3/6/2006
Otx2 0.652 0.000 0.800 0.000 0.000 0.726 Nrbp2
Rb1 0.000 0.000 0.000 0.700 0.836 0.768 Nrbp2
Neurod1 0.000 0.000 0.900 0.700 0.000 0.800 Brd1
Rb1 0.000 0.690 0.800 0.900 0.000 0.797 Brd1
Nrl 0.000 0.000 0.671 0.000 0.664 0.667 Atp13a3
Rho 0.000 0.000 0.894 0.000 0.670 0.782 Atp13a3
Nrl 0.000 0.802 0.700 0.700 0.000 0.734 Map4k3
Crx 0.000 0.886 0.667 0.000 0.000 0.777 Map4k3
Rb1 0.000 0.000 0.900 0.700 0.000 0.800 D030070L09Rik
Crx 0.000 0.714 0.718 0.000 0.000 0.716 D030070L09Rik
Neurod1 0.000 0.000 0.700 0.800 0.000 0.750
Rb1 0.000 0.000 0.900 0.900 0.000 0.900
Neurod1 0.765 0.000 0.700 0.000 0.000 0.732 Suv420h1
Otx2 0.747 0.000 0.900 0.000 0.000 0.823 Suv420h1
Nrl 0.000 0.000 0.800 0.000 0.909 0.855 Eml3
Rho 0.000 0.000 0.900 0.000 0.852 0.876 Eml3
Nrl 0.000 0.000 0.821 0.000 0.927 0.874 6030443O07Rik
Rho 0.000 0.000 0.667 0.000 0.952 0.810 6030443O07Rik
Rho 0.000 0.000 0.900 0.700 0.788 0.796 Ablim1
Nrl 0.000 0.738 0.700 0.800 0.736 0.744 Ablim1
Rho 0.000 0.000 0.700 0.900 0.929 0.843 Ppp2r5a
Nrl 0.000 0.786 0.000 0.000 0.909 0.847 Ppp2r5a
Rho 0.000 0.000 0.900 0.000 0.943 0.922 Lpgat1
Nrl 0.000 0.000 0.700 0.000 0.891 0.795 Lpgat1
Crx 0.831 0.667 0.000 0.700 0.000 0.733 BC038286
Nrl 0.844 0.929 0.000 0.000 0.000 0.886 BC038286
Nrl 0.000 0.000 1.000 0.000 0.909 0.955 Rabgap1
Rho 0.000 0.000 0.900 0.000 0.897 0.899 Rabgap1
Rho 0.000 0.000 0.000 0.800 0.806 0.803 Pkp4
Nrl 0.000 0.000 0.000 0.700 0.836 0.768 Pkp4
Rho 0.859 0.000 0.700 0.000 0.000 0.779 Madd
Crx 0.673 0.000 0.821 0.000 0.000 0.747 Madd
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Crx 0.000 0.857 0.667 0.000 0.000 0.762 1110051M20Rik
Nr2e3 0.000 0.000 0.700 0.000 0.791 0.745 1110051M20Rik
Nrl 0.000 0.000 0.800 0.000 0.873 0.836 4932438A13Rik
Rho 0.673 0.000 0.900 0.000 0.879 0.817 4932438A13Rik
Rho 0.000 0.000 0.900 0.700 0.770 0.790 B430110G05Rik
Nrl 0.000 0.000 0.700 0.800 0.755 0.752 B430110G05Rik
Rho 0.000 0.000 0.700 0.700 0.000 0.700 Ahcyl1
Nrl 0.000 0.738 0.000 0.800 0.000 0.769 Ahcyl1
Rho 0.000 0.000 1.000 0.000 0.797 0.899 C230096C10Rik
Nrl 0.000 0.000 0.900 0.000 0.809 0.855 C230096C10Rik
Rho 0.000 0.000 0.900 0.000 0.870 0.885 5730509K17Rik
Nrl 0.000 0.000 0.800 0.000 0.864 0.832 5730509K17Rik
Crx 0.000 0.667 0.000 0.900 0.000 0.783 BC038311
Nrl 0.000 0.738 0.700 0.000 0.000 0.719 BC038311
Crx 0.000 0.714 0.975 0.000 0.000 0.844 E330036I19Rik
Nrl 0.000 0.833 0.000 0.000 0.809 0.821 E330036I19Rik
Neurod1 0.675 0.000 0.000 0.800 0.000 0.738 AU022870
Crx 0.708 0.000 0.718 0.000 0.000 0.713 AU022870
Nrl 0.777 0.000 0.975 0.000 0.727 0.826 Mat2a
Rho 0.842 0.000 0.975 0.000 0.697 0.838 Mat2a
Nrl 0.000 0.000 0.800 0.000 0.909 0.855 Frmd4b
Rho 0.000 0.000 0.900 0.000 0.929 0.915 Frmd4b
Nrl 0.000 0.970 0.718 0.000 0.691 0.793 Suv420h2
Crx 0.000 0.731 0.000 0.900 0.000 0.815 Suv420h2
Nrl 0.000 0.000 0.000 0.800 0.800 0.800 U2af1l4
Rho 0.000 0.000 0.000 0.700 0.702 0.701 U2af1l4
Nrl 0.000 0.000 0.700 0.000 0.745 0.723 Nipa1
Rho 0.000 0.000 0.900 0.000 0.856 0.878 Nipa1
Chx10 0.652 0.000 0.000 1.000 0.000 0.826 Aars
Nrl 0.000 0.810 0.000 0.000 0.809 0.809 Aars
Rb1 0.000 0.738 0.900 0.700 0.000 0.779 Usp3
Neurod1 0.000 0.000 0.700 0.900 0.000 0.800 Usp3
Rho 0.744 0.000 0.000 0.000 0.934 0.839 Camkv
Nrl 0.810 0.000 0.000 0.000 0.855 0.832 Camkv
Nrl 0.000 0.000 0.000 0.700 0.882 0.791 BC023829
Rho 0.000 0.000 0.000 0.800 0.856 0.828 BC023829
Rho 0.000 0.000 0.900 0.000 0.847 0.874 Tmtc3
Nrl 0.000 0.000 1.000 0.000 0.755 0.877 Tmtc3
Rho 0.000 0.000 0.900 0.000 0.815 0.858 Lrrc21
Nrl 0.000 0.000 0.700 0.000 0.736 0.718 Lrrc21
Nrl 0.000 0.000 0.700 0.000 0.845 0.773 D15Bwg0759e
Rho 0.000 0.000 0.900 0.000 0.806 0.853 D15Bwg0759e
Rho 0.000 0.000 1.000 0.000 0.907 0.953 Kcnv2
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Nrl 0.000 0.000 0.900 0.000 0.836 0.868 Kcnv2
Nrl 0.000 0.000 0.700 0.000 0.764 0.732 Plekha6
Rho 0.000 0.000 0.900 0.000 0.715 0.808 Plekha6
Rb1 0.000 0.786 0.900 0.000 0.000 0.843 Impad1
Neurod1 0.000 0.000 0.700 0.700 0.000 0.700 Impad1
Rho 0.000 0.000 0.900 0.800 0.907 0.869 Wdr78
Nrl 0.000 0.810 0.800 0.700 0.873 0.796 Wdr78
Rho 0.758 0.000 0.700 0.000 0.000 0.729 Slc1a7
Crx 0.926 0.000 0.821 0.000 0.000 0.873 Slc1a7
Rho 0.000 0.000 0.900 0.000 0.888 0.894 Rgs9bp
Nrl 0.000 0.000 0.700 0.000 0.845 0.773 Rgs9bp
Rho 0.000 0.000 0.900 0.000 0.890 0.895 BC038479
Nrl 0.000 0.000 0.700 0.000 0.829 0.765 BC038479
Rb1 0.000 0.868 0.000 0.000 0.773 0.820 Vps54
Nrl 0.000 0.000 0.000 0.900 0.973 0.936 Vps54
Nrl 0.000 0.000 0.975 0.000 0.809 0.892 Plekhg3
Rho 0.000 0.000 0.821 0.000 0.907 0.864 Plekhg3
Neurod1 0.000 0.810 0.700 0.000 0.000 0.755 Cyb5r4
Rb1 0.000 0.786 0.900 0.000 0.697 0.794 Cyb5r4
Nrl 0.000 0.000 0.000 0.700 0.818 0.759 Ube2z
Rho 0.000 0.000 0.700 0.800 0.843 0.781 Ube2z
Rho 0.000 0.000 0.900 0.700 0.000 0.800 6330442E10Rik
Nrl 0.000 0.833 0.800 0.800 0.655 0.772 6330442E10Rik
Rho 0.000 0.000 0.700 0.000 0.884 0.792 A830039N20Rik
Nrl 0.757 0.000 0.000 0.000 0.864 0.810 A830039N20Rik
Chx10 0.000 0.755 0.000 0.900 0.000 0.827 Nrip1
Crx 0.000 0.000 0.667 0.900 0.000 0.783 Nrip1
Rho 0.000 0.000 0.900 0.000 0.679 0.789 Nfasc
Nrl 0.000 0.000 1.000 0.000 0.700 0.850 Nfasc
Nrl 0.747 0.000 0.900 0.000 0.936 0.861 Plcl4
Rho 0.000 0.000 0.800 0.000 0.870 0.835 Plcl4
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Aak1
Nrl 0.000 0.810 0.700 0.000 0.000 0.755 Aak1
Rho 0.000 0.000 0.821 0.000 0.847 0.834 Chsy1
Nrl 0.000 0.000 0.667 0.000 0.800 0.733 Chsy1
Nrl 0.000 0.000 0.900 0.000 0.955 0.927 Rp1hl1
Rho 0.000 0.000 1.000 0.000 0.943 0.972 Rp1hl1
Rho 0.000 0.000 0.900 1.000 0.000 0.950 C130065N10Rik
Nrl 0.000 0.810 0.800 0.000 0.000 0.805 C130065N10Rik
Rho 0.000 0.000 0.900 0.000 0.973 0.936 Lrtm1
Nrl 0.000 0.000 0.700 0.000 0.961 0.831 Lrtm1
Nrl 0.000 0.000 0.821 0.000 0.782 0.801 C730048C13Rik
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Rho 0.000 0.000 0.667 0.000 0.856 0.762 C730048C13Rik
Nrl 0.000 0.000 0.700 0.000 0.736 0.718 9630033F20Rik
Rho 0.000 0.000 0.900 0.000 0.733 0.817 9630033F20Rik
Nrl 0.000 0.000 0.900 0.000 0.709 0.805 Sbf2
Rho 0.000 0.000 1.000 0.000 0.770 0.885 Sbf2
Nrl 0.000 0.000 0.700 0.000 0.727 0.714 Hook3
Rho 0.000 0.000 0.900 0.000 0.770 0.835 Hook3
Nrl 0.000 0.000 0.700 0.000 0.864 0.782 6430547I21Rik
Rho 0.000 0.000 0.900 0.000 0.866 0.883 6430547I21Rik
Nrl 0.000 0.000 0.900 0.000 0.873 0.886 B230112C05Rik
Rho 0.000 0.000 1.000 0.000 0.806 0.903 B230112C05Rik
Rho 0.000 0.000 0.700 0.000 0.770 0.735 D530031C13Rik
Nrl 0.000 0.810 0.000 0.000 0.700 0.755 D530031C13Rik
Rho 0.000 0.000 1.000 0.000 0.843 0.921 A530058N18Rik
Nrl 0.000 0.000 0.900 0.000 0.800 0.850 A530058N18Rik
Rb1 0.000 0.833 0.700 0.000 0.000 0.767 AU021838
Crx 0.000 0.000 0.872 0.900 0.000 0.886 AU021838
Nrl 0.000 0.786 0.000 0.000 0.691 0.738 Kctd10
Crx 0.000 0.667 0.821 0.000 0.000 0.744 Kctd10
Rho 0.000 0.000 1.000 0.000 0.788 0.894 Dixdc1
Nrl 0.000 0.000 0.900 0.000 0.709 0.805 Dixdc1
Nrl 0.000 0.000 0.800 0.000 0.773 0.786 G630014P10Rik
Rho 0.000 0.000 0.900 0.000 0.806 0.853 G630014P10Rik
Neurod1 0.725 0.000 0.800 0.000 0.000 0.762 Zranb1
Chx10 0.000 0.000 0.700 0.800 0.000 0.750 Zranb1
Nrl 0.000 0.905 1.000 0.800 0.000 0.902 Nefh
Rho 0.000 0.000 0.900 0.700 0.000 0.800 Nefh
Crx 0.000 0.850 0.821 0.000 0.000 0.836 Tmem106c
Nrl 0.000 0.922 0.000 0.900 0.000 0.911 Tmem106c
Rho 0.000 0.000 0.900 0.000 0.793 0.846 Adcy1
Nrl 0.000 0.000 0.700 0.000 0.736 0.718 Adcy1
Neurod1 0.000 0.000 0.900 0.900 0.000 0.900 2700059D21Rik
Rb1 0.000 0.738 0.800 1.000 0.000 0.846 2700059D21Rik
Crx 0.000 0.000 0.718 0.900 0.000 0.809 AU014645
Rb1 0.000 0.762 0.900 0.000 0.000 0.831 AU014645
Nrl 0.000 0.000 1.000 0.000 0.773 0.886 Zfp213
Rho 0.000 0.000 0.900 0.000 0.720 0.810 Zfp213








Seed gene Gene symbol Gene name
Nrl 0.923 Arr3 arrestin 3, retinal
Rho 0.994 Arr3 arrestin 3, retinal
Crx 0.727 Aipl1 aryl hydrocarbon receptor-interacting protein-like 1
Rho 0.890 Aipl1 aryl hydrocarbon receptor-interacting protein-like 1
Nr2e3 0.687 Aipl1 aryl hydrocarbon receptor-interacting protein-like 1
Nrl 0.838 Aipl1 aryl hydrocarbon receptor-interacting protein-like 1
Rho 0.889 Abca4 ATP-binding cassette, sub-family A (ABC1), member 4
Crx 0.679 Abca4 ATP-binding cassette, sub-family A (ABC1), member 4
Nrl 0.921 Abca4 ATP-binding cassette, sub-family A (ABC1), member 4
Nrl 0.836 Bbs2 Bardet-Biedl syndrome 2 homolog (human)
Rho 0.823 Bbs2 Bardet-Biedl syndrome 2 homolog (human)
Crx 0.794 Bbs2 Bardet-Biedl syndrome 2 homolog (human)
Nrl 0.937 Cacna1f calcium channel, voltage-dependent, alpha 1F subunit
Crx 0.811 Cacna1f calcium channel, voltage-dependent, alpha 1F subunit
Nr2e3 0.804 Cacna1f calcium channel, voltage-dependent, alpha 1F subunit
Rho 0.931 Cacna1f calcium channel, voltage-dependent, alpha 1F subunit
Rho 0.962 Crb1 crumbs homolog 1 (Drosophila)
Nrl 0.923 Crb1 crumbs homolog 1 (Drosophila)
Rho 0.942 Cnga1 cyclic nucleotide gated channel alpha 1
Crx 0.780 Cnga1 cyclic nucleotide gated channel alpha 1
Nrl 0.892 Cnga1 cyclic nucleotide gated channel alpha 1
Rho 0.750 Gabrr2 gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2
Nrl 0.695 Gabrr2 gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2
Crx 0.810 Gja9 gap junction membrane channel protein alpha 9
Nrl 0.890 Gja9 gap junction membrane channel protein alpha 9
Nrl 0.799 Gnat1 guanine nucleotide binding protein, alpha transducing 1
Rho 0.837 Gnat1 guanine nucleotide binding protein, alpha transducing 1
Crx 0.735 Gnat1 guanine nucleotide binding protein, alpha transducing 1
Rho 0.926 Gnat2 guanine nucleotide binding protein, alpha transducing 2
Nrl 0.913 Gnat2 guanine nucleotide binding protein, alpha transducing 2
Rho 0.789 Guca1a guanylate cyclase activator 1a (retina)
Nrl 0.815 Guca1a guanylate cyclase activator 1a (retina)
Nrl 0.691 Guca1b guanylate cyclase activator 1B
Rho 0.817 Guca1b guanylate cyclase activator 1B
Crx 0.931 Pdc phosducin
Rho 0.841 Pdc phosducin
Nrl 0.882 Pdc phosducin
Nr2e3 0.823 Pdc phosducin
Rho 0.875 Pde6a phosphodiesterase 6A, cGMP-specific, rod, alpha
Crx 0.709 Pde6a phosphodiesterase 6A, cGMP-specific, rod, alpha
Nrl 0.761 Pde6a phosphodiesterase 6A, cGMP-specific, rod, alpha
Nrl 0.914 Pde6b phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide
Nr2e3 0.849 Pde6b phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide
Rho 0.925 Pde6b phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide
Nrl 0.896 Pde6g phosphodiesterase 6G, cGMP-specific, rod, gamma






Supplementary Table 2 continued
Seed gene Gene symbol Gene name
Rho 0.943 Pde6g phosphodiesterase 6G, cGMP-specific, rod, gamma
Nr2e3 0.804 Pde6g phosphodiesterase 6G, cGMP-specific, rod, gamma
Crx 0.883 Ppef2 protein phosphatase, EF hand calcium-binding domain 2
Rho 0.728 Ppef2 protein phosphatase, EF hand calcium-binding domain 2
Nrl 0.862 Ppef2 protein phosphatase, EF hand calcium-binding domain 2
Nr2e3 0.797 Pcdh21 protocadherin 21
Rho 0.803 Pcdh21 protocadherin 21
Nrl 0.838 Pcdh21 protocadherin 21
Nr2e3 0.799 Rcvrn recoverin
Nrl 0.906 Rcvrn recoverin
Rho 0.898 Rcvrn recoverin
Crx 0.775 Rcvrn recoverin
Rho 0.894 Rgs9bp regulator of G-protein signalling 9 binding protein
Nrl 0.773 Rgs9bp regulator of G-protein signalling 9 binding protein
Rho 0.878 Rds retinal degeneration, slow (retinitis pigmentosa 7)
Nrl 0.917 Rds retinal degeneration, slow (retinitis pigmentosa 7)
Nrl 0.901 Sag retinal S-antigen
Nr2e3 0.862 Sag retinal S-antigen
Rho 0.897 Sag retinal S-antigen
Rho 0.840 Rlbp1 retinaldehyde binding protein 1
Nrl 0.866 Rlbp1 retinaldehyde binding protein 1
Nr2e3 0.786 Rlbp1 retinaldehyde binding protein 1
Rho 0.832 Rp1h retinitis pigmentosa 1 homolog (human)
Nr2e3 0.892 Rp1h retinitis pigmentosa 1 homolog (human)
Nrl 0.975 Rp1h retinitis pigmentosa 1 homolog (human)
Nrl 0.927 Rp1hl1 retinitis pigmentosa 1 homolog (human)-like 1
Rho 0.972 Rp1hl1 retinitis pigmentosa 1 homolog (human)-like 1
Crx 0.786 Rpgrip1 retinitis pigmentosa GTPase regulator interacting protein 1
Nr2e3 0.834 Rpgrip1 retinitis pigmentosa GTPase regulator interacting protein 1
Rho 0.977 Rpgrip1 retinitis pigmentosa GTPase regulator interacting protein 1
Nrl 0.891 Rpgrip1 retinitis pigmentosa GTPase regulator interacting protein 1
Crx 0.786 Rbp3 retinol binding protein 3, interstitial
Rho 0.871 Rbp3 retinol binding protein 3, interstitial
Nrl 0.828 Rbp3 retinol binding protein 3, interstitial
Crx 0.746 Rdh12 retinol dehydrogenase 12
Nr2e3 0.799 Rdh12 retinol dehydrogenase 12
Rho 0.951 Rdh12 retinol dehydrogenase 12
Nrl 0.901 Rdh12 retinol dehydrogenase 12
Rho 0.950 Rom1 rod outer segment membrane protein 1
Crx 0.821 Rom1 rod outer segment membrane protein 1
Nrl 0.931 Rom1 rod outer segment membrane protein 1
Nr2e3 0.839 Rom1 rod outer segment membrane protein 1
Rho 0.861 Slc24a1 solute carrier family 24 (sodium/potassium/calcium exchanger), member 1
Nrl 0.814 Slc24a1 solute carrier family 24 (sodium/potassium/calcium exchanger), member 1
Nrl 0.859 Tub tubby candidate gene






Supplementary Table 2 continued
Seed gene Gene symbol Gene name
Crx 0.750 Tub tubby candidate gene
Crx 0.901 Tulp1 tubby like protein 1
Nrl 0.903 Tulp1 tubby like protein 1
Rho 0.901 Tulp1 tubby like protein 1
Rho 0.899 Unc119 unc-119 homolog (C. elegans)
Nrl 0.823 Unc119 unc-119 homolog (C. elegans)
Crx 0.794 Unc119 unc-119 homolog (C. elegans)
Nr2e3 0.700 Unc119 unc-119 homolog (C. elegans)
Mean cor
 
